{"meta":{"query_hash":"f9114deedd5b","filters":{"venue":"Nature Reviews Clinical Oncology"},"cohort_total":128,"direct_labels_cover":0,"predictions_cover":128,"exported":128,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f9114deedd5b","api":"https://metacan.xera.ac/api/v1/cohort?venue=Nature+Reviews+Clinical+Oncology"},"results":[{"id":"W1275532855","doi":"10.1038/nrclinonc.2015.146","title":"HPV-FASTER: broadening the scope for prevention of HPV-related cancer","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":210,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Ottawa Mental Health Centre","funders":"Sanofi Pasteur; European Commission; World Health Organization; Cancer Research UK; GlaxoSmithKline","keywords":"Medicine; Scope (computer science); Oncology; MEDLINE; HPV vaccines; Internal medicine; Virology; Cervical cancer; Cancer; HPV infection","score_opus":0.40482748180218875,"score_gpt":0.6393141744777583,"score_spread":0.23448669267556954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1275532855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040218703,0.9989661,0.000043841905,0.00045128053,0.00016325884,0.0000024862088,0.0000128047,0.0000037597995,0.00031628425],"genre_scores_gemma":[0.0005218912,0.9986313,0.00009275319,0.00040986942,0.00014566445,0.0000031652069,0.0000146825305,0.000001162118,0.0001794316],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995122,0.0001226685,0.00007701182,0.00008213242,0.00015478944,0.00005124172],"domain_scores_gemma":[0.99869484,0.0008373699,0.00016107151,0.000035019184,0.00020456483,0.000067179884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014530503,0.00078235776,0.0022137444,0.0024317745,0.00028293685,0.0013545692,0.0011221034,0.0017873266,0.0074373186],"category_scores_gemma":[0.002565994,0.00035576778,0.0011840019,0.001840843,0.00061620143,0.0024771506,0.0011869469,0.0027046609,0.0016269169],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008641062,0.000048278845,0.0002983736,0.037465237,0.00019799781,0.00009887385,0.00006715805,0.00021941414,0.00078680355,0.0054515493,0.021362487,0.93391734],"study_design_scores_gemma":[0.000042776217,0.00013868288,0.0014206442,0.026788449,0.00051073055,0.0007919807,0.0001428524,0.00010191078,0.00039778752,0.0040111234,0.9656223,0.000030721414],"about_ca_topic_score_codex":0.002253931,"about_ca_topic_score_gemma":0.004201659,"teacher_disagreement_score":0.0074373186,"about_ca_system_score_codex":0.0009699631,"about_ca_system_score_gemma":0.001966814,"threshold_uncertainty_score":0.02488029},"labels":[],"label_agreement":null},{"id":"W1556819620","doi":"10.1038/nrclinonc.2015.89","title":"Rationale for metronomic chemotherapy in phase III trials","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Capecitabine; Bevacizumab; Chemotherapy; Oncology; Internal medicine; Colorectal cancer; Maximum tolerated dose; Cancer","score_opus":0.48883996569624805,"score_gpt":0.645525693405134,"score_spread":0.15668572770888595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1556819620","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003119987,0.9768828,0.0029348696,0.013807834,0.0019697612,0.00065172854,0.00036802492,0.000048494512,0.0030245434],"genre_scores_gemma":[0.019036144,0.87724894,0.023684442,0.06676449,0.0050344057,0.0039623934,0.00051407964,0.00008024578,0.003674848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9864509,0.0073468434,0.0030706523,0.0011421697,0.0016837969,0.00030559007],"domain_scores_gemma":[0.9664147,0.026826378,0.003562772,0.0006653339,0.0019218264,0.00060899206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030684948,0.0014502855,0.0057231495,0.0019999852,0.00060835504,0.0041076737,0.0029367357,0.0045487,0.0064530564],"category_scores_gemma":[0.040738724,0.0011046781,0.0038895297,0.0019463662,0.0025862162,0.0029543443,0.0018578043,0.012429589,0.0018021205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040815724,0.00015334775,0.00062152976,0.10386404,0.002489019,0.00019618732,0.00020328937,0.0012399378,0.0016253584,0.039442744,0.056594133,0.7894887],"study_design_scores_gemma":[0.009107976,0.0018222963,0.0026169268,0.15015562,0.008309436,0.00091629155,0.00010720223,0.001102554,0.001503325,0.042477015,0.78171355,0.00016794738],"about_ca_topic_score_codex":0.0009980148,"about_ca_topic_score_gemma":0.0028818126,"teacher_disagreement_score":0.030684948,"about_ca_system_score_codex":0.00376278,"about_ca_system_score_gemma":0.006396468,"threshold_uncertainty_score":0.16227943},"labels":[],"label_agreement":null},{"id":"W1968260891","doi":"10.1038/nrclinonc.2013.87","title":"Maintenance therapy in breast cancer—many questions remain","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canada Research Chairs","keywords":"Medicine; Breast cancer; Oncology; Chemotherapy; Internal medicine; Clinical trial; Disease; Maintenance therapy; Cancer","score_opus":0.19734653868178328,"score_gpt":0.5794666941963679,"score_spread":0.38212015551458456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968260891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009687073,0.99787474,0.00010012261,0.0010848325,0.0002654725,0.000003846846,0.000024704215,0.000006081016,0.0005433612],"genre_scores_gemma":[0.0011355365,0.99633527,0.00021738643,0.0012739716,0.00046067318,0.000008850586,0.000031187803,0.0000024585067,0.00053456303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978894,0.000061418345,0.00004194723,0.0000393847,0.000049824735,0.00001846026],"domain_scores_gemma":[0.99939907,0.00036393036,0.00009089759,0.000021065916,0.00009342378,0.000031573032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011690786,0.0005404581,0.0017853243,0.0008190282,0.00021373935,0.0011305969,0.00093637477,0.0009778333,0.0052568964],"category_scores_gemma":[0.001557938,0.00022975015,0.0005547162,0.0012046689,0.0006267196,0.0019115073,0.0006188308,0.0025539887,0.0018964335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015835781,0.000059987367,0.00015999864,0.011165169,0.0001029833,0.00006368277,0.000032689266,0.00020289767,0.0006277207,0.0024378367,0.03646625,0.9485224],"study_design_scores_gemma":[0.000117948235,0.0002416808,0.0011059609,0.0073867273,0.00030852217,0.0005447446,0.00006343103,0.00013502265,0.00026861092,0.0027204289,0.9870861,0.0000208529],"about_ca_topic_score_codex":0.00094928994,"about_ca_topic_score_gemma":0.0032048938,"teacher_disagreement_score":0.0052568964,"about_ca_system_score_codex":0.00059202255,"about_ca_system_score_gemma":0.0011707001,"threshold_uncertainty_score":0.017586052},"labels":[],"label_agreement":null},{"id":"W1972098018","doi":"10.1038/nrclinonc.2012.102","title":"Breast cancer in young women","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":249,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Cancer; Young adult; Oncology; Internal medicine; Male breast cancer; Gynecology","score_opus":0.17904000779884738,"score_gpt":0.5603095753350166,"score_spread":0.3812695675361692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972098018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010651699,0.9991472,0.000018048415,0.00018139309,0.00010820192,0.0000026455414,0.000015790296,0.0000017063363,0.00041856428],"genre_scores_gemma":[0.0008261898,0.9985251,0.000035658686,0.00026862108,0.00010743065,0.0000040093873,0.0000149506795,4.3574627e-7,0.00021770784],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980396,0.000045592373,0.000037274738,0.00003268676,0.00006063862,0.000019801146],"domain_scores_gemma":[0.9995216,0.00028399462,0.000107348205,0.000009734625,0.00005217105,0.000025163205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005038017,0.00064900203,0.001352387,0.0017110369,0.0001773691,0.0006911772,0.00034315538,0.00075364,0.0037213531],"category_scores_gemma":[0.0014308324,0.00028949272,0.0005548325,0.0019230216,0.00029665206,0.0006685755,0.0006317619,0.000780437,0.0007167052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009830155,0.000030181434,0.00084075605,0.036004223,0.00019670898,0.00014703865,0.000054761393,0.00011774024,0.00032664443,0.0005948195,0.020525927,0.94106275],"study_design_scores_gemma":[0.00010899198,0.00022226604,0.009511538,0.05896065,0.0018819441,0.0032324207,0.00023547455,0.000088874236,0.0003822326,0.0013152191,0.92402446,0.000035985642],"about_ca_topic_score_codex":0.002748882,"about_ca_topic_score_gemma":0.0078001777,"teacher_disagreement_score":0.0037213531,"about_ca_system_score_codex":0.00054968346,"about_ca_system_score_gemma":0.0013697775,"threshold_uncertainty_score":0.012449205},"labels":[],"label_agreement":null},{"id":"W1973767788","doi":"10.1038/nrclinonc.2012.209","title":"Understanding the mechanisms and treatment options in cancer cachexia","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":941,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cachexia; Medicine; Anorexia; Wasting; Weight loss; Cancer; Quality of life (healthcare); Palliative care; Wasting Syndrome; Systemic inflammation; Intensive care medicine; Bioinformatics; Inflammation; Internal medicine; Oncology; Obesity","score_opus":0.766349811132346,"score_gpt":0.6383445516646545,"score_spread":0.12800525946769148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973767788","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035434456,0.9992267,0.00005160922,0.0003095901,0.00012193525,0.000002027315,0.000007749829,0.0000024945246,0.00024251202],"genre_scores_gemma":[0.0002443223,0.99915254,0.0000904421,0.0001935923,0.00015683266,0.0000031630013,0.0000110873025,4.5809352e-7,0.00014747317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973494,0.00005913868,0.000036833928,0.00003860295,0.00010196997,0.000028527102],"domain_scores_gemma":[0.9994479,0.00028951935,0.00008792313,0.000014221084,0.00012272636,0.000037675312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010050217,0.0011167678,0.002436575,0.001955397,0.0003434509,0.001484598,0.0011348169,0.0018026017,0.0031818815],"category_scores_gemma":[0.0013248344,0.00039276938,0.00067117455,0.0025438913,0.00082132913,0.002008662,0.001169165,0.0030227653,0.0014691848],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012849254,0.00008549014,0.00020658184,0.01785059,0.00013983854,0.00015559657,0.00004940001,0.0004116536,0.0010979183,0.0037145321,0.033142123,0.9430178],"study_design_scores_gemma":[0.00006140001,0.0001396049,0.001295256,0.0082547255,0.00030195984,0.0010087036,0.00010539197,0.00019798685,0.0003587514,0.004121131,0.98412055,0.00003462246],"about_ca_topic_score_codex":0.0017514137,"about_ca_topic_score_gemma":0.004154953,"teacher_disagreement_score":0.0031818815,"about_ca_system_score_codex":0.000855191,"about_ca_system_score_gemma":0.0014884355,"threshold_uncertainty_score":0.010644436},"labels":[],"label_agreement":null},{"id":"W1975769848","doi":"10.1038/nrclinonc.2011.75","title":"The role of local therapy in the management of lung and liver oligometastases","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ablative case; Radiation therapy; Systemic therapy; Radiofrequency ablation; Metastasis; Lung cancer; Oncology; Lung; Ablation Therapy; Radiology; Cancer; Ablation; Internal medicine; Breast cancer; Prostate cancer","score_opus":0.17468940798963412,"score_gpt":0.5128772309702628,"score_spread":0.3381878229806287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975769848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057438792,0.99936885,0.00006438959,0.00018946172,0.00006768944,0.0000012980263,0.0000041605226,0.0000022801546,0.00024449892],"genre_scores_gemma":[0.00066709565,0.99865353,0.00013206848,0.00022050233,0.00016636819,0.0000024253382,0.000011567905,0.0000010481228,0.00014544878],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973434,0.00006287512,0.000037632206,0.000046798898,0.0000937691,0.00002452268],"domain_scores_gemma":[0.99916756,0.0005193967,0.000118835815,0.00001747569,0.00013096258,0.000045657696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095914636,0.0007347007,0.0020934867,0.0017484099,0.00024291093,0.0010760732,0.0010398766,0.0010431961,0.0022667234],"category_scores_gemma":[0.0012760577,0.00026290122,0.0006299948,0.0017789563,0.000826099,0.0013691324,0.000731807,0.002161064,0.0010423368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006582284,0.00003478495,0.00022836328,0.009578843,0.00007761338,0.0003034728,0.000032374905,0.00043835337,0.0008322128,0.0014304832,0.014658363,0.9723192],"study_design_scores_gemma":[0.000076241224,0.0002282884,0.002551534,0.009690887,0.0003655843,0.005417611,0.00011661754,0.00028511186,0.0006596873,0.0026325597,0.97793055,0.000045316585],"about_ca_topic_score_codex":0.0015653638,"about_ca_topic_score_gemma":0.0042913547,"teacher_disagreement_score":0.0022667234,"about_ca_system_score_codex":0.00070292334,"about_ca_system_score_gemma":0.0009908321,"threshold_uncertainty_score":0.0075829625},"labels":[],"label_agreement":null},{"id":"W1978293462","doi":"10.1038/nrclinonc.2014.126","title":"Vessel calibre—a potential MRI biomarker of tumour response in clinical trials","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"MRI in cancer diagnosis","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Research Resources; National Institute of Neurological Disorders and Stroke; National Cancer Institute; Cancer Research Society; Suomen Lääketieteen Säätiö; Massachusetts Institute of Technology; American Association for Cancer Research","keywords":"Medicine; Clinical trial; Biomarker; Angiogenesis; In vivo; Imaging biomarker; Radiology; Magnetic resonance imaging; Medical physics; Pathology; Internal medicine","score_opus":0.3696068064717427,"score_gpt":0.6259125676573805,"score_spread":0.25630576118563775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978293462","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015356907,0.9988217,0.00016329612,0.0003435891,0.0001258282,0.0000066277557,0.000019347957,0.000005003732,0.0003609822],"genre_scores_gemma":[0.0042408262,0.99363166,0.000604892,0.00066825276,0.00045470143,0.000030965282,0.000048099766,0.000002850495,0.0003178296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994143,0.00017954524,0.000095160896,0.00009793699,0.00017811335,0.00003488682],"domain_scores_gemma":[0.9967752,0.0024035475,0.00043055197,0.000043573044,0.00028392227,0.000063304455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023475918,0.000887942,0.0031522317,0.0019289475,0.0001649583,0.0015054926,0.0009379047,0.0014614001,0.0021602272],"category_scores_gemma":[0.0049969424,0.00041906323,0.0008994833,0.0018329831,0.00071769144,0.0013146619,0.000600056,0.0019035258,0.000791839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031578352,0.000052892137,0.0011076682,0.020610712,0.00044812387,0.00011720183,0.000033429897,0.0005122721,0.0010964283,0.0025520439,0.017399553,0.9557539],"study_design_scores_gemma":[0.0005852177,0.0012431763,0.010763972,0.038861305,0.004644555,0.0028694167,0.00018781231,0.001914252,0.0031273484,0.010040773,0.9256097,0.00015246784],"about_ca_topic_score_codex":0.0011163482,"about_ca_topic_score_gemma":0.0022679523,"teacher_disagreement_score":0.0031522317,"about_ca_system_score_codex":0.0007879208,"about_ca_system_score_gemma":0.0011712773,"threshold_uncertainty_score":0.012415409},"labels":[],"label_agreement":null},{"id":"W1980246989","doi":"10.1038/nrclinonc.2009.116","title":"Breast cancer in a BRCA2 mutation carrier with a history of prostate cancer","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Male Breast Health Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; University of Toronto","funders":"University of Toronto","keywords":"Medicine; Breast cancer; Gynecomastia; Prostate cancer; Oncology; Internal medicine; Hormonal therapy; BRCA mutation; Cancer; Family history; Male breast cancer; Androgen deprivation therapy; Radiation therapy; Gynecology","score_opus":0.11593446981234697,"score_gpt":0.524147513450953,"score_spread":0.40821304363860605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980246989","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041724902,0.9987741,0.000019082796,0.00018268758,0.00007175741,0.0000013651269,0.000017912836,0.0000013377312,0.00051453186],"genre_scores_gemma":[0.0039602607,0.99522275,0.00006960838,0.00036743574,0.00011606924,0.000001991699,0.000028863777,7.722851e-7,0.00023213486],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99974877,0.0000748166,0.000041087627,0.00004547396,0.00007432676,0.000015464242],"domain_scores_gemma":[0.9991472,0.0005955847,0.00014348295,0.000015802018,0.000071605275,0.000026307538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005108601,0.00034938566,0.0014371722,0.0020880767,0.00016351412,0.0006207092,0.0004896979,0.00093515194,0.002326454],"category_scores_gemma":[0.0021034412,0.00018817939,0.00051045424,0.002108936,0.00034047593,0.0004977557,0.00031450484,0.0005382351,0.00041793342],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027577963,0.000041192725,0.006458444,0.05054195,0.0008182879,0.003934585,0.00012641294,0.0001236591,0.0014356689,0.0010746574,0.03598984,0.8991796],"study_design_scores_gemma":[0.00018164831,0.00041474844,0.059781335,0.08255068,0.008136042,0.065962106,0.0009100276,0.00016183013,0.0016286616,0.0017565397,0.77841884,0.00009752372],"about_ca_topic_score_codex":0.0030318047,"about_ca_topic_score_gemma":0.007522003,"teacher_disagreement_score":0.0030318047,"about_ca_system_score_codex":0.0003444901,"about_ca_system_score_gemma":0.00066305214,"threshold_uncertainty_score":0.0077827573},"labels":[],"label_agreement":null},{"id":"W1982291583","doi":"10.1038/nrclinonc.2013.158","title":"Drug rechallenge and treatment beyond progression—implications for drug resistance","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":281,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Drug resistance; Disease; Drug; Intensive care medicine; Cancer; Chemotherapy; Pharmacotherapy; Oncology; Internal medicine; Pharmacology; Biology","score_opus":0.19520676732876532,"score_gpt":0.5925349983358467,"score_spread":0.39732823100708137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982291583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011318425,0.99814403,0.00011416023,0.0006834401,0.00014895905,0.0000021452577,0.000015227679,0.0000069074645,0.0007719383],"genre_scores_gemma":[0.0019999736,0.99570423,0.0002319384,0.00095875305,0.00030568166,0.000006839853,0.000031517742,0.000002740625,0.00075836165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997378,0.000053223317,0.000033979537,0.00005398083,0.0000922355,0.000028764447],"domain_scores_gemma":[0.99946386,0.00033667957,0.00007468965,0.000014722616,0.00007860652,0.00003140612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007513046,0.0005958555,0.0016169446,0.0010732159,0.00021319446,0.0011018636,0.0008633548,0.0014398271,0.0036403688],"category_scores_gemma":[0.0010973315,0.00025204514,0.0006622848,0.0010169448,0.0006302308,0.0013238506,0.0005542651,0.0026777976,0.0013422602],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089055175,0.0000451826,0.00024528755,0.005302505,0.00011245171,0.00017139007,0.000030533676,0.00042429383,0.0013902059,0.0042453534,0.03802941,0.94991434],"study_design_scores_gemma":[0.000052560477,0.00014799366,0.0011719008,0.0033183356,0.00019076717,0.0016018763,0.000046661757,0.00024448358,0.00053539715,0.00451103,0.98815376,0.000025253546],"about_ca_topic_score_codex":0.001067676,"about_ca_topic_score_gemma":0.003617321,"teacher_disagreement_score":0.0036403688,"about_ca_system_score_codex":0.0008860915,"about_ca_system_score_gemma":0.0009578345,"threshold_uncertainty_score":0.012178302},"labels":[],"label_agreement":null},{"id":"W1983138070","doi":"10.1038/nrclinonc.2013.88","title":"Secobarbital in Seattle—why lose sleep?","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"Canada Research Chairs","keywords":"Medicine; Alliance; Secobarbital; New england; Sleep (system call); Psychiatry; Family medicine; Gerontology; Internal medicine","score_opus":0.5067369171827889,"score_gpt":0.6360649559348964,"score_spread":0.12932803875210752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983138070","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018062895,0.99774975,0.000029561594,0.0012118977,0.0002624394,0.0000025485692,0.000015734444,0.0000036541887,0.00054383685],"genre_scores_gemma":[0.0016974336,0.9962838,0.000067148336,0.0012273099,0.00033310003,0.0000046696764,0.00001972189,0.0000012551793,0.00036560494],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997955,0.000060643888,0.00005535492,0.000030313427,0.00004063459,0.000017675495],"domain_scores_gemma":[0.9994598,0.00026165857,0.00016621803,0.000009543747,0.000063878,0.000038916973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056116225,0.0005362242,0.0011735483,0.00094061,0.00022030514,0.0007314329,0.00049083563,0.0013476092,0.0024050314],"category_scores_gemma":[0.001587457,0.00023307296,0.0005672259,0.0011377193,0.0005523744,0.0010330889,0.0005323153,0.001984365,0.0007094645],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024432226,0.000042350846,0.0009021381,0.014115517,0.00019407456,0.00035790095,0.0000649976,0.0001277678,0.00038559103,0.0016009671,0.05387129,0.9280931],"study_design_scores_gemma":[0.00020010753,0.00035404833,0.007335933,0.02452151,0.00082429737,0.004299253,0.00028880572,0.00016113861,0.0004594923,0.0020179288,0.9594913,0.00004619856],"about_ca_topic_score_codex":0.002834827,"about_ca_topic_score_gemma":0.0118333325,"teacher_disagreement_score":0.002834827,"about_ca_system_score_codex":0.00063703244,"about_ca_system_score_gemma":0.0015131105,"threshold_uncertainty_score":0.008045614},"labels":[],"label_agreement":null},{"id":"W1984628012","doi":"10.1038/ncponc1323","title":"Effect of bisphosphonates on pain and quality of life in patients with bone metastases","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":171,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"Novartis Pharmaceuticals Corporation","keywords":"Medicine; Spinal cord compression; Bone pain; Zoledronic acid; Bone resorption; Bone remodeling; Bisphosphonate; Palliative care; Osteolysis; Bone Density Conservation Agents; Prostate cancer; Bone metastasis; Pathologic fracture; Osteoporosis; Oncology; Surgery; Internal medicine; Cancer; Bone density; Spinal cord","score_opus":0.10682037539149301,"score_gpt":0.5208671530690386,"score_spread":0.4140467776775456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984628012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036612866,0.9990872,0.000032794353,0.00009883272,0.000051690822,0.0000036299887,0.000025603384,0.0000022145198,0.00033199522],"genre_scores_gemma":[0.0036924584,0.9956689,0.00010703513,0.00020913775,0.00008740844,0.0000065737136,0.000038232232,6.6028264e-7,0.00018959686],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997204,0.000060567436,0.00005336602,0.000035663055,0.00010912009,0.000020814161],"domain_scores_gemma":[0.99956936,0.00026651798,0.000092808456,0.0000060212838,0.000050979288,0.000014290113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005492527,0.0005780802,0.0022956817,0.00096417224,0.00011489589,0.00046340373,0.0006535863,0.0006460626,0.0025526844],"category_scores_gemma":[0.0010719738,0.00020877061,0.0010729413,0.0014663,0.00022939469,0.00031535933,0.0002901921,0.0009189638,0.00046036713],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069161085,0.00013290634,0.0009887547,0.04034913,0.0013202174,0.00016526444,0.000034330613,0.00031468936,0.0011116148,0.0004296075,0.009919906,0.944542],"study_design_scores_gemma":[0.0027575593,0.003689707,0.07361448,0.056467094,0.018714733,0.0073646423,0.00041765557,0.0009676759,0.00244953,0.0028430186,0.8305457,0.00016820128],"about_ca_topic_score_codex":0.0020502557,"about_ca_topic_score_gemma":0.006058825,"teacher_disagreement_score":0.0025526844,"about_ca_system_score_codex":0.00032872244,"about_ca_system_score_gemma":0.0006226108,"threshold_uncertainty_score":0.008539617},"labels":[],"label_agreement":null},{"id":"W1991900845","doi":"10.1038/nrclinonc.2014.3","title":"Bilateral breast cancers","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Breast cancer; Medicine; Mastectomy; Cancer; Oncology; Prophylactic Mastectomy; Internal medicine; Gynecology; Surgery","score_opus":0.08416437266293572,"score_gpt":0.5034406087044148,"score_spread":0.419276236041479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991900845","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048878556,0.98632485,0.0007202558,0.0010302596,0.0009237825,0.000010513753,0.000067503766,0.000045505807,0.010388684],"genre_scores_gemma":[0.0075688935,0.9800923,0.0007087816,0.0019890124,0.0013616241,0.000012729957,0.00019364782,0.000010375244,0.008062667],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99985385,0.000020498404,0.000011878624,0.00003109424,0.00005769016,0.0000249768],"domain_scores_gemma":[0.99986637,0.00005166482,0.000019615367,0.000009141186,0.00002719353,0.000026015323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025166958,0.00053932925,0.00076346437,0.0013719297,0.00021192718,0.00069465826,0.0005365691,0.0008168334,0.0078287],"category_scores_gemma":[0.0006990327,0.00022096865,0.00030804542,0.0008395395,0.00040956552,0.0006486109,0.00067695125,0.0013474307,0.0032286982],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003983885,0.000020327463,0.00037144803,0.0021282756,0.000034303266,0.0012512596,0.000017020911,0.00020344542,0.0013128498,0.002410414,0.07150527,0.92070544],"study_design_scores_gemma":[0.000018994697,0.000025129832,0.0012360009,0.0017394382,0.00007092654,0.019682817,0.000036676214,0.000098389144,0.00062545703,0.0016461281,0.9748069,0.0000131928755],"about_ca_topic_score_codex":0.00088913017,"about_ca_topic_score_gemma":0.002882724,"teacher_disagreement_score":0.0078287,"about_ca_system_score_codex":0.0004614932,"about_ca_system_score_gemma":0.00058397185,"threshold_uncertainty_score":0.026189625},"labels":[],"label_agreement":null},{"id":"W1996301092","doi":"10.1038/nrclinonc.2009.90","title":"Eleven years disease-free: role of chemotherapy in metastatic BRCA2-related breast cancer","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"University of California, Irvine","keywords":"Medicine; Breast cancer; Oncology; Tamoxifen; Context (archaeology); Internal medicine; Chemotherapy; Anthracycline; Radiation therapy; Cancer; Surgery","score_opus":0.0449411934382233,"score_gpt":0.45789371921362554,"score_spread":0.41295252577540226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996301092","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008472805,0.99891686,0.000059999995,0.00036290017,0.00016786142,0.0000014983606,0.000011441374,0.0000035569997,0.0003911422],"genre_scores_gemma":[0.0009767676,0.99782455,0.0001068877,0.00041612904,0.00024104153,0.0000040758837,0.000027593134,0.000001480195,0.00040154782],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998115,0.000045421464,0.00002401621,0.00003142783,0.00006764435,0.000019931853],"domain_scores_gemma":[0.9995326,0.00028998216,0.000059823164,0.000013590028,0.000073874355,0.000030164112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081428594,0.00069670856,0.002024842,0.0010098068,0.00020852809,0.0007350403,0.0011000774,0.0013171629,0.0021917515],"category_scores_gemma":[0.001225798,0.00024197338,0.0004734755,0.0012947472,0.0005188613,0.0008842693,0.0005047431,0.0022191026,0.0010736765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016680676,0.00004563406,0.00026448106,0.005919563,0.0000937915,0.00020538882,0.000032258973,0.00046899868,0.0007074048,0.0024177544,0.045993667,0.9436843],"study_design_scores_gemma":[0.00008724993,0.0001903999,0.0019538074,0.003878161,0.00024055285,0.0023610462,0.00004926172,0.00017455439,0.00035750473,0.0021832057,0.98850083,0.0000233616],"about_ca_topic_score_codex":0.0013140974,"about_ca_topic_score_gemma":0.0036894984,"teacher_disagreement_score":0.0021917515,"about_ca_system_score_codex":0.0007828525,"about_ca_system_score_gemma":0.0008001758,"threshold_uncertainty_score":0.007332146},"labels":[],"label_agreement":null},{"id":"W1998048991","doi":"10.1038/nrclinonc.2010.194","title":"Preclinical development of molecular-targeted agents for cancer","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cancer; Drug development; Computational biology; Clinical trial; Pharmacology; Bioinformatics; Drug; Internal medicine; Biology","score_opus":0.23838387864681165,"score_gpt":0.5689647708044061,"score_spread":0.33058089215759445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998048991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011028834,0.9904455,0.0020073347,0.0006448249,0.00044109827,0.00007770684,0.00010566205,0.00005496505,0.005120034],"genre_scores_gemma":[0.0044925404,0.9907259,0.001492692,0.0005244741,0.00019012093,0.00005306499,0.00022428184,0.000009149681,0.0022878961],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977356,0.000045020875,0.000018352564,0.0000386836,0.00008797636,0.0000364611],"domain_scores_gemma":[0.9996705,0.00012824812,0.000052098374,0.000018291144,0.00008887352,0.000041953663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013352437,0.0017723182,0.0014841775,0.0016462604,0.000300776,0.0011755107,0.0014702603,0.0012484881,0.003926798],"category_scores_gemma":[0.0009208395,0.0005162883,0.00057988055,0.001039012,0.00067448197,0.0015987471,0.0007253658,0.0029815002,0.002765984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003016227,0.0004440379,0.00017057975,0.007908195,0.00010183626,0.00023833665,0.00005163203,0.0015605781,0.02526714,0.005317759,0.035759505,0.92287886],"study_design_scores_gemma":[0.0001907689,0.0005867181,0.0006287073,0.0012105269,0.00015425675,0.000892762,0.000029473396,0.0003534102,0.0105948225,0.0022177529,0.98311317,0.000027664308],"about_ca_topic_score_codex":0.0010838711,"about_ca_topic_score_gemma":0.002582246,"teacher_disagreement_score":0.003926798,"about_ca_system_score_codex":0.0009748302,"about_ca_system_score_gemma":0.0012486676,"threshold_uncertainty_score":0.013136387},"labels":[],"label_agreement":null},{"id":"W2000110198","doi":"10.1038/nrclinonc.2010.21","title":"mTOR signaling and drug development in cancer","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"PI3K/AKT/mTOR signaling in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":415,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Drug development; Discovery and development of mTOR inhibitors; Drug; PI3K/AKT/mTOR pathway; Cancer drugs; Cancer; Oncology; Cancer research; Pharmacology; Internal medicine; Signal transduction; Genetics","score_opus":0.10817719052914442,"score_gpt":0.4996171613394671,"score_spread":0.39143997081032267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000110198","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007236025,0.99775785,0.00017136602,0.0004556357,0.00033210192,0.000005147606,0.000015963406,0.000013233193,0.0011763502],"genre_scores_gemma":[0.000823347,0.9971208,0.00026006697,0.0004160738,0.00040770392,0.000008848936,0.000033316137,0.0000024055746,0.00092738663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997514,0.000048876955,0.000025872621,0.000038877944,0.000105297106,0.000029621098],"domain_scores_gemma":[0.99968016,0.00013994468,0.00004137712,0.000012906204,0.000085383945,0.000040372466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009444093,0.0012137595,0.0018822756,0.0019075922,0.00035215713,0.0011777445,0.0010767679,0.0016639322,0.0043675816],"category_scores_gemma":[0.0008900482,0.000423134,0.00050358055,0.0025917052,0.0007826001,0.0014235135,0.00072332047,0.00273771,0.002878355],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001495589,0.00008553763,0.00012809102,0.006047906,0.00009356685,0.00019184797,0.000025888512,0.00069158495,0.0018067011,0.004496761,0.084598236,0.9016844],"study_design_scores_gemma":[0.000059968475,0.00008221175,0.00040083838,0.0009184806,0.00009429095,0.0006978219,0.00001909623,0.00017288447,0.0004030125,0.0022252102,0.99491334,0.0000127583],"about_ca_topic_score_codex":0.0013601054,"about_ca_topic_score_gemma":0.0034639616,"teacher_disagreement_score":0.0043675816,"about_ca_system_score_codex":0.0011363345,"about_ca_system_score_gemma":0.0012732715,"threshold_uncertainty_score":0.014611065},"labels":[],"label_agreement":null},{"id":"W2000803692","doi":"10.1038/nrclinonc.2011.5","title":"Hypoxia modification with radiotherapy for bladder cancer","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Bladder cancer; Hypoxia (environmental); Context (archaeology); Oncology; Cancer; Cancer therapy; Internal medicine","score_opus":0.30217606434239314,"score_gpt":0.5572233347455076,"score_spread":0.2550472704031144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000803692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013204594,0.9990546,0.00007517835,0.00011313236,0.00011284875,0.0000054504994,0.0000125839115,0.0000043977348,0.0004897548],"genre_scores_gemma":[0.0011381656,0.997979,0.00010248694,0.00017276152,0.0001326125,0.000008830609,0.000021367987,0.000001439417,0.00044347486],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998678,0.000031511354,0.000020860018,0.000026518956,0.00003847106,0.000014746247],"domain_scores_gemma":[0.9998233,0.00009045235,0.000043442695,0.0000062353092,0.000025354719,0.000011265347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048413742,0.00075904065,0.0015940745,0.0010471506,0.00018679645,0.00047260456,0.0006946579,0.0007152369,0.0040235347],"category_scores_gemma":[0.00053439225,0.00028365475,0.0006174498,0.0011735098,0.00030335318,0.0007079337,0.0005283555,0.0012569543,0.0010767125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017747225,0.000088642366,0.00012210524,0.02592579,0.00020403256,0.00009292635,0.000029583955,0.0003815658,0.002017383,0.0007102391,0.01871744,0.95153284],"study_design_scores_gemma":[0.00018259582,0.00072814734,0.002496933,0.009865541,0.0010465945,0.0014085182,0.0000661529,0.0002148962,0.0024430235,0.0012756079,0.9802319,0.00004007519],"about_ca_topic_score_codex":0.001123015,"about_ca_topic_score_gemma":0.0031233646,"teacher_disagreement_score":0.0040235347,"about_ca_system_score_codex":0.0004441392,"about_ca_system_score_gemma":0.00074130314,"threshold_uncertainty_score":0.01346004},"labels":[],"label_agreement":null},{"id":"W2002193164","doi":"10.1038/nrclinonc.2012.27","title":"Exercise rehabilitation in patients with cancer","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":163,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Rehabilitation; Physical therapy; MEDLINE; Cancer; Oncology; Physical medicine and rehabilitation; Internal medicine","score_opus":0.10050910908960778,"score_gpt":0.5026674209300335,"score_spread":0.4021583118404257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002193164","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010942114,0.9992285,0.00003019793,0.00015628853,0.00010907618,0.0000044800795,0.000015237624,0.0000023395617,0.00034442893],"genre_scores_gemma":[0.0012601502,0.9979436,0.000080807054,0.00031876191,0.00014363287,0.000010891894,0.00002109627,9.2070223e-7,0.00022010993],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972206,0.000068350746,0.000067379166,0.000052979707,0.000068300316,0.000020907917],"domain_scores_gemma":[0.9993886,0.00040637713,0.00010687427,0.000011823469,0.000060674727,0.00002570995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000657774,0.00080446876,0.0022636382,0.0020179457,0.00021736715,0.00075253885,0.0006331985,0.0010588185,0.0038185802],"category_scores_gemma":[0.0019318745,0.0002764727,0.0009407668,0.0022908768,0.00035566994,0.00073936547,0.0006962253,0.0012921594,0.0007713619],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017586362,0.00008364231,0.00036611327,0.045562066,0.0003620659,0.000059661306,0.00003585307,0.00014163986,0.00023619717,0.00041373877,0.01268509,0.93987805],"study_design_scores_gemma":[0.00056460884,0.00089966215,0.016654884,0.11641598,0.0047404435,0.0021778636,0.00033062682,0.00032593394,0.0004819496,0.0020015233,0.8553262,0.00008034308],"about_ca_topic_score_codex":0.0019782598,"about_ca_topic_score_gemma":0.006766443,"teacher_disagreement_score":0.0038185802,"about_ca_system_score_codex":0.0004411131,"about_ca_system_score_gemma":0.0009993151,"threshold_uncertainty_score":0.012774408},"labels":[],"label_agreement":null},{"id":"W2004554659","doi":"10.1038/nrclinonc.2011.88","title":"Local treatment of metastatic cancer—killing the seed or disturbing the soil?","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"Marsden Fund; Elekta; National Institute for Health and Care Research; Canadian Association of Radiation Oncology","keywords":"Medicine; Primary tumor; Prostate cancer; Disease; Clinical trial; Cancer; Metastasis; Randomized controlled trial; Breast cancer; Oncology; Metastatic breast cancer; Internal medicine","score_opus":0.36689963617980204,"score_gpt":0.5629204825720135,"score_spread":0.1960208463922115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004554659","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007634919,0.99877733,0.00010064983,0.00037989306,0.00020203077,0.0000023636214,0.000007178334,0.0000049502096,0.00044921896],"genre_scores_gemma":[0.0008466888,0.99775094,0.0001559222,0.00046069705,0.00023001805,0.000004365749,0.000016304586,0.000002070106,0.0005329298],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981064,0.000052292606,0.000019405494,0.00003216343,0.00006426214,0.00002126909],"domain_scores_gemma":[0.99974984,0.00012984766,0.00003847914,0.000011156454,0.00005044865,0.000020211864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006656614,0.0007536465,0.0020409836,0.0010886203,0.00025226537,0.00095962937,0.0012287865,0.001275707,0.0032997867],"category_scores_gemma":[0.000736643,0.00030450412,0.0006412752,0.0012232495,0.00090154423,0.0012921779,0.0005106121,0.0026213164,0.0020907938],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008625574,0.000071803,0.0001400336,0.008992656,0.00010435872,0.00017307697,0.000048298003,0.00041426063,0.0017888115,0.0036706515,0.04735212,0.9371578],"study_design_scores_gemma":[0.000086753396,0.000185365,0.00090583274,0.0042492733,0.00015579138,0.0021597687,0.00008516935,0.00016413021,0.0006170165,0.0032892898,0.9880725,0.00002913753],"about_ca_topic_score_codex":0.0017495954,"about_ca_topic_score_gemma":0.005266003,"teacher_disagreement_score":0.0032997867,"about_ca_system_score_codex":0.00060043565,"about_ca_system_score_gemma":0.0006879977,"threshold_uncertainty_score":0.01103884},"labels":[],"label_agreement":null},{"id":"W2005616606","doi":"10.1038/nrclinonc.2010.173","title":"Metastamirs: a stepping stone towards improved cancer management","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"MicroRNA in disease regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":186,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"microRNA; Metastasis; Cancer research; Angiogenesis; Biomarker; Suppressor; Context (archaeology); Oncomir; Cancer; Medicine; Epithelial–mesenchymal transition; Computational biology; Bioinformatics; Biology; Gene; Internal medicine; Genetics","score_opus":0.09099727883105213,"score_gpt":0.4983215491465548,"score_spread":0.40732427031550267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005616606","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00031623288,0.9895738,0.0018423769,0.005692309,0.0010830559,0.0000094832,0.00002768844,0.000049373444,0.0014058267],"genre_scores_gemma":[0.005014399,0.98043424,0.003827159,0.0056332042,0.0025078582,0.00004654129,0.000119945216,0.000025156081,0.0023915537],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995535,0.00011327471,0.000047040987,0.00006329042,0.000174214,0.000048583504],"domain_scores_gemma":[0.9988863,0.00069790805,0.00010239363,0.000028170092,0.00017865073,0.00010663776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00212316,0.00095867255,0.0023094148,0.0011357805,0.0003423202,0.0016936912,0.0014115659,0.0024851735,0.003519314],"category_scores_gemma":[0.0022445172,0.00038868125,0.00056731515,0.0008046002,0.0011240981,0.002505761,0.0011739245,0.0059121223,0.0019208712],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015944554,0.00009784615,0.0004462567,0.0040898575,0.0001006712,0.00024748527,0.000057346006,0.0007682197,0.0037763112,0.012553957,0.07563933,0.9020633],"study_design_scores_gemma":[0.00008358273,0.00019042318,0.00082327204,0.0015435749,0.00011996835,0.0014441849,0.00006856764,0.0006779185,0.001807419,0.0092282025,0.983978,0.00003481868],"about_ca_topic_score_codex":0.0006451147,"about_ca_topic_score_gemma":0.0021863542,"teacher_disagreement_score":0.003519314,"about_ca_system_score_codex":0.001130108,"about_ca_system_score_gemma":0.0014229816,"threshold_uncertainty_score":0.011773348},"labels":[],"label_agreement":null},{"id":"W2008243627","doi":"10.1038/nrclinonc.2009.83","title":"Cetuximab, chemotherapy and KRAS status in mCRC","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Cetuximab; Medicine; Bevacizumab; KRAS; Colorectal cancer; Chemotherapy; Oncology; Internal medicine; Panitumumab; Monoclonal antibody; Cancer; Antibody; Immunology","score_opus":0.15783667549239647,"score_gpt":0.553432103833239,"score_spread":0.3955954283408426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008243627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000100562655,0.99949133,0.000015344864,0.00010501723,0.000057209596,0.000002343565,0.000010381795,0.0000017177853,0.00021603426],"genre_scores_gemma":[0.0008723535,0.99864537,0.000061379345,0.00014952874,0.00006281257,0.0000033736658,0.000017356648,4.7212126e-7,0.00018742857],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99978334,0.00004940646,0.00005338908,0.000029931829,0.00007052751,0.000013439697],"domain_scores_gemma":[0.99941754,0.0003698961,0.0001226495,0.000009665143,0.000058855116,0.000021510892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008194108,0.0006093337,0.002199664,0.001996653,0.00014792335,0.00073604507,0.00066449103,0.0008518456,0.003162168],"category_scores_gemma":[0.0017143575,0.00033452405,0.00071977713,0.0025136014,0.00029385713,0.00070666586,0.0004674735,0.0010063435,0.00054947],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032392776,0.00006424694,0.00032121514,0.04143301,0.00048502587,0.00013363792,0.00002529267,0.000385471,0.00060509186,0.0005226728,0.020030625,0.9356698],"study_design_scores_gemma":[0.0005382479,0.00065850606,0.007449817,0.04081494,0.0050081406,0.0021823356,0.00011761647,0.0004730041,0.00085677346,0.0015502746,0.94029325,0.000057094672],"about_ca_topic_score_codex":0.0028005475,"about_ca_topic_score_gemma":0.008387204,"teacher_disagreement_score":0.003162168,"about_ca_system_score_codex":0.0006125248,"about_ca_system_score_gemma":0.0011122985,"threshold_uncertainty_score":0.010578513},"labels":[],"label_agreement":null},{"id":"W2012946235","doi":"10.1038/nrclinonc.2010.166","title":"BRCA mutations in the management of breast cancer: the state of the art","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":161,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Olaparib; BRCA mutation; Genetic testing; Oncology; Ovarian cancer; Cancer; Internal medicine; Genetic counseling; Gynecology; Genetics; Gene","score_opus":0.06094619099305645,"score_gpt":0.4737882625077883,"score_spread":0.4128420715147319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012946235","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046401445,0.99906784,0.00007520918,0.00040534968,0.00014371982,0.0000018379924,0.000005711197,0.0000047179988,0.00024931392],"genre_scores_gemma":[0.0003795251,0.99868673,0.00015771564,0.00029447378,0.00030960253,0.0000031486848,0.000012876432,0.0000013102434,0.0001547333],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954945,0.00009328791,0.00005175342,0.00006794579,0.00019445094,0.00004315023],"domain_scores_gemma":[0.99852955,0.00089303433,0.00012909144,0.000028036928,0.0002889346,0.000131413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016053718,0.0010922009,0.0024727795,0.0018683723,0.0003056626,0.0013607129,0.0018259804,0.0021570185,0.0028482827],"category_scores_gemma":[0.0024787395,0.00033956018,0.00060299085,0.0021676116,0.0008332565,0.0014786124,0.00089685764,0.0030103163,0.0015480717],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011602417,0.000058759288,0.0002258878,0.0064585656,0.00006438581,0.00017975063,0.000030704436,0.0005259748,0.00066769536,0.0016582886,0.046718746,0.9432953],"study_design_scores_gemma":[0.00006762944,0.00013580763,0.0015456722,0.007007538,0.00024494145,0.002264228,0.000087776025,0.0003003705,0.0003510488,0.002640537,0.98532015,0.000034304485],"about_ca_topic_score_codex":0.0022218812,"about_ca_topic_score_gemma":0.0042353445,"teacher_disagreement_score":0.0028482827,"about_ca_system_score_codex":0.0011842799,"about_ca_system_score_gemma":0.001488517,"threshold_uncertainty_score":0.009528518},"labels":[],"label_agreement":null},{"id":"W2013581577","doi":"10.1038/nrclinonc.2010.207","title":"Neoadjuvant radiotherapy for locally advanced and high-risk prostate cancer","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Radiation therapy; Prostate cancer; Randomized controlled trial; Clinical trial; Oncology; Cancer; Brachytherapy; Internal medicine; Surgery","score_opus":0.06985595778117436,"score_gpt":0.5036500943469786,"score_spread":0.43379413656580423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013581577","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017014571,0.9986187,0.00008177098,0.0001545402,0.0001525172,0.0000054507723,0.000017080536,0.0000050855015,0.0007946036],"genre_scores_gemma":[0.001134785,0.9977391,0.00011732447,0.00024365133,0.00012004697,0.000008461125,0.000029959896,0.0000018785624,0.0006048681],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99987745,0.000030313598,0.000022092661,0.000021602673,0.00003862392,0.000009950273],"domain_scores_gemma":[0.9997626,0.0001344277,0.00004978153,0.0000075268113,0.00003030983,0.000015379565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040079176,0.00055755366,0.0013314976,0.0010392456,0.00013990277,0.00044100313,0.00050120364,0.00040583056,0.0035457402],"category_scores_gemma":[0.0007412911,0.00024467983,0.00038965567,0.0012265274,0.0002741866,0.000550461,0.00036404774,0.00094017497,0.0010045326],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001250853,0.000043010747,0.00019154821,0.020235186,0.000111531706,0.00010862294,0.00002181677,0.00035867677,0.0015096529,0.0005738954,0.024575613,0.95214546],"study_design_scores_gemma":[0.00012704062,0.00034027384,0.0033884156,0.009859169,0.0006555642,0.0028576388,0.00005532639,0.00015436864,0.0010965774,0.00084473897,0.9805927,0.000028135575],"about_ca_topic_score_codex":0.0010645336,"about_ca_topic_score_gemma":0.0046551013,"teacher_disagreement_score":0.0035457402,"about_ca_system_score_codex":0.00051655975,"about_ca_system_score_gemma":0.00079487165,"threshold_uncertainty_score":0.011861682},"labels":[],"label_agreement":null},{"id":"W2016004402","doi":"10.1038/nrclinonc.2012.3","title":"The potential of exploiting DNA-repair defects for optimizing lung cancer treatment","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Cancer Research; European Society for Medical Oncology; Institut National Du Cancer","keywords":"ERCC1; DNA repair; Medicine; Gemcitabine; Lung cancer; Synthetic lethality; DNA mismatch repair; Oncology; DNA damage; Cancer research; Chemotherapy; Cancer; Bioinformatics; DNA; Internal medicine; Nucleotide excision repair; Biology; Genetics","score_opus":0.09933348595744591,"score_gpt":0.47432545535902126,"score_spread":0.37499196940157536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016004402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019352755,0.99781966,0.00051010534,0.00046420554,0.0001771869,0.0000049756977,0.000021265318,0.000012257195,0.0007967766],"genre_scores_gemma":[0.0016925196,0.9965599,0.0005529612,0.0003399035,0.0001543599,0.000008132439,0.000041205505,0.0000033508866,0.00064771855],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99979323,0.00003826052,0.000016772525,0.000037769794,0.00008579661,0.000028085371],"domain_scores_gemma":[0.9996624,0.00017486788,0.000043182725,0.000013760812,0.000079136145,0.000026702246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084316323,0.0009826944,0.0014410149,0.0013349672,0.00024305204,0.0010178918,0.0010057517,0.0014948366,0.0025077283],"category_scores_gemma":[0.0007640091,0.00030055444,0.0005260397,0.0012067534,0.0007042613,0.0012137231,0.0007530862,0.0028078023,0.0014244058],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000127691,0.00012317198,0.00021519283,0.008800363,0.000100266545,0.00027926423,0.000036354817,0.0010112043,0.012670487,0.006487001,0.030584252,0.9395649],"study_design_scores_gemma":[0.000051098115,0.00014736234,0.00071201456,0.0013417514,0.00013760698,0.0013954887,0.0000392881,0.00035902523,0.0050512105,0.0047626053,0.9859685,0.000034106564],"about_ca_topic_score_codex":0.00079392095,"about_ca_topic_score_gemma":0.001998889,"teacher_disagreement_score":0.0025077283,"about_ca_system_score_codex":0.00078459637,"about_ca_system_score_gemma":0.0007316916,"threshold_uncertainty_score":0.008389175},"labels":[],"label_agreement":null},{"id":"W2016370944","doi":"10.1038/ncponc1320","title":"Unintended pregnancy during radiotherapy for cancer","year":2009,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Radiation therapy; Pregnancy; Cancer; Unintended pregnancy; MEDLINE; Oncology; Obstetrics; Gynecology; Medical physics; Internal medicine; Family planning; Environmental health; Research methodology","score_opus":0.24699852706825695,"score_gpt":0.5984097964357625,"score_spread":0.35141126936750555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016370944","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060666203,0.9990471,0.00003394913,0.00024931587,0.00017194569,0.0000019791885,0.0000089870155,0.000001696382,0.0004242258],"genre_scores_gemma":[0.00060936227,0.99866927,0.00006221313,0.0002656183,0.00014523609,0.0000041396643,0.000010915126,7.5454335e-7,0.00023251084],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995734,0.00014227544,0.0000738035,0.00005847097,0.00012190906,0.00003018218],"domain_scores_gemma":[0.99872106,0.0009243488,0.00020230145,0.000024606281,0.000086148335,0.000041487892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010196485,0.0007118026,0.0015906359,0.00133966,0.00026905068,0.0007763681,0.00058668543,0.0012807039,0.0035342316],"category_scores_gemma":[0.0034579064,0.0003341989,0.0005832237,0.0015504484,0.00056030025,0.0009379078,0.0007495639,0.0013682656,0.0008425114],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000974618,0.000033160846,0.0005682983,0.023309376,0.00015885313,0.0003496081,0.000085060565,0.00022642358,0.00022786953,0.0014989645,0.028978398,0.9444666],"study_design_scores_gemma":[0.000061032486,0.00019348713,0.003435465,0.036437735,0.0007754475,0.005230444,0.00022908856,0.000076380806,0.00035478378,0.0018181332,0.9513564,0.000031567055],"about_ca_topic_score_codex":0.0023485133,"about_ca_topic_score_gemma":0.005972172,"teacher_disagreement_score":0.0035342316,"about_ca_system_score_codex":0.0007566982,"about_ca_system_score_gemma":0.0020320592,"threshold_uncertainty_score":0.011823177},"labels":[],"label_agreement":null},{"id":"W2018652183","doi":"10.1038/nrclinonc.2013.153","title":"The Society for Immunotherapy of Cancer consensus statement on tumour immunotherapy for the treatment of cutaneous melanoma","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"","keywords":"Medicine; Ipilimumab; Immunotherapy; Melanoma; Intensive care medicine; Clinical trial; Oncology; Cancer; Internal medicine; Cancer research","score_opus":0.1545630070054307,"score_gpt":0.5229324565085092,"score_spread":0.3683694495030785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018652183","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017530735,0.27929762,0.0136807775,0.5341775,0.10446124,0.0039168713,0.0032774722,0.00049618265,0.058939297],"genre_scores_gemma":[0.021644918,0.42902008,0.0939586,0.31627315,0.047607116,0.012496398,0.018525628,0.0007451753,0.059729025],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9547215,0.01910142,0.007913212,0.0014431536,0.01428695,0.0025337387],"domain_scores_gemma":[0.9049923,0.018520012,0.012443358,0.0022839818,0.052690793,0.009069483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.050646387,0.001990293,0.0038667857,0.0072984304,0.0030264088,0.0054425444,0.0070796427,0.016124351,0.0058792513],"category_scores_gemma":[0.06597156,0.0013697727,0.0074228304,0.0066259895,0.002371304,0.0030644885,0.006420159,0.020096546,0.007854838],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022396051,0.00013387176,0.0008586414,0.00815133,0.00038263513,0.00026436025,0.00024782767,0.0007351387,0.00094424793,0.0047700256,0.8415679,0.14172003],"study_design_scores_gemma":[0.00020173105,0.00017147277,0.0012410139,0.01150715,0.00040542628,0.00063659606,0.00017495519,0.00021984075,0.0005882469,0.003609864,0.98118526,0.00005848858],"about_ca_topic_score_codex":0.009083832,"about_ca_topic_score_gemma":0.01315413,"teacher_disagreement_score":0.050646387,"about_ca_system_score_codex":0.008372246,"about_ca_system_score_gemma":0.051129982,"threshold_uncertainty_score":0.26784688},"labels":[],"label_agreement":null},{"id":"W2030665986","doi":"10.1038/nrclinonc.2011.19","title":"Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Oncology; Breast cancer; Chemotherapy; Adjuvant; Internal medicine; Stage (stratigraphy); Adjuvant chemotherapy; Cancer","score_opus":0.08632046898964518,"score_gpt":0.4584442888768769,"score_spread":0.3721238198872317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030665986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004249862,0.99333113,0.00012542876,0.0046162275,0.00037430436,0.0000034850493,0.000024390698,0.000004968791,0.0010951214],"genre_scores_gemma":[0.0039536958,0.99132735,0.00025365996,0.0028394673,0.0008301349,0.000011907736,0.000038081937,0.0000022689821,0.0007433947],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99985754,0.00004408261,0.000016215541,0.000021711912,0.00004308654,0.00001743058],"domain_scores_gemma":[0.99955815,0.0002905881,0.000057922956,0.000010793331,0.00005850862,0.000023995042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068532606,0.000419862,0.001241406,0.00040899005,0.00022581579,0.00063919753,0.000654375,0.0012223364,0.0032713541],"category_scores_gemma":[0.0016840686,0.00015175682,0.00036807507,0.0006779388,0.0004851986,0.00081041973,0.0003573607,0.0018817057,0.0009009663],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003064066,0.000074126925,0.0010991925,0.0065335548,0.00013404628,0.00020415889,0.000041932348,0.00020130926,0.00091721583,0.0025690296,0.043113817,0.9448053],"study_design_scores_gemma":[0.00034817826,0.00037470783,0.009016407,0.008519406,0.0006045157,0.0032064908,0.00032174122,0.00015594723,0.00089798804,0.011858977,0.964657,0.000038703452],"about_ca_topic_score_codex":0.0009943243,"about_ca_topic_score_gemma":0.0034311314,"teacher_disagreement_score":0.0032713541,"about_ca_system_score_codex":0.00040617236,"about_ca_system_score_gemma":0.00076450687,"threshold_uncertainty_score":0.010943711},"labels":[],"label_agreement":null},{"id":"W2047080566","doi":"10.1038/nrclinonc.2014.169","title":"Management of familial cancer: sequencing, surveillance and society","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Izaak Walton Killam Health Centre; Hospital for Sick Children; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Context (archaeology); Cancer; Genetic counseling; Medicine; Personalized medicine; Genetic testing; Proband; DNA sequencing; Genetics; Computational biology; Bioinformatics; Biology; Mutation; Gene","score_opus":0.08380407246663417,"score_gpt":0.4848599894130483,"score_spread":0.4010559169464141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047080566","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000081043225,0.9973339,0.00031205534,0.0012354011,0.0003077464,0.0000032119035,0.000013696628,0.000008548983,0.00070444663],"genre_scores_gemma":[0.0010797209,0.99657285,0.0004146407,0.0008675913,0.00059153273,0.000006077671,0.000028090006,0.0000026068788,0.00043688226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994854,0.00014822403,0.000052455125,0.00007797037,0.0001889486,0.000046967987],"domain_scores_gemma":[0.99894696,0.00063841103,0.00010294239,0.000024964596,0.0002037342,0.000083055565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001899852,0.00075623073,0.0013932011,0.001617104,0.00026531224,0.0011186874,0.0013617228,0.001823387,0.0025419237],"category_scores_gemma":[0.0029244937,0.0002843555,0.00056694594,0.0014272212,0.0008166785,0.0012053387,0.00086482865,0.0024521844,0.0010206574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004779479,0.000030725787,0.00038036983,0.0034946867,0.00007176737,0.00021748227,0.00003055875,0.0005786103,0.00033457132,0.003916313,0.048217878,0.94267917],"study_design_scores_gemma":[0.000038500348,0.0000693067,0.0016342147,0.0063989814,0.00015495766,0.0026221548,0.00008006022,0.00025795246,0.00021825165,0.005686115,0.982811,0.000028565606],"about_ca_topic_score_codex":0.0019909325,"about_ca_topic_score_gemma":0.0044431267,"teacher_disagreement_score":0.0025419237,"about_ca_system_score_codex":0.0012126167,"about_ca_system_score_gemma":0.0013580996,"threshold_uncertainty_score":0.010047495},"labels":[],"label_agreement":null},{"id":"W2047409231","doi":"10.1038/nrclinonc.2014.172","title":"Advances in biology and therapy","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ubiquitin and proteasome pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Medicine; Medical physics; Engineering ethics; Intensive care medicine; Engineering","score_opus":0.0960430805836337,"score_gpt":0.5209912276319424,"score_spread":0.4249481470483087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047409231","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000672104,0.9938788,0.00043856536,0.0014781269,0.0013074676,0.000007838946,0.000024831921,0.000023765619,0.002773495],"genre_scores_gemma":[0.0010545242,0.99259394,0.00046996132,0.0016166788,0.001355953,0.0000128795555,0.000045902692,0.00000580227,0.0028443374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995395,0.000089287205,0.00003303129,0.00006900574,0.00020671233,0.00006252511],"domain_scores_gemma":[0.9995171,0.00021539097,0.0000425335,0.000026789547,0.00012448207,0.00007367052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011663891,0.0013430127,0.0016589384,0.0017384407,0.00041320422,0.0017663277,0.0011299993,0.0019170409,0.007940822],"category_scores_gemma":[0.001574119,0.00038079498,0.000491492,0.0016519261,0.0012163642,0.0020401876,0.0015160145,0.004643371,0.00396259],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007410015,0.000062282765,0.00011367739,0.0044886144,0.000045031487,0.00013760371,0.000044396427,0.00046206475,0.0019428205,0.009953755,0.1277872,0.85488844],"study_design_scores_gemma":[0.000012646342,0.000026835294,0.00016957143,0.00087453047,0.000023897937,0.00028024445,0.00002215835,0.00007678691,0.00019889031,0.0036391988,0.9946666,0.000008633651],"about_ca_topic_score_codex":0.0011481565,"about_ca_topic_score_gemma":0.0026830977,"teacher_disagreement_score":0.007940822,"about_ca_system_score_codex":0.001260161,"about_ca_system_score_gemma":0.0019088537,"threshold_uncertainty_score":0.026564717},"labels":[],"label_agreement":null},{"id":"W2051410494","doi":"10.1038/nrclinonc.2010.136","title":"Drug resistance in metastatic castration-resistant prostate cancer","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":340,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV","keywords":"Prostate cancer; Medicine; Docetaxel; Androgen receptor; Drug resistance; Cancer; Cabazitaxel; Oncology; Cancer research; Internal medicine; Enzalutamide; Tumor microenvironment; Metastasis; Androgen deprivation therapy; Biology","score_opus":0.1910857334701918,"score_gpt":0.5670317297040429,"score_spread":0.3759459962338511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051410494","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014604964,0.99881244,0.000096153904,0.00020609032,0.00012510123,0.000003808964,0.000017514587,0.000006791223,0.00058601063],"genre_scores_gemma":[0.0009308683,0.9980501,0.00012230346,0.00023110236,0.000113153415,0.0000042595016,0.000029433308,0.0000013860791,0.0005174019],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998061,0.000038946873,0.000029807257,0.0000319791,0.00007474929,0.000018519719],"domain_scores_gemma":[0.9996935,0.00014285953,0.00006874429,0.000010088718,0.00006189007,0.000022914599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058220926,0.00071692996,0.0018114867,0.0018706868,0.00017974037,0.0008115627,0.0007392886,0.0006937972,0.002991536],"category_scores_gemma":[0.0007891163,0.00027625563,0.00046289625,0.0019586214,0.0003691706,0.00086790783,0.000520237,0.0012251764,0.001236505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009390207,0.00004928807,0.00025507246,0.01087895,0.000102014135,0.00016925794,0.00003038717,0.00042628878,0.0014192073,0.0011562865,0.03192311,0.95349634],"study_design_scores_gemma":[0.00006435032,0.00019099856,0.001734458,0.004092726,0.00038478777,0.002130555,0.0000551645,0.00023527257,0.0007453698,0.0011579047,0.9891834,0.000024869614],"about_ca_topic_score_codex":0.0013638695,"about_ca_topic_score_gemma":0.0037451608,"teacher_disagreement_score":0.002991536,"about_ca_system_score_codex":0.0005803096,"about_ca_system_score_gemma":0.0007641722,"threshold_uncertainty_score":0.010007679},"labels":[],"label_agreement":null},{"id":"W2058374643","doi":"10.1038/nrclinonc.2010.19","title":"Zoledronic acid for breast cancer therapy-induced bone loss","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; St. Michael's Hospital; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Zoledronic acid; Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.22815931231604225,"score_gpt":0.5823688584877984,"score_spread":0.35420954617175615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058374643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017802628,0.998701,0.000083888604,0.00016787476,0.00016327655,0.0000063598927,0.000028679176,0.000007792408,0.0006630774],"genre_scores_gemma":[0.0016399886,0.9967338,0.000174891,0.00035396093,0.00015198822,0.000008445114,0.000044904027,0.0000017806371,0.00089023],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998497,0.000024090834,0.000029587192,0.000023030796,0.00005891561,0.0000146878465],"domain_scores_gemma":[0.9998223,0.00008265183,0.00004403572,0.000005438549,0.000034458615,0.000011213629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033489743,0.0006595669,0.001737256,0.0017461701,0.00014724505,0.00053860206,0.0006828233,0.00077525544,0.0041898014],"category_scores_gemma":[0.00059725426,0.0002366215,0.0006204968,0.0016417672,0.0002732544,0.00041997244,0.0003725791,0.0010314358,0.0014501896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028706048,0.00007681781,0.00012892172,0.020870635,0.00028874466,0.00018734652,0.000020762925,0.0002716582,0.0016982827,0.0009290471,0.032381646,0.9428591],"study_design_scores_gemma":[0.00044844576,0.00042457422,0.0022888929,0.006309966,0.0012487621,0.0029170697,0.000049526516,0.00021077244,0.0014331308,0.0012171967,0.9834246,0.000027159214],"about_ca_topic_score_codex":0.001619753,"about_ca_topic_score_gemma":0.0053931447,"teacher_disagreement_score":0.0041898014,"about_ca_system_score_codex":0.00050237763,"about_ca_system_score_gemma":0.0007915251,"threshold_uncertainty_score":0.014016271},"labels":[],"label_agreement":null},{"id":"W2059075557","doi":"10.1038/nrclinonc.2014.200","title":"Current treatment landscape for relapsed and/or refractory multiple myeloma","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":198,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Pomalidomide; Medicine; Multiple myeloma; Carfilzomib; Refractory (planetary science); Lenalidomide; Bortezomib; Oncology; Internal medicine; Regimen; Ixazomib; Disease; Thalidomide; Clinical trial","score_opus":0.2542302185574246,"score_gpt":0.5603429840524028,"score_spread":0.3061127654949782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059075557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000034128352,0.9990337,0.000048139154,0.00040748803,0.00012134854,0.0000021896003,0.000009659431,0.0000042210963,0.00033925113],"genre_scores_gemma":[0.0005341591,0.99829954,0.00012575353,0.000556273,0.00023242565,0.000005423052,0.000018043855,0.0000011688979,0.0002272527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970764,0.00007118172,0.000057393478,0.00004651036,0.00008954494,0.000027727825],"domain_scores_gemma":[0.9994338,0.0003287694,0.00009866544,0.000011200712,0.000095567826,0.000032029595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009035217,0.00069477316,0.0018244097,0.0018386433,0.00029448984,0.0011940849,0.0008859391,0.0012030705,0.0043516196],"category_scores_gemma":[0.001554171,0.00031268052,0.000705084,0.0017040102,0.0005037313,0.0014877128,0.000840782,0.0021572968,0.0013232664],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097998345,0.0000392375,0.00015913407,0.018146457,0.00010800264,0.00009805658,0.000039415125,0.00025880904,0.00043600638,0.00194478,0.037811395,0.9408605],"study_design_scores_gemma":[0.000073599746,0.00013649992,0.00084704795,0.011709128,0.00044434148,0.000989571,0.00007564859,0.00015122973,0.00020877588,0.0025401164,0.9828001,0.000023822397],"about_ca_topic_score_codex":0.0013116066,"about_ca_topic_score_gemma":0.003802406,"teacher_disagreement_score":0.0043516196,"about_ca_system_score_codex":0.0008424127,"about_ca_system_score_gemma":0.0013995623,"threshold_uncertainty_score":0.0145576},"labels":[],"label_agreement":null},{"id":"W2061859480","doi":"10.1038/nrclinonc.2014.147","title":"Delirium in patients with cancer: assessment, impact, mechanisms and management","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Intensive Care Unit Cognitive Disorders","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bruyère","funders":"","keywords":"Delirium; Medicine; Intensive care medicine; Distress; Dementia; Neurocognitive; Sedation; Midazolam; Cancer; Palliative care; Intervention (counseling); Psychiatry; Disease; Internal medicine; Cognition; Nursing; Anesthesia; Clinical psychology","score_opus":0.06240061580795696,"score_gpt":0.5148131530139222,"score_spread":0.4524125372059652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061859480","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001738722,0.99950266,0.000027278089,0.00015569445,0.000044462427,0.0000029938226,0.000009690259,0.0000010465848,0.0000823657],"genre_scores_gemma":[0.0016671554,0.99797183,0.00010655202,0.00010979216,0.00008885832,0.00000539434,0.000014341608,3.0904488e-7,0.000035824574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994659,0.00011951251,0.00014952733,0.00007058713,0.00016303876,0.00003156084],"domain_scores_gemma":[0.9983683,0.00090028415,0.00036690783,0.000019475136,0.00028574347,0.000059313872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011826786,0.00092868257,0.0026119098,0.0015491564,0.000290178,0.0013471781,0.0010556233,0.0010436549,0.0008615408],"category_scores_gemma":[0.0036516173,0.00027199456,0.0011539013,0.001569147,0.0004860487,0.0010444163,0.00090256275,0.0013716017,0.0002048457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021046028,0.00008039331,0.0028654567,0.047505695,0.00075383316,0.00018416431,0.00010696186,0.00046100002,0.00034717258,0.00088439597,0.009158432,0.9374421],"study_design_scores_gemma":[0.00049343624,0.0015128813,0.06423678,0.18601361,0.008161542,0.009966835,0.0015762007,0.0015208041,0.0011389938,0.009635167,0.7153639,0.000379806],"about_ca_topic_score_codex":0.0038859048,"about_ca_topic_score_gemma":0.010222767,"teacher_disagreement_score":0.0038859048,"about_ca_system_score_codex":0.0007367318,"about_ca_system_score_gemma":0.0025368182,"threshold_uncertainty_score":0.00772655},"labels":[],"label_agreement":null},{"id":"W2075647502","doi":"10.1038/nrclinonc.2012.203","title":"Past, present, and future of radiotherapy for the benefit of patients","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":445,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal General Hospital","funders":"","keywords":"Radiation therapy; Medicine; Timeline; Medical physics; Surgery","score_opus":0.07865278484667142,"score_gpt":0.48457258811811893,"score_spread":0.4059198032714475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075647502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048830443,0.998142,0.00013929243,0.0007025062,0.00021422666,0.0000019933605,0.000007672995,0.000004812856,0.00073869404],"genre_scores_gemma":[0.00048190565,0.99825245,0.00020235198,0.0003392553,0.00038055386,0.0000025689847,0.000009956467,0.0000015481683,0.00032937597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995347,0.00010775939,0.000050091745,0.00007268052,0.00019870556,0.00003602709],"domain_scores_gemma":[0.998899,0.000583564,0.00014302874,0.000039570314,0.00025857106,0.00007631685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016552536,0.0008686384,0.0012964896,0.0018203562,0.00041912217,0.0014282743,0.0013118833,0.001931188,0.004137774],"category_scores_gemma":[0.0019122552,0.00037272205,0.00057640346,0.0020023107,0.0011885166,0.0028147374,0.0010364549,0.0029586216,0.0017046543],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007647941,0.000042169293,0.00026813036,0.0100878095,0.00006637641,0.00013714285,0.000076841585,0.0005845892,0.0013283225,0.007318915,0.035149913,0.9448633],"study_design_scores_gemma":[0.00001628345,0.00005586714,0.0009415155,0.0039851395,0.000075485295,0.0014813842,0.00008330279,0.00013006233,0.00033553707,0.004789874,0.98807806,0.000027557748],"about_ca_topic_score_codex":0.0014409053,"about_ca_topic_score_gemma":0.0041425987,"teacher_disagreement_score":0.004137774,"about_ca_system_score_codex":0.0010510264,"about_ca_system_score_gemma":0.0021969466,"threshold_uncertainty_score":0.013842285},"labels":[],"label_agreement":null},{"id":"W2076764562","doi":"10.1038/nrclinonc.2013.101","title":"Biopsies: next-generation biospecimens for tailoring therapy","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; McGill University; Jewish General Hospital","funders":"Fonds de Recherche du Québec - Santé","keywords":"Biobank; Medicine; Procurement; Medical physics; Biorepository; Data science; Disease; Computer science; Bioinformatics; Pathology; Biology; Business","score_opus":0.33398476079712514,"score_gpt":0.5006813748694565,"score_spread":0.16669661407233138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076764562","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023090036,0.9901558,0.004776817,0.001853454,0.00088486564,0.000020756472,0.00009679708,0.00007372991,0.0019068548],"genre_scores_gemma":[0.002623623,0.98734087,0.0043248213,0.0023905556,0.0008620789,0.00003866747,0.0002128119,0.000016762402,0.0021897645],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993693,0.00014974762,0.000036221823,0.00011033181,0.00027966805,0.000054724365],"domain_scores_gemma":[0.99849665,0.0008961953,0.00012504616,0.000057043537,0.0003165034,0.00010847283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024200238,0.0012615162,0.0018373303,0.001894915,0.00028459312,0.0017354507,0.0017581608,0.0022144164,0.004115482],"category_scores_gemma":[0.0024772943,0.0005837512,0.0006840393,0.0014181498,0.0011788,0.0023857846,0.0015443227,0.0037327043,0.0026903744],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008100412,0.000054207383,0.00032727642,0.0036680598,0.000070014685,0.00015630787,0.000033316446,0.00064261444,0.004586129,0.007501582,0.038978487,0.94390094],"study_design_scores_gemma":[0.00002975246,0.0000762003,0.00057132624,0.001619363,0.00008258514,0.001237971,0.0000580478,0.0006096672,0.0031863358,0.007624806,0.98486286,0.000041066225],"about_ca_topic_score_codex":0.0010572738,"about_ca_topic_score_gemma":0.0024766286,"teacher_disagreement_score":0.004115482,"about_ca_system_score_codex":0.0009982459,"about_ca_system_score_gemma":0.0011076728,"threshold_uncertainty_score":0.013767719},"labels":[],"label_agreement":null},{"id":"W2078922516","doi":"10.1038/nrclinonc.2011.110","title":"Hormone replacement therapy and the risk of breast cancer","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Breast cancer; Menopause; Hormone replacement therapy (female-to-male); Estrogen; Climacteric; Oncology; Internal medicine; Cancer; Gynecology; Risk factors for breast cancer; Hormone; Hormone therapy; Obstetrics; Testosterone (patch)","score_opus":0.06146250601322517,"score_gpt":0.4354960011655808,"score_spread":0.3740334951523556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078922516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060163227,0.99893576,0.000058128917,0.0003265995,0.00016581938,0.0000010212902,0.000012957284,0.0000031766124,0.00043641616],"genre_scores_gemma":[0.00084490184,0.9979285,0.00009311602,0.00027752476,0.0004053748,0.0000025118725,0.000020979265,7.784713e-7,0.0004263778],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999762,0.00004594711,0.000023054905,0.00003870736,0.00011146737,0.000018963128],"domain_scores_gemma":[0.9996057,0.00022206995,0.000056273893,0.000012736075,0.00007765375,0.000025509258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006505328,0.0007567281,0.0012396596,0.0010571752,0.00017922968,0.000708364,0.0007422659,0.0013511864,0.002787709],"category_scores_gemma":[0.0012032866,0.0002592524,0.00037579684,0.0016872373,0.00049422716,0.0005859765,0.00044202714,0.0015938431,0.0012831857],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014125826,0.000053294676,0.0006378274,0.0049665635,0.00012900344,0.00023488089,0.000018997402,0.00048607544,0.0010400148,0.002926709,0.051030386,0.938335],"study_design_scores_gemma":[0.000055811764,0.00008630795,0.0030438849,0.0019657363,0.00019900384,0.0016404061,0.000042534735,0.0001557474,0.00033752792,0.0034770097,0.98897564,0.000020323727],"about_ca_topic_score_codex":0.0022050396,"about_ca_topic_score_gemma":0.003620001,"teacher_disagreement_score":0.002787709,"about_ca_system_score_codex":0.0007393774,"about_ca_system_score_gemma":0.0010287013,"threshold_uncertainty_score":0.009325802},"labels":[],"label_agreement":null},{"id":"W2088071966","doi":"10.1038/nrclinonc.2010.39","title":"Tumor size and survival in breast cancer—a reappraisal","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":128,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; McGill University","funders":"","keywords":"Breast cancer; Medicine; Cancer; Oncology; Lymph node; CA15-3; Internal medicine; Pathology","score_opus":0.06137663211828988,"score_gpt":0.48711788209049506,"score_spread":0.4257412499722052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088071966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006389764,0.9986123,0.00004457946,0.00080156076,0.00027306983,0.000001042177,0.000010249619,0.0000021881342,0.00019102727],"genre_scores_gemma":[0.00052206096,0.99814093,0.000075482494,0.00051017053,0.0005804754,0.0000026229827,0.000010936821,0.0000011891029,0.00015612051],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963975,0.00007790043,0.000053093092,0.00007726973,0.00012481751,0.000027123762],"domain_scores_gemma":[0.9984151,0.001038771,0.000104765684,0.000043504933,0.00032499977,0.00007281371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022604913,0.0011836648,0.0026717936,0.0016284109,0.00034879192,0.0017490151,0.001419664,0.002183079,0.0024244252],"category_scores_gemma":[0.0034056036,0.00048106216,0.00068029587,0.0033238507,0.0017124261,0.0024604613,0.0010334763,0.0040970896,0.0014456792],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003647395,0.000087968474,0.0007676297,0.00968012,0.00020732486,0.00018071281,0.000056248726,0.00059729523,0.0009812167,0.007404602,0.06490976,0.9147625],"study_design_scores_gemma":[0.00010596648,0.00022891357,0.0042884764,0.0073655066,0.00047349648,0.0013527037,0.00017841908,0.00029822582,0.0004979124,0.009547185,0.97560424,0.00005893942],"about_ca_topic_score_codex":0.002953555,"about_ca_topic_score_gemma":0.0043034134,"teacher_disagreement_score":0.002953555,"about_ca_system_score_codex":0.0015193006,"about_ca_system_score_gemma":0.002081462,"threshold_uncertainty_score":0.011954784},"labels":[],"label_agreement":null},{"id":"W2091749101","doi":"10.1038/nrclinonc.2014.70","title":"Managing bone metastases and reducing skeletal related events in prostate cancer","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":137,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Medicine; Denosumab; Prostate cancer; Cabozantinib; Enzalutamide; Zoledronic acid; Oncology; Internal medicine; Androgen deprivation therapy; Bisphosphonate; Osteoclast; Cancer; Bone mineral; Osteoporosis; Androgen receptor","score_opus":0.1038734455543476,"score_gpt":0.53018600332383,"score_spread":0.4263125577694824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091749101","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053281787,0.999374,0.00003501861,0.0001788863,0.00008377519,0.000004581402,0.00000965178,0.0000027168928,0.0002581883],"genre_scores_gemma":[0.0005704139,0.99875,0.00010965878,0.0002866143,0.00010650837,0.0000050440003,0.000012527146,7.482994e-7,0.00015852047],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970406,0.00006272385,0.000053166936,0.00004076532,0.00011492,0.000024440642],"domain_scores_gemma":[0.9994598,0.0003403574,0.00008258152,0.000008199958,0.00008450298,0.000024644827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000703736,0.000765618,0.0018880041,0.0017356565,0.00021192456,0.00081808673,0.00085402775,0.0011988464,0.0041603902],"category_scores_gemma":[0.0017984855,0.00034694604,0.00087284605,0.0016374789,0.00041224342,0.0007869948,0.00059957016,0.0022244144,0.00086603017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012475562,0.00009170154,0.00013825632,0.041864872,0.00032392907,0.000074264586,0.000035497513,0.00037695933,0.0004858065,0.0010400333,0.019365728,0.9360783],"study_design_scores_gemma":[0.0003474102,0.0005071887,0.0029358622,0.037081514,0.0017759613,0.0013898853,0.00013080382,0.00028253195,0.00042205452,0.0030160001,0.95205307,0.000057667054],"about_ca_topic_score_codex":0.002658038,"about_ca_topic_score_gemma":0.008107424,"teacher_disagreement_score":0.0041603902,"about_ca_system_score_codex":0.00053012534,"about_ca_system_score_gemma":0.0012550905,"threshold_uncertainty_score":0.013917923},"labels":[],"label_agreement":null},{"id":"W2096210342","doi":"10.1038/nrclinonc.2012.194","title":"Image-guided radiotherapy: from current concept to future perspectives","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":499,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation","keywords":"Radiation therapy; Medicine; Medical physics; Context (archaeology); Radiation oncology; Image-guided radiation therapy; Precision medicine; Personalized medicine; Radiology; Bioinformatics; Pathology","score_opus":0.10728901813918192,"score_gpt":0.5314880463345762,"score_spread":0.42419902819539435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096210342","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048613652,0.998466,0.00026932108,0.0004395062,0.00023310354,0.0000022750378,0.0000065893278,0.000006999935,0.0005277018],"genre_scores_gemma":[0.00049672375,0.9981804,0.0003417561,0.00034393155,0.00032538478,0.00000390879,0.000012147411,0.0000024613244,0.00029325642],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99968505,0.000057202567,0.00003423921,0.000058307985,0.00013852776,0.000026779155],"domain_scores_gemma":[0.99901736,0.0005343461,0.00009979164,0.000027388189,0.0002498099,0.00007125165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012765768,0.0009651152,0.0016013851,0.0021814995,0.00028867275,0.0017819122,0.0014707966,0.0018373487,0.0033896433],"category_scores_gemma":[0.001523978,0.00040184366,0.0005766351,0.0020573186,0.0014642124,0.0025415644,0.000892907,0.0028990859,0.0016752788],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007031918,0.00007013715,0.00017633637,0.010316699,0.000060278577,0.00014510333,0.000051131472,0.0006313945,0.0014427693,0.0048642647,0.0325224,0.9496493],"study_design_scores_gemma":[0.00002910547,0.00009669835,0.0006501348,0.004326557,0.000101478654,0.0019045004,0.00008408778,0.0003271182,0.00057292887,0.004152265,0.9877198,0.00003529223],"about_ca_topic_score_codex":0.0017800668,"about_ca_topic_score_gemma":0.003306265,"teacher_disagreement_score":0.0033896433,"about_ca_system_score_codex":0.001121217,"about_ca_system_score_gemma":0.001801377,"threshold_uncertainty_score":0.011339545},"labels":[],"label_agreement":null},{"id":"W2112474929","doi":"10.1038/nrclinonc.2009.236","title":"Advanced pancreatic carcinoma: current treatment and future challenges","year":2010,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":791,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Vedecká Grantová Agentúra MŠVVaŠ SR a SAV","keywords":"Medicine; Pancreatic carcinoma; Current (fluid); Oncology; Carcinoma; Internal medicine; General surgery; Medical physics; Intensive care medicine; Pancreatic cancer; Cancer","score_opus":0.2586644263938099,"score_gpt":0.5656768351710881,"score_spread":0.30701240877727826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112474929","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000053564985,0.9986952,0.00007190964,0.00057210115,0.00022206349,0.0000015656155,0.000008615971,0.0000048479396,0.00037013987],"genre_scores_gemma":[0.00040044377,0.9985442,0.00011736116,0.0003470096,0.0003473785,0.0000026937762,0.000015368616,0.0000010828585,0.0002244255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999726,0.00005900233,0.0000418576,0.000050513834,0.00009186693,0.000030746756],"domain_scores_gemma":[0.9992538,0.00038120267,0.00009936659,0.00001921251,0.00017806063,0.000068308305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012549363,0.0010372502,0.0025744839,0.001786193,0.00031833717,0.0018022303,0.00093787385,0.001504632,0.0036784161],"category_scores_gemma":[0.0013961942,0.00038180113,0.00068856805,0.0025883017,0.00080895267,0.003292515,0.0010328217,0.0024854098,0.0020045624],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012075514,0.000055183074,0.00026809768,0.010339469,0.00007959559,0.00020761405,0.00003662869,0.0004603142,0.00053769985,0.0019780344,0.047823858,0.9380927],"study_design_scores_gemma":[0.000057471607,0.00014152697,0.0009677006,0.0059697675,0.00023894946,0.0016283528,0.00016037842,0.00022154246,0.00020901934,0.0027922746,0.9875825,0.00003052171],"about_ca_topic_score_codex":0.0012687595,"about_ca_topic_score_gemma":0.003991552,"teacher_disagreement_score":0.0036784161,"about_ca_system_score_codex":0.0009043174,"about_ca_system_score_gemma":0.0017613615,"threshold_uncertainty_score":0.012305498},"labels":[],"label_agreement":null},{"id":"W2128625986","doi":"10.1038/nrclinonc.2012.196","title":"Predicting outcomes in radiation oncology—multifactorial decision support systems","year":2012,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":395,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research","funders":"Interreg; National Cancer Institute; KWF Kankerbestrijding; Center for Translational Molecular Medicine; European Commission","keywords":"Medicine; Radiation oncology; Predictive modelling; Outcome (game theory); Decision support system; Medical physics; Clinical decision support system; Clinical Oncology; Population; Precision medicine; Oncology; Radiation therapy; Intensive care medicine; Internal medicine; Data mining; Pathology; Computer science; Machine learning; Cancer","score_opus":0.1317209994531531,"score_gpt":0.5501465579063007,"score_spread":0.41842555845314766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128625986","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00069474854,0.99304646,0.0044362885,0.0010529173,0.00020246129,0.000013334567,0.00006710866,0.000032918273,0.00045383335],"genre_scores_gemma":[0.013513627,0.97732943,0.007203931,0.0006241253,0.000820967,0.000029989342,0.00018689719,0.0000058659607,0.00028527976],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99922013,0.00022450654,0.000094738316,0.0001351751,0.00029136075,0.000034127075],"domain_scores_gemma":[0.99700636,0.0023361908,0.000280882,0.00004695639,0.00027475948,0.000054917058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022155042,0.0010908429,0.0019958094,0.0014986529,0.0001626852,0.0013349525,0.0015723447,0.0011578221,0.0011667296],"category_scores_gemma":[0.0056999046,0.00036264988,0.0012205446,0.001708161,0.00047012346,0.0014113683,0.0007145188,0.0017541711,0.0005661592],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055034197,0.00007881361,0.0012591304,0.0046218736,0.0004138503,0.000055907258,0.000019558292,0.003333803,0.00030791305,0.0015273164,0.0075876103,0.9807391],"study_design_scores_gemma":[0.00031860813,0.001329123,0.024990253,0.034527995,0.004366214,0.0048725014,0.00037054552,0.07993817,0.004553502,0.11163831,0.73257524,0.0005193841],"about_ca_topic_score_codex":0.0012870585,"about_ca_topic_score_gemma":0.0018462621,"teacher_disagreement_score":0.0022155042,"about_ca_system_score_codex":0.00057976396,"about_ca_system_score_gemma":0.0012316885,"threshold_uncertainty_score":0.011716843},"labels":[],"label_agreement":null},{"id":"W2142138307","doi":"10.1038/nrclinonc.2014.96","title":"The oligometastatic state—separating truth from wishful thinking","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":280,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre","funders":"Ontario Institute for Cancer Research","keywords":"Medicine; Radiosurgery; Ablative case; Radiation therapy; Wishful thinking; Disease; Oncology; Intensive care medicine; Internal medicine","score_opus":0.16479687837889093,"score_gpt":0.5457368453934333,"score_spread":0.38093996701454236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142138307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000031547097,0.9974246,0.00006906302,0.0017292872,0.00034749397,0.0000010172471,0.0000034884818,0.0000022110576,0.0003912877],"genre_scores_gemma":[0.0008793052,0.9960367,0.00013959351,0.0018310475,0.000861789,0.000003138231,0.0000070763226,0.0000015430136,0.00023987831],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99927694,0.00024570758,0.00008461863,0.00007799196,0.00025868125,0.000056052526],"domain_scores_gemma":[0.9973701,0.0019721652,0.00020678288,0.000041430114,0.0002945928,0.00011484081],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001856118,0.00065485324,0.0017181352,0.002056158,0.0004696386,0.002645106,0.0010336756,0.0025046556,0.0024729478],"category_scores_gemma":[0.0041951444,0.00032219407,0.0004767626,0.0023250189,0.0030505282,0.0033623802,0.0014395027,0.0046380605,0.00081820914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006932026,0.0000403394,0.00029586052,0.014369219,0.000116923686,0.00027932893,0.00023897558,0.00031943855,0.0004057795,0.02330279,0.08416134,0.8764007],"study_design_scores_gemma":[0.000028204679,0.000040570063,0.0005818977,0.013180502,0.000091611604,0.0016009889,0.00030377824,0.000121648045,0.00013149063,0.020164473,0.9637197,0.000035122655],"about_ca_topic_score_codex":0.0018514876,"about_ca_topic_score_gemma":0.0048131957,"teacher_disagreement_score":0.002645106,"about_ca_system_score_codex":0.0015930162,"about_ca_system_score_gemma":0.0026730811,"threshold_uncertainty_score":0.011558235},"labels":[],"label_agreement":null},{"id":"W2143852804","doi":"10.1038/nrclinonc.2011.21","title":"Antiangiogenic therapy: impact on invasion, disease progression, and metastasis","year":2011,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":676,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"National Cancer Institute","keywords":"Medicine; Antiangiogenic therapy; Oncology; Disease; Clinical trial; Internal medicine; Adjuvant therapy; Adjuvant; Drug; Angiogenesis; Cancer; Pharmacology","score_opus":0.16187340228044506,"score_gpt":0.5144781344395424,"score_spread":0.3526047321590973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143852804","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009586138,0.9987668,0.00013319918,0.0003538231,0.00018330438,0.000002886041,0.000011772785,0.000005563478,0.00044694578],"genre_scores_gemma":[0.0008825628,0.99798787,0.00017160425,0.00025501527,0.00023223633,0.0000067487463,0.000022458822,0.0000014536927,0.0004400121],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971837,0.00004598947,0.000027412269,0.000045224035,0.00013343547,0.000029461902],"domain_scores_gemma":[0.99941516,0.00031786523,0.00006329476,0.000013946179,0.00013128719,0.000058456248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010282838,0.0010655427,0.0018752614,0.0012440834,0.00028918678,0.0012322471,0.0008842297,0.0016331427,0.002483682],"category_scores_gemma":[0.0010924678,0.0003357036,0.00041123078,0.0016199179,0.0007034943,0.0011831411,0.00061555725,0.0030287532,0.0012950815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014579257,0.000097825156,0.00021450565,0.0054318574,0.000074612755,0.00015177748,0.000025760286,0.0005583042,0.0029520208,0.0043496136,0.045475304,0.94052255],"study_design_scores_gemma":[0.000088870154,0.00020158304,0.001305976,0.001840272,0.00017007954,0.0015603194,0.00004319339,0.00033698106,0.0013168374,0.0031389596,0.9899672,0.000029667448],"about_ca_topic_score_codex":0.0011882213,"about_ca_topic_score_gemma":0.0027785632,"teacher_disagreement_score":0.002483682,"about_ca_system_score_codex":0.00090622454,"about_ca_system_score_gemma":0.0011341511,"threshold_uncertainty_score":0.008308768},"labels":[],"label_agreement":null},{"id":"W2165952695","doi":"10.1038/nrclinonc.2014.73","title":"Management of low risk prostate cancer—active surveillance and focal therapy","year":2014,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre","funders":"National Institutes of Health; Prostate Cancer UK; University College London Hospitals NHS Foundation Trust; National Institute for Health and Care Research","keywords":"Medicine; Prostate cancer; Disease; Radiation therapy; Cancer; Prostate; Internal medicine; Oncology; Biopsy; Risk assessment; Intensive care medicine; Gynecology","score_opus":0.08557453831440603,"score_gpt":0.504704247737107,"score_spread":0.41912970942270095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165952695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004081892,0.999355,0.0000530971,0.00017837339,0.00008663397,0.0000025991094,0.0000054833154,0.0000021308956,0.00027579154],"genre_scores_gemma":[0.0005841128,0.9986267,0.00012100379,0.00031838415,0.00018118764,0.000003405725,0.00001484054,8.346701e-7,0.00014952409],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996026,0.00008920807,0.00007284611,0.0000631132,0.00014335106,0.000028927116],"domain_scores_gemma":[0.9993832,0.0003860083,0.000103638304,0.000011122814,0.00008757819,0.000028367122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000817042,0.0007788675,0.00197244,0.0019420718,0.00021647058,0.0011298959,0.001176543,0.0011180057,0.0026999076],"category_scores_gemma":[0.0016209702,0.00033322125,0.0009922133,0.001380013,0.0006222771,0.0011722249,0.00072458433,0.0019306468,0.0009492039],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000643676,0.000038495706,0.00023394932,0.026469158,0.00018794017,0.00011823806,0.00003083559,0.00036654525,0.0003760268,0.0016327669,0.019091934,0.95138973],"study_design_scores_gemma":[0.000098615186,0.00021211382,0.0029678035,0.038535386,0.00089066295,0.003449223,0.00013512433,0.000315948,0.00033390563,0.0036800937,0.94932514,0.000056000506],"about_ca_topic_score_codex":0.0021164515,"about_ca_topic_score_gemma":0.0052710106,"teacher_disagreement_score":0.0026999076,"about_ca_system_score_codex":0.00079458574,"about_ca_system_score_gemma":0.0012076803,"threshold_uncertainty_score":0.00903213},"labels":[],"label_agreement":null},{"id":"W2173653020","doi":"10.1038/nrclinonc.2015.203","title":"The importance of overdiagnosis in breast-cancer screening","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Overdiagnosis; Medicine; Breast cancer; Mammography; Breast cancer screening; Cancer; Population; Mammography screening; Gynecology; Oncology; Medical physics; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.3845793694743051,"score_gpt":0.5979906439529697,"score_spread":0.21341127447866465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2173653020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046969064,0.9987632,0.000040195773,0.00071983115,0.00021585052,0.0000013504797,0.000009938407,0.0000018795027,0.00020084916],"genre_scores_gemma":[0.0011830895,0.9971411,0.00009497506,0.0010138873,0.00045884823,0.0000030944989,0.0000140436805,0.0000011947935,0.00008971748],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978002,0.0007135074,0.00040793853,0.0002903931,0.00067941524,0.000108534536],"domain_scores_gemma":[0.98863924,0.008300283,0.0015944629,0.00012931647,0.0011480578,0.00018871935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038110183,0.00091230037,0.0024908325,0.00390958,0.0002877078,0.0018774469,0.0010407433,0.0021511703,0.003379486],"category_scores_gemma":[0.012396983,0.00051512424,0.0012245015,0.003790939,0.0010617165,0.00205254,0.0014595753,0.0024555777,0.00064864766],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007882402,0.000024799649,0.0014226595,0.047579367,0.0005406933,0.00016481472,0.00012925554,0.00028226836,0.00019344247,0.0026902494,0.02556518,0.9213284],"study_design_scores_gemma":[0.00008691094,0.0001793,0.010323619,0.10482328,0.0035315175,0.0028977185,0.00055923976,0.00034608544,0.00042207798,0.006504086,0.8702343,0.00009193494],"about_ca_topic_score_codex":0.004607131,"about_ca_topic_score_gemma":0.010393713,"teacher_disagreement_score":0.004607131,"about_ca_system_score_codex":0.0017973619,"about_ca_system_score_gemma":0.0037187994,"threshold_uncertainty_score":0.020154834},"labels":[],"label_agreement":null},{"id":"W2204191358","doi":"10.1038/nrclinonc.2015.173","title":"Population genetic testing for cancer susceptibility: founder mutations to genomes","year":2015,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":107,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University and Génome Québec Innovation Centre; McGill University","funders":"National Human Genome Research Institute; National Institutes of Health; National Society of Genetic Counselors","keywords":"Genetic testing; Population; Medicine; Cancer; Genetics; Genetic predisposition; Mutation; Exome; Genetic counseling; Disease; Exome sequencing; Bioinformatics; Biology; Gene; Environmental health; Internal medicine","score_opus":0.2628726937656278,"score_gpt":0.5534412217413754,"score_spread":0.29056852797574767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204191358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000089873174,0.99671054,0.00058868167,0.0014856657,0.00037510134,0.0000042188094,0.000040960575,0.00001687754,0.00068801484],"genre_scores_gemma":[0.0014615589,0.9948672,0.0006361847,0.001545343,0.00079951785,0.000008347835,0.000058513277,0.0000052310015,0.00061810383],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99939144,0.00019535115,0.000062126026,0.000115900235,0.0001970503,0.000038186612],"domain_scores_gemma":[0.99755293,0.0018268543,0.00012379773,0.00005303048,0.00034782867,0.00009555897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019420433,0.0008681998,0.0016388724,0.0019815632,0.00021107275,0.00093702757,0.0012272473,0.0017852451,0.0030956122],"category_scores_gemma":[0.0048987907,0.00033000042,0.0006680157,0.0015441527,0.000965807,0.0011260932,0.0010299251,0.0026336696,0.0010802905],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006091625,0.0000373392,0.00083383784,0.004702655,0.00013360936,0.00030322775,0.000041611293,0.0006067667,0.00079670065,0.005681653,0.064142615,0.922659],"study_design_scores_gemma":[0.00004162258,0.000068650545,0.0026264118,0.006022171,0.00024657333,0.002403893,0.000072963645,0.00040749175,0.00051615096,0.014033858,0.9735212,0.000039051385],"about_ca_topic_score_codex":0.002589953,"about_ca_topic_score_gemma":0.0045893523,"teacher_disagreement_score":0.0030956122,"about_ca_system_score_codex":0.0010230907,"about_ca_system_score_gemma":0.0011320977,"threshold_uncertainty_score":0.01035589},"labels":[],"label_agreement":null},{"id":"W2268138802","doi":"10.1038/nrclinonc.2015.236","title":"Academic research sheds light on issues that matter to patients","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Breast cancer; Adjuvant; Oncology; Adjuvant chemotherapy; Disease; Stage (stratigraphy); Clinical trial; Intensive care medicine; Internal medicine; Cancer","score_opus":0.34109635688056944,"score_gpt":0.6409072574456448,"score_spread":0.29981090056507537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2268138802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000086775246,0.98966354,0.000082536695,0.0066560786,0.0011274664,0.0000042804063,0.000019610952,0.0000041252056,0.0023556948],"genre_scores_gemma":[0.0016776918,0.99044037,0.00018829304,0.005032778,0.0017048327,0.000011422266,0.000024963965,0.000003526399,0.0009161721],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849725,0.0006059567,0.00022724332,0.00015553324,0.00041013563,0.00010380498],"domain_scores_gemma":[0.99379265,0.0044614165,0.00059660425,0.00012529822,0.00078124675,0.00024273044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039251735,0.00069295004,0.0015296537,0.002207084,0.00062104553,0.0027664367,0.0007193105,0.0024472903,0.0087884],"category_scores_gemma":[0.009821895,0.00025420947,0.00062703533,0.0029758122,0.001672872,0.002846762,0.0014983674,0.003603461,0.0018052026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090591704,0.000061008726,0.00052375614,0.023524996,0.00016779458,0.00013053742,0.000263839,0.0002127952,0.0003500643,0.020920571,0.12528062,0.8284735],"study_design_scores_gemma":[0.00002917659,0.000040137293,0.0006393697,0.012867381,0.00015995179,0.0003366149,0.00029106348,0.000030628402,0.000098208315,0.0057880445,0.9797054,0.000014038427],"about_ca_topic_score_codex":0.0011865586,"about_ca_topic_score_gemma":0.003994818,"teacher_disagreement_score":0.0087884,"about_ca_system_score_codex":0.001543176,"about_ca_system_score_gemma":0.004445114,"threshold_uncertainty_score":0.02940017},"labels":[],"label_agreement":null},{"id":"W2269087069","doi":"10.1038/nrclinonc.2015.224","title":"Can advanced-stage ovarian cancer be cured?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Ovarian cancer; Stage (stratigraphy); Oncology; Cancer; Internal medicine; Gynecology","score_opus":0.19827072950754132,"score_gpt":0.5608637098340041,"score_spread":0.3625929803264628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2269087069","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004818133,0.998692,0.000028267486,0.0005229331,0.00024200066,0.0000018529175,0.000011953658,0.0000023164275,0.0004504089],"genre_scores_gemma":[0.0007105685,0.9981933,0.000047452824,0.0004728232,0.0002726823,0.0000035362937,0.000017174902,6.703219e-7,0.000281753],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998141,0.00004560031,0.00003311232,0.000028540084,0.00005882554,0.000019792324],"domain_scores_gemma":[0.9996284,0.00022063761,0.00006539169,0.00000965897,0.00004862511,0.00002716653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066343206,0.0005646292,0.0013984158,0.0012366711,0.00019624196,0.000856888,0.000547191,0.00091863115,0.0052381456],"category_scores_gemma":[0.0015965557,0.00024947908,0.00051658583,0.0010077812,0.00046231944,0.0014489423,0.0007588237,0.0018613002,0.0011445709],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011162372,0.000031120508,0.00023162036,0.025600394,0.00012559387,0.00010969536,0.000043271164,0.0001851456,0.00046897403,0.0023219131,0.03451017,0.93626046],"study_design_scores_gemma":[0.000083282044,0.00012954192,0.001230086,0.011961164,0.00038142301,0.00083033263,0.000076943856,0.00006685119,0.0002003883,0.002137938,0.98288625,0.00001578199],"about_ca_topic_score_codex":0.00085081457,"about_ca_topic_score_gemma":0.0028894288,"teacher_disagreement_score":0.0052381456,"about_ca_system_score_codex":0.0004392932,"about_ca_system_score_gemma":0.0009977843,"threshold_uncertainty_score":0.017523348},"labels":[],"label_agreement":null},{"id":"W2396078839","doi":"10.1038/nrclinonc.2016.64","title":"Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pharmacokinetics; Chemotherapy; Oncology; Clinical trial; Pharmacology; Drug; Colorectal cancer; Intensive care medicine; Cancer; Internal medicine","score_opus":0.1640822111862569,"score_gpt":0.5620383089072559,"score_spread":0.39795609772099905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396078839","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026336993,0.996802,0.0005089056,0.0014244633,0.00019628949,0.0000029615856,0.000020461695,0.00000962728,0.0007718618],"genre_scores_gemma":[0.0040901867,0.9935256,0.00046980457,0.00079649687,0.0005193106,0.000007201173,0.000034944307,0.000005825145,0.00055061135],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962115,0.00012318717,0.000049602382,0.00006269479,0.00011901001,0.000024276847],"domain_scores_gemma":[0.99894875,0.00062487065,0.0001635577,0.00003572209,0.00018457847,0.000042565665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010084093,0.000539146,0.0018178133,0.0006776678,0.000151496,0.0014068111,0.0007289314,0.0009588261,0.002116682],"category_scores_gemma":[0.0018859296,0.00024338155,0.00043831454,0.00093570095,0.0006177821,0.0017170756,0.0005516778,0.0023542296,0.0009151371],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022773522,0.000058935282,0.00038344087,0.009490258,0.000119728975,0.00016077973,0.000052680127,0.0006041382,0.0035200273,0.0057945102,0.022126619,0.95746124],"study_design_scores_gemma":[0.00006905563,0.0003721045,0.0020106114,0.005033743,0.000338565,0.0027651207,0.000084286425,0.0006488634,0.0030229257,0.006737875,0.97887063,0.000046210087],"about_ca_topic_score_codex":0.0007215377,"about_ca_topic_score_gemma":0.0014939501,"teacher_disagreement_score":0.002116682,"about_ca_system_score_codex":0.0007287807,"about_ca_system_score_gemma":0.0014200264,"threshold_uncertainty_score":0.007080972},"labels":[],"label_agreement":null},{"id":"W2508265039","doi":"10.1038/nrclinonc.2016.120","title":"Cancer, obesity, diabetes, and antidiabetic drugs: is the fog clearing?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":215,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Obesity; Cancer; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Intensive care medicine; Bioinformatics; Internal medicine; Endocrinology","score_opus":0.058055389790396275,"score_gpt":0.45216803911155623,"score_spread":0.39411264932115997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2508265039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024524265,0.997283,0.00005019241,0.0015846301,0.0006226221,0.0000013748544,0.000010109201,0.000006551986,0.00041700332],"genre_scores_gemma":[0.0002833169,0.9969529,0.00009845394,0.0012901409,0.000872653,0.0000029966093,0.000017379594,0.0000018602095,0.000480361],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994593,0.00012371865,0.000060416525,0.000068525034,0.00022595467,0.000062102474],"domain_scores_gemma":[0.99872357,0.0005899559,0.0001461424,0.000042851163,0.0003279782,0.00016949273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001532955,0.0011363821,0.002970472,0.0018024165,0.00060799596,0.0025546607,0.0016139629,0.0029579042,0.0060639246],"category_scores_gemma":[0.0022624806,0.00047706466,0.000784709,0.0026999216,0.001411902,0.003960372,0.0016209324,0.005049224,0.0030017474],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016991424,0.00006268664,0.00025405263,0.009288283,0.00011506132,0.00018195079,0.00007822666,0.0002300758,0.0007437534,0.007807239,0.1655288,0.81553996],"study_design_scores_gemma":[0.000024432486,0.000042504234,0.0003448263,0.0022456537,0.00007337527,0.00039044063,0.00007643308,0.0000410084,0.00006752191,0.0030573306,0.99362,0.000016556223],"about_ca_topic_score_codex":0.0022765668,"about_ca_topic_score_gemma":0.0055367975,"teacher_disagreement_score":0.0060639246,"about_ca_system_score_codex":0.0013520296,"about_ca_system_score_gemma":0.0030728169,"threshold_uncertainty_score":0.020285904},"labels":[],"label_agreement":null},{"id":"W2524154560","doi":"10.1038/nrclinonc.2016.160","title":"Stage III NSCLC — is it time to centralize care?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Stage (stratigraphy); Oncology; MEDLINE; Internal medicine; Family medicine","score_opus":0.15045788609815203,"score_gpt":0.5317290995752756,"score_spread":0.38127121347712356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2524154560","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001817894,0.9954952,0.00006625156,0.0031858238,0.0004945249,0.0000039890797,0.000014965221,0.000004453617,0.0005529309],"genre_scores_gemma":[0.0049320697,0.99007845,0.00026251792,0.0034234338,0.000911193,0.00001704103,0.000045777106,0.0000025320633,0.00032705584],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940133,0.00020750557,0.00010453676,0.00007378784,0.00012838292,0.00008440235],"domain_scores_gemma":[0.9984156,0.0007260631,0.00035874412,0.000031313877,0.00030386663,0.0001644411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019639893,0.00043254116,0.0011810821,0.00086833746,0.00020229524,0.0014533825,0.0007948959,0.00093657186,0.00270887],"category_scores_gemma":[0.0049829716,0.00018745518,0.0007076454,0.001327849,0.00056267367,0.0017850642,0.0011304881,0.0020714535,0.00052834465],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010769812,0.000035433575,0.0013336894,0.020503586,0.0003189487,0.00008909078,0.0000889217,0.00025508134,0.00019332804,0.0034419484,0.053397458,0.92023486],"study_design_scores_gemma":[0.00017549051,0.0002192456,0.0062621576,0.045723274,0.00094356504,0.0006911513,0.00037927105,0.00016435684,0.00019147084,0.0042465995,0.9409713,0.000032076172],"about_ca_topic_score_codex":0.0036365965,"about_ca_topic_score_gemma":0.010148468,"teacher_disagreement_score":0.0036365965,"about_ca_system_score_codex":0.0016794686,"about_ca_system_score_gemma":0.0048888307,"threshold_uncertainty_score":0.012185454},"labels":[],"label_agreement":null},{"id":"W2530952499","doi":"10.1038/nrclinonc.2016.162","title":"Imaging biomarker roadmap for cancer studies","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1078,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"Innovative Medicines Initiative; European Commission; Wellbeing of Women; Engineering and Physical Sciences Research Council; National Institute for Health and Care Research; National Cancer Institute; Cancer Research UK; Medical Research Council; European Federation of Pharmaceutical Industries and Associations","keywords":"Medicine; Clinical trial; Medical physics; Drug development; Translational research; Standardization; Biomarker; Internal medicine; Pathology; Drug; Pharmacology; Computer science","score_opus":0.2445465864156629,"score_gpt":0.6209623229717565,"score_spread":0.37641573655609356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2530952499","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045328896,0.9975503,0.00028819958,0.0013293655,0.0002758259,0.00000757623,0.000030201918,0.000010564154,0.00046257302],"genre_scores_gemma":[0.0009965877,0.99575233,0.0008322368,0.0014087694,0.00056701445,0.000018963383,0.00007506646,0.0000049035307,0.00034412096],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990318,0.00034702197,0.00015545692,0.00014197314,0.0002443703,0.00007948372],"domain_scores_gemma":[0.993507,0.004383261,0.00048464353,0.00014504544,0.001278351,0.00020159682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004416814,0.0012567288,0.0027054867,0.004380456,0.000442655,0.002756095,0.0018107685,0.0028170578,0.0072851935],"category_scores_gemma":[0.008966057,0.00060961366,0.0012537194,0.0034051733,0.0012228725,0.004158923,0.0019785075,0.0034511413,0.0023353205],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013367031,0.000056653305,0.00042124238,0.019878712,0.00020433126,0.0002527311,0.00006902315,0.00048678063,0.0008006376,0.011490555,0.05375892,0.9124467],"study_design_scores_gemma":[0.000053070406,0.00011598553,0.0007319348,0.015342196,0.00041715326,0.00096028874,0.00010555568,0.0003239715,0.0004215667,0.015240443,0.96624494,0.00004298149],"about_ca_topic_score_codex":0.0021166408,"about_ca_topic_score_gemma":0.004047714,"teacher_disagreement_score":0.0072851935,"about_ca_system_score_codex":0.0017555553,"about_ca_system_score_gemma":0.0047344454,"threshold_uncertainty_score":0.024371445},"labels":[],"label_agreement":null},{"id":"W2553180822","doi":"10.1038/nrclinonc.2016.184","title":"HPV vaccination in boys — will the UK join the fight?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"University Health Network","keywords":"Join (topology); Medicine; Vaccination; Family medicine; Virology","score_opus":0.2189165276759974,"score_gpt":0.5782711926976772,"score_spread":0.35935466502167984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2553180822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006859941,0.99595547,0.000008744807,0.003139653,0.00045029286,0.0000013243164,0.000015481623,0.0000017980375,0.00035872465],"genre_scores_gemma":[0.0009420533,0.9966859,0.000023809163,0.0016547622,0.00038102327,0.0000028720306,0.0000145615795,0.0000012035068,0.00029382357],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943143,0.0001924827,0.000097605596,0.000061609004,0.00013166676,0.00008519712],"domain_scores_gemma":[0.9979755,0.0012445614,0.00027639282,0.000035407877,0.00030090296,0.00016726129],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016288782,0.00048013218,0.0018534517,0.00108196,0.0003306296,0.0015668148,0.0006981425,0.0026332652,0.0076440508],"category_scores_gemma":[0.004519359,0.00024981017,0.0007743074,0.0015885034,0.00068429427,0.0019741154,0.0010081395,0.0026427512,0.0011413025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024680162,0.000025237896,0.0005225844,0.028332204,0.00017595442,0.00011909544,0.00015723403,0.0001056688,0.00024177541,0.0029389334,0.091084085,0.87605035],"study_design_scores_gemma":[0.000077242265,0.00013577697,0.0027508687,0.044186227,0.00040216095,0.00058615697,0.00037859255,0.000033744553,0.000105200656,0.0013599509,0.9499631,0.000021088625],"about_ca_topic_score_codex":0.0075611193,"about_ca_topic_score_gemma":0.013688867,"teacher_disagreement_score":0.0076440508,"about_ca_system_score_codex":0.0014019301,"about_ca_system_score_gemma":0.0032679245,"threshold_uncertainty_score":0.025571942},"labels":[],"label_agreement":null},{"id":"W2555271530","doi":"10.1038/nrclinonc.2016.189","title":"Screening and treatment: where do we go from here?","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Stage (stratigraphy); Internal medicine; Prostate-specific antigen; Randomized controlled trial; Cancer; Gynecology","score_opus":0.18242483890280148,"score_gpt":0.5137869171961926,"score_spread":0.33136207829339115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555271530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000012702685,0.9975224,0.00002999484,0.0016533665,0.00052918826,0.0000016738858,0.000008615329,0.0000032305818,0.00023882577],"genre_scores_gemma":[0.0002877056,0.9969893,0.00008578681,0.0017221408,0.0006675565,0.000004228232,0.0000113774995,0.0000016636075,0.00023018467],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987764,0.00039643887,0.00020181779,0.00015730287,0.00035858943,0.000109402834],"domain_scores_gemma":[0.9966993,0.0018272408,0.00044076648,0.000063606734,0.00069894025,0.00027005406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029832232,0.001397633,0.004219547,0.0029574698,0.00071951,0.0036296733,0.0015281803,0.0041355584,0.00775313],"category_scores_gemma":[0.0059435763,0.000676057,0.0013620432,0.0034085666,0.0017185778,0.0049799206,0.0020065268,0.0059392564,0.0025445397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013279461,0.00005966435,0.00029256343,0.03777558,0.0002868481,0.00011496153,0.00012754496,0.0003062479,0.00023586437,0.0059959455,0.13172768,0.82294434],"study_design_scores_gemma":[0.000056323144,0.000091311704,0.00071423827,0.03743414,0.00040596392,0.00051750476,0.00021566298,0.000083572944,0.000059635087,0.0034284336,0.9569532,0.00004010501],"about_ca_topic_score_codex":0.0045420476,"about_ca_topic_score_gemma":0.012915535,"teacher_disagreement_score":0.00775313,"about_ca_system_score_codex":0.002458613,"about_ca_system_score_gemma":0.0065398067,"threshold_uncertainty_score":0.025936842},"labels":[],"label_agreement":null},{"id":"W2564174616","doi":"10.1038/nrclinonc.2016.195","title":"RECIST — learning from the past to build the future","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute; Amgen","keywords":"Medicine; Medical physics; MEDLINE","score_opus":0.06508934699397997,"score_gpt":0.44918318371777877,"score_spread":0.3840938367237988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564174616","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067725865,0.9906031,0.00045256282,0.0056311507,0.0015715149,0.0000043550044,0.000024002788,0.00003364059,0.0016119836],"genre_scores_gemma":[0.0011948887,0.9886757,0.0006169059,0.005444516,0.0017588811,0.000010305428,0.000059791575,0.00001875485,0.002220261],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993445,0.00019686225,0.00005561542,0.00008528466,0.00023886646,0.00007878587],"domain_scores_gemma":[0.99840325,0.0009245178,0.00012860305,0.000068546695,0.00028995544,0.00018510892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023531655,0.0008709208,0.0013407079,0.0014583339,0.00045158455,0.002740487,0.0017425474,0.002863965,0.0060530994],"category_scores_gemma":[0.004122034,0.00034114002,0.0005134947,0.0011846754,0.002082727,0.004110876,0.0018132472,0.006912353,0.0036821929],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008472358,0.000035502326,0.00017370644,0.0050695376,0.00007255222,0.00019286961,0.00013239044,0.00026364438,0.0005717203,0.014715482,0.17665488,0.80203295],"study_design_scores_gemma":[0.000012329781,0.000017935039,0.00011633843,0.0016288108,0.000022209062,0.00041544854,0.000044402306,0.00003960602,0.00013576148,0.004831395,0.99272305,0.000012790987],"about_ca_topic_score_codex":0.0013646439,"about_ca_topic_score_gemma":0.003540772,"teacher_disagreement_score":0.0060530994,"about_ca_system_score_codex":0.0012706819,"about_ca_system_score_gemma":0.0024173555,"threshold_uncertainty_score":0.020249605},"labels":[],"label_agreement":null},{"id":"W2589693917","doi":"10.1038/nrclinonc.2017.18","title":"Approvals in 2016: questioning the clinical benefit of anticancer therapies","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of New Brunswick; University of Toronto; Canada Research Chairs; Queen's University","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Oncology; Medical physics; Internal medicine","score_opus":0.40883118857482037,"score_gpt":0.5399416392635282,"score_spread":0.13111045068870786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589693917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003263051,0.9847254,0.00017624795,0.011728401,0.000946304,0.000009264114,0.00013355822,0.000005688555,0.0019487763],"genre_scores_gemma":[0.010503408,0.9778641,0.00026767154,0.008432593,0.0019173665,0.000024194413,0.00015758228,0.000009065346,0.000823916],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99593496,0.0016742906,0.0005521851,0.000329223,0.0012712175,0.00023811893],"domain_scores_gemma":[0.97662735,0.017365871,0.002536837,0.00030877307,0.0027134432,0.00044765967],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.00957435,0.00060920767,0.0024566806,0.0017185598,0.00034790306,0.002905595,0.0012874777,0.003738154,0.00864345],"category_scores_gemma":[0.026786942,0.00033748342,0.0018893022,0.002609836,0.0017382561,0.0036790487,0.001446407,0.0048489217,0.0011019128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005565088,0.000047616904,0.0007479273,0.019460898,0.00060327223,0.00020677608,0.000079567595,0.0015227967,0.00032156912,0.04943967,0.0940397,0.83297366],"study_design_scores_gemma":[0.00021916648,0.00013276929,0.0026218903,0.01932918,0.00068908016,0.0005247663,0.00013004853,0.00040679311,0.00023757695,0.024974868,0.95068914,0.00004475345],"about_ca_topic_score_codex":0.003141496,"about_ca_topic_score_gemma":0.0072809015,"teacher_disagreement_score":0.99042565,"about_ca_system_score_codex":0.0034951828,"about_ca_system_score_gemma":0.0060675414,"threshold_uncertainty_score":0.050634623},"labels":[],"label_agreement":null},{"id":"W2606269644","doi":"10.1038/nrclinonc.2017.57","title":"Cancer, obesity, and diabetes: TKIs exert multiple effects on glucose homeostasis","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Glucose homeostasis; Diabetes mellitus; Obesity; Cancer; Homeostasis; Oncology; Internal medicine; Bioinformatics; Endocrinology; Insulin resistance","score_opus":0.11735467934617697,"score_gpt":0.48703406104377206,"score_spread":0.36967938169759507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2606269644","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006826141,0.9981127,0.00009899797,0.0007621679,0.000387873,0.000002598836,0.00002127359,0.00000953533,0.0005365831],"genre_scores_gemma":[0.00044203564,0.9982527,0.0000952501,0.00046142488,0.0002848952,0.0000040547106,0.000026625408,0.0000013137193,0.00043166045],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997502,0.000037183974,0.00002966273,0.00003891447,0.00011040251,0.000033686083],"domain_scores_gemma":[0.9996176,0.00015569603,0.000052494943,0.000012776641,0.00010907652,0.000052300657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006025473,0.0010108035,0.0017977828,0.0013156389,0.00030542872,0.0014998985,0.0011128517,0.0015304164,0.0038944783],"category_scores_gemma":[0.0008282106,0.00029669024,0.0005382618,0.0019678553,0.0006160872,0.001439511,0.0010385069,0.0030465834,0.0020388374],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014409011,0.000057459296,0.00021551645,0.009068663,0.000112587426,0.00014047776,0.000035434907,0.0003447852,0.0018717396,0.005004998,0.07108842,0.9119157],"study_design_scores_gemma":[0.000033695913,0.000055982724,0.0005137199,0.0017456328,0.0001025333,0.0005352907,0.000038962742,0.000060692164,0.00029911558,0.0021567668,0.99444026,0.00001735225],"about_ca_topic_score_codex":0.001204162,"about_ca_topic_score_gemma":0.0034537646,"teacher_disagreement_score":0.0038944783,"about_ca_system_score_codex":0.000900847,"about_ca_system_score_gemma":0.0015022627,"threshold_uncertainty_score":0.013028324},"labels":[],"label_agreement":null},{"id":"W2741665883","doi":"10.1038/nrclinonc.2017.96","title":"HER2-positive breast cancer is lost in translation: time for patient-centered research","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Breast cancer; Biomarker; Translational research; Disease; Drug development; Biomarker discovery; Cancer; Translational science; Oncology; Clinical research; Trastuzumab; Internal medicine; Bioinformatics; Drug; Pathology; Proteomics","score_opus":0.5935254299144336,"score_gpt":0.6815331907619722,"score_spread":0.08800776084753859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2741665883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003939806,0.98808134,0.000106190186,0.009280685,0.0019970527,0.000002443815,0.000017078984,0.0000114561,0.00046437114],"genre_scores_gemma":[0.0009117416,0.9879616,0.00030784958,0.0075837597,0.002705601,0.000008315047,0.000039387087,0.000008092359,0.00047358827],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997767,0.0009025336,0.00025244404,0.00020005116,0.0006720981,0.00020588521],"domain_scores_gemma":[0.9892771,0.0074625956,0.0005996387,0.00028514402,0.0017336416,0.00064183475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061505777,0.000987282,0.0034244235,0.0018716964,0.00076946564,0.004644603,0.0018702095,0.0046236375,0.0093482165],"category_scores_gemma":[0.009931719,0.00044756237,0.0012074043,0.0021237978,0.0025371343,0.008263157,0.0029243964,0.008084842,0.003183119],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001143379,0.000064296604,0.0002111905,0.020741072,0.00017733149,0.0002187733,0.00028568215,0.00027688168,0.00054307486,0.01654741,0.24658296,0.7142369],"study_design_scores_gemma":[0.000025404297,0.000042155105,0.00022083375,0.007760437,0.000087661254,0.00029872454,0.00026859823,0.00005612616,0.000079412785,0.0067792786,0.9843604,0.000021029233],"about_ca_topic_score_codex":0.0014807935,"about_ca_topic_score_gemma":0.0038817078,"teacher_disagreement_score":0.0093482165,"about_ca_system_score_codex":0.0021255326,"about_ca_system_score_gemma":0.0063644513,"threshold_uncertainty_score":0.032527745},"labels":[],"label_agreement":null},{"id":"W2762027870","doi":"10.1038/nrclinonc.2017.153","title":"Patient-reported outcomes in cancer care — hearing the patient voice at greater volume","year":2017,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":255,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Cambia Health Foundation; Cancer Care Ontario; American Cancer Society","keywords":"Context (archaeology); Health care; Data collection; Workflow; Medicine; Quality (philosophy); MEDLINE; Cancer; Medical physics; Family medicine; Computer science","score_opus":0.2736460353004048,"score_gpt":0.5316970210127823,"score_spread":0.25805098571237745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2762027870","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010972292,0.99912447,0.000017107743,0.00034529433,0.0001515131,0.000002792022,0.000020443269,0.0000014397449,0.00022731494],"genre_scores_gemma":[0.0026843569,0.9962979,0.000075141266,0.00050972897,0.00029983817,0.000010327043,0.000029260944,0.0000010852647,0.00009234771],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99829763,0.00060010026,0.00028662113,0.00018191455,0.00052415504,0.00010965679],"domain_scores_gemma":[0.9956547,0.0030554277,0.0006145617,0.00004834713,0.0004929442,0.0001339751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026000289,0.0007302945,0.0025348787,0.0021541836,0.0003118701,0.001853729,0.0011988145,0.0012762411,0.0037074995],"category_scores_gemma":[0.009744765,0.00029530097,0.0017379127,0.003383338,0.0008093621,0.0014928202,0.001276983,0.0023229967,0.0004904589],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010242546,0.000069031834,0.0024215498,0.046349276,0.0010397276,0.00005639493,0.0001366481,0.00022784124,0.00009095698,0.0022643933,0.025865614,0.9213762],"study_design_scores_gemma":[0.00020153291,0.00047966672,0.03609084,0.1938016,0.0052797617,0.0012718465,0.0010604761,0.00039591026,0.00028389136,0.007677494,0.7532625,0.00019443007],"about_ca_topic_score_codex":0.004194459,"about_ca_topic_score_gemma":0.010452127,"teacher_disagreement_score":0.004194459,"about_ca_system_score_codex":0.0014319371,"about_ca_system_score_gemma":0.002513911,"threshold_uncertainty_score":0.013750434},"labels":[],"label_agreement":null},{"id":"W2782739600","doi":"10.1038/nrclinonc.2013.17","title":"Tamoxifen—when more might be better","year":2013,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Tamoxifen; Breast cancer; Oestrogen receptor; Oncology; Adverse effect; Internal medicine; Gynecology; Cancer","score_opus":0.09073277744549883,"score_gpt":0.4784138782681507,"score_spread":0.38768110082265184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2782739600","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008364904,0.9932406,0.00017739383,0.0043978794,0.000978399,0.000005070579,0.000040976403,0.000013536263,0.0010625441],"genre_scores_gemma":[0.0010177689,0.9916353,0.00031245456,0.0044549406,0.0013405242,0.000015428705,0.000058766054,0.000004509586,0.0011602454],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99972886,0.000075223914,0.000043748114,0.00003849103,0.00008595143,0.000027737433],"domain_scores_gemma":[0.99944097,0.0003326066,0.000056615398,0.000018139877,0.00010929537,0.000042462256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013108316,0.0007992462,0.0016563548,0.0013001084,0.00027700356,0.0012094352,0.0010348142,0.0019874857,0.0040159347],"category_scores_gemma":[0.0022403148,0.00028710003,0.00043295516,0.0012100281,0.0007732397,0.0018316732,0.00067318475,0.0032830252,0.0017948167],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017703619,0.000041088668,0.00019049225,0.0064086686,0.00011596616,0.00018781943,0.000043632128,0.0003082088,0.0010693518,0.006214558,0.1465761,0.8386671],"study_design_scores_gemma":[0.00007970197,0.000059377995,0.0005056068,0.0027096125,0.0001260749,0.0005368784,0.000059859452,0.00008388034,0.00022033573,0.005350927,0.99024945,0.00001833955],"about_ca_topic_score_codex":0.0015626171,"about_ca_topic_score_gemma":0.0054094368,"teacher_disagreement_score":0.0040159347,"about_ca_system_score_codex":0.0010166614,"about_ca_system_score_gemma":0.00091870944,"threshold_uncertainty_score":0.013434589},"labels":[],"label_agreement":null},{"id":"W2785975065","doi":"10.1038/nrclinonc.2018.14","title":"Bridging the gap: are animal models consistent with clinical cancer cachexia?","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Canadian Institutes of Health Research; Alberta Cancer Foundation","keywords":"Cachexia; Cancer cachexia; Medicine; Cancer; Bridging (networking); Parallels; Cancer treatment; Pace; Bioinformatics; Intensive care medicine; Oncology; Internal medicine; Biology; Computer science","score_opus":0.6230091410809944,"score_gpt":0.6374622087566653,"score_spread":0.014453067675670894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2785975065","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038626613,0.99310416,0.00059816113,0.004211954,0.0006339481,0.000015394944,0.000104273706,0.000013660083,0.0009322265],"genre_scores_gemma":[0.0035959429,0.99114907,0.0009283943,0.0031514328,0.0006670677,0.000048528265,0.00015392437,0.0000080269765,0.00029760413],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988943,0.00047266675,0.00016878947,0.00015773052,0.00024369093,0.00006299147],"domain_scores_gemma":[0.99375856,0.004442047,0.0005663542,0.000289598,0.0007939766,0.00014944964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054867007,0.0008392612,0.0034830535,0.0013898688,0.00028988213,0.0024127513,0.0018951677,0.003201806,0.0031189881],"category_scores_gemma":[0.0073191747,0.0002950415,0.0008541478,0.0012248836,0.0019754216,0.002760677,0.0011147015,0.004589261,0.0012341852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012023455,0.00031073164,0.0018564705,0.05943467,0.000918189,0.00052679714,0.00027675432,0.0005700219,0.006071328,0.039847095,0.0989656,0.7900199],"study_design_scores_gemma":[0.00020521448,0.0004905069,0.0024973578,0.020656066,0.00090314355,0.0019124454,0.00035474592,0.00023866058,0.0016132112,0.026476061,0.944578,0.000074634794],"about_ca_topic_score_codex":0.00094559515,"about_ca_topic_score_gemma":0.0017158369,"teacher_disagreement_score":0.0054867007,"about_ca_system_score_codex":0.0007649299,"about_ca_system_score_gemma":0.00226792,"threshold_uncertainty_score":0.029016793},"labels":[],"label_agreement":null},{"id":"W2789017398","doi":"10.1038/nrclinonc.2018.27","title":"Cancer immunotherapy and the value of cure","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":188,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Oncology; Cancer immunotherapy; Clinical Oncology; Cancer; Internal medicine; Value (mathematics); Immune checkpoint; Intensive care medicine","score_opus":0.12489199908178489,"score_gpt":0.5402313480486471,"score_spread":0.41533934896686225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789017398","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024813007,0.9964469,0.00006988649,0.0018521079,0.00075125456,0.0000022150482,0.000011417864,0.000004504375,0.0008368802],"genre_scores_gemma":[0.0006250933,0.9961272,0.00009777111,0.0015113696,0.0010658618,0.000005640747,0.000016260705,0.0000017552686,0.0005490114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993144,0.00019604305,0.00008191445,0.00007753996,0.00026498555,0.00006507326],"domain_scores_gemma":[0.99741083,0.0017825012,0.00022561308,0.00006570922,0.0003792539,0.0001361673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019167227,0.0009418753,0.0017096521,0.0025356202,0.00047445117,0.0022148243,0.0011495446,0.002742016,0.0060386634],"category_scores_gemma":[0.0042489604,0.00035741672,0.00058100827,0.0019152437,0.0016798131,0.0032868816,0.0016473219,0.0046427185,0.0021942714],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010964272,0.000041666357,0.00017902054,0.016523503,0.000112876056,0.00017266865,0.00009579182,0.00040588225,0.00055220566,0.026493553,0.1080661,0.847247],"study_design_scores_gemma":[0.000015555093,0.000024293642,0.00017946462,0.0046760547,0.000049891976,0.0002669103,0.00004441066,0.00005054883,0.000068384674,0.0065324935,0.98808086,0.0000111138825],"about_ca_topic_score_codex":0.0011612135,"about_ca_topic_score_gemma":0.0024370572,"teacher_disagreement_score":0.0060386634,"about_ca_system_score_codex":0.0014542775,"about_ca_system_score_gemma":0.0026494095,"threshold_uncertainty_score":0.020201325},"labels":[],"label_agreement":null},{"id":"W2789727733","doi":"10.1038/nrclinonc.2018.30","title":"Epigenome-based cancer risk prediction: rationale, opportunities and challenges","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":173,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University and Génome Québec Innovation Centre","funders":"National Institute for Health and Care Research","keywords":"Epigenome; Epigenomics; DNA methylation; Medicine; Risk analysis (engineering); Cancer; Epigenetics; Bioinformatics; Biology; Genetics; Internal medicine","score_opus":0.32373190214194764,"score_gpt":0.48276934153648154,"score_spread":0.1590374393945339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2789727733","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026520374,0.99280566,0.002366303,0.0034894668,0.00032298124,0.000007265948,0.00008513979,0.000018510927,0.000639591],"genre_scores_gemma":[0.007211964,0.9848905,0.0033879348,0.0023343898,0.0014013895,0.000028234375,0.00017125807,0.000009774034,0.0005645696],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99894625,0.00038764643,0.000094337614,0.00025337542,0.0002598386,0.000058607628],"domain_scores_gemma":[0.99451715,0.0040983357,0.00024448568,0.0001383856,0.0008665521,0.00013510154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046951845,0.0010842104,0.0027124176,0.0016400714,0.00029899884,0.0020108856,0.0021010963,0.0020295861,0.0020289265],"category_scores_gemma":[0.0078055565,0.0004742992,0.0008291403,0.0013211305,0.001309887,0.0019771492,0.00128195,0.0038456114,0.0009303139],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013212119,0.000054573335,0.002867869,0.0060181543,0.00042218386,0.00018261334,0.00008090947,0.0013206131,0.0010685339,0.014270602,0.021922924,0.95165896],"study_design_scores_gemma":[0.00008849267,0.0002573905,0.006728067,0.013527415,0.0014036054,0.0031114032,0.00031142784,0.004371972,0.002469739,0.059850365,0.9077077,0.00017245281],"about_ca_topic_score_codex":0.0021898043,"about_ca_topic_score_gemma":0.0036033152,"teacher_disagreement_score":0.0046951845,"about_ca_system_score_codex":0.0011496355,"about_ca_system_score_gemma":0.0020520545,"threshold_uncertainty_score":0.024830818},"labels":[],"label_agreement":null},{"id":"W2794419219","doi":"10.1038/nrclinonc.2018.9","title":"Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":673,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; National Institutes of Health","keywords":"Medicine; Immunotherapy; Bevacizumab; Ipilimumab; Modalities; Cancer immunotherapy; Therapeutic modalities; Oncology; Hypoxia (environmental); Angiogenesis; Cancer; Cancer research; Internal medicine; Chemotherapy","score_opus":0.07002965191508446,"score_gpt":0.45947744276645835,"score_spread":0.3894477908513739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794419219","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001971561,0.99723864,0.00020639253,0.0010239007,0.00042412936,0.0000055260266,0.00002537092,0.000009384511,0.0008694979],"genre_scores_gemma":[0.0028876315,0.9935632,0.00041766447,0.0012392551,0.0011170156,0.000017322254,0.000052320152,0.000003919239,0.00070176716],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997017,0.00007051792,0.00004075601,0.0000558589,0.00008849721,0.00004266007],"domain_scores_gemma":[0.99943405,0.000343476,0.000073729556,0.000016743586,0.00009930966,0.000032587468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012283548,0.0007169593,0.0013804494,0.000968392,0.00018970565,0.001264767,0.0006655764,0.0012832315,0.003926535],"category_scores_gemma":[0.0016858043,0.00017145004,0.00071009697,0.00078200444,0.00044311897,0.001123084,0.00054705003,0.0024103664,0.0010387136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017384655,0.00009167616,0.0003759837,0.008657164,0.00021008511,0.00012574879,0.000025917874,0.00045617507,0.0014194436,0.007419723,0.03792417,0.9431202],"study_design_scores_gemma":[0.00015560038,0.0003094079,0.0016569254,0.00553615,0.00055229664,0.0013466978,0.000053017615,0.0003203103,0.001115172,0.007428906,0.98149335,0.0000322964],"about_ca_topic_score_codex":0.0004548565,"about_ca_topic_score_gemma":0.001103374,"teacher_disagreement_score":0.003926535,"about_ca_system_score_codex":0.00048568516,"about_ca_system_score_gemma":0.00089827605,"threshold_uncertainty_score":0.013135612},"labels":[],"label_agreement":null},{"id":"W2797068438","doi":"10.1038/s41571-018-0006-2","title":"The gut microbiota influences anticancer immunosurveillance and general health","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":504,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Immunosurveillance; Medicine; Gut flora; Cancer; Immunology; Internal medicine","score_opus":0.09779276010841215,"score_gpt":0.5360423370807821,"score_spread":0.43824957697236994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2797068438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015931248,0.99836224,0.000099684075,0.00059926294,0.00025115485,0.0000015147622,0.00001558554,0.0000047687677,0.00050648383],"genre_scores_gemma":[0.0017320281,0.996915,0.00011401249,0.00036388263,0.000408368,0.0000029947357,0.00002247659,0.0000014130246,0.0004398565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982613,0.00003613754,0.000016249149,0.000030324709,0.00006740238,0.00002370959],"domain_scores_gemma":[0.99968696,0.00014202697,0.000050860668,0.000010945116,0.000068691676,0.000040603878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005010045,0.00050219835,0.0008929457,0.00075936585,0.00017767175,0.0010766371,0.00045042034,0.0011580978,0.0026282594],"category_scores_gemma":[0.0010514696,0.0001495415,0.00026035294,0.0009393373,0.00049043505,0.00088139996,0.000784043,0.0015571824,0.00083303143],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015618397,0.000042767522,0.0005951217,0.00764044,0.00010797418,0.00017721523,0.000044457232,0.00030947558,0.0027408893,0.005869704,0.03299142,0.94932425],"study_design_scores_gemma":[0.000025551824,0.00007500136,0.0022539366,0.0031862706,0.00015214107,0.00083866826,0.00007659332,0.00012472285,0.0007780981,0.0042278287,0.98823905,0.00002215831],"about_ca_topic_score_codex":0.0006359378,"about_ca_topic_score_gemma":0.0013730505,"teacher_disagreement_score":0.0026282594,"about_ca_system_score_codex":0.0004428179,"about_ca_system_score_gemma":0.0009868405,"threshold_uncertainty_score":0.0087924},"labels":[],"label_agreement":null},{"id":"W2800009061","doi":"10.1038/s41571-018-0016-0","title":"The paradox of precision medicine","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":64,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University","funders":"Genome Canada","keywords":"Precision medicine; Medicine; Personalized medicine; Medical physics; Intensive care medicine; Bioinformatics; Pathology","score_opus":0.11869901755552532,"score_gpt":0.518780425510443,"score_spread":0.4000814079549177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800009061","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000514248,0.9803806,0.00050684076,0.0149931265,0.002240838,0.000002502503,0.000018074506,0.00001627476,0.0017903117],"genre_scores_gemma":[0.0027358432,0.9659981,0.00073493423,0.020370139,0.008303386,0.000015927577,0.000040450534,0.000013021895,0.0017882122],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998201,0.00067751994,0.00012646511,0.00020857155,0.00066353095,0.00012289044],"domain_scores_gemma":[0.9923888,0.0057613254,0.0002695668,0.00029073525,0.00094172405,0.00034788923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050767823,0.0011164965,0.0019358229,0.002452245,0.0008589236,0.003990906,0.0014688063,0.0051816637,0.0046005123],"category_scores_gemma":[0.009065411,0.00044554277,0.0005856295,0.0019345208,0.006717696,0.0070031653,0.003036849,0.009660189,0.0018097295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010133034,0.000050273935,0.00021652202,0.0062115323,0.000115865776,0.00028811817,0.00033603603,0.0006053917,0.00060008734,0.1514145,0.22196329,0.61809707],"study_design_scores_gemma":[0.000015294587,0.000017314038,0.00014952311,0.0021837188,0.000022375643,0.00029785265,0.000090600886,0.00009642243,0.000083119354,0.04853702,0.94849014,0.000016734148],"about_ca_topic_score_codex":0.001570864,"about_ca_topic_score_gemma":0.002507886,"teacher_disagreement_score":0.0051816637,"about_ca_system_score_codex":0.0027861996,"about_ca_system_score_gemma":0.004810853,"threshold_uncertainty_score":0.026848912},"labels":[],"label_agreement":null},{"id":"W2801498218","doi":"10.1038/s41571-018-0030-2","title":"Low-value approvals and high prices might incentivize ineffective drug development","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Drug development; Drug; Portfolio; Drug approval; Incentive; Pipeline (software); Clinical trial; Value (mathematics); Actuarial science; Risk analysis (engineering); Intensive care medicine; Public economics; Pharmacology; Finance; Business; Internal medicine; Economics; Microeconomics","score_opus":0.0935634486123407,"score_gpt":0.4775639335498192,"score_spread":0.3840004849374785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2801498218","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002084649,0.94278145,0.004489879,0.018369753,0.0023911789,0.000047693607,0.00010828995,0.00012226493,0.029604902],"genre_scores_gemma":[0.05450494,0.8972702,0.006381332,0.020201307,0.002920538,0.00011642351,0.00020685949,0.0000502051,0.01834819],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989536,0.0003104159,0.000076758544,0.00013082522,0.00042260546,0.00010574894],"domain_scores_gemma":[0.99773383,0.0014525692,0.0003628316,0.000082183564,0.00025844318,0.00011004269],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002520212,0.0006352863,0.0006368634,0.0011613009,0.00023859538,0.0019063943,0.00072495115,0.0026541715,0.009066987],"category_scores_gemma":[0.0045662853,0.0001876401,0.00046110625,0.0007417129,0.0012258961,0.001802595,0.0010699776,0.002429118,0.0018971737],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013884617,0.00008659083,0.00042082585,0.005514759,0.000110309265,0.00021648339,0.00005947045,0.0004890687,0.0025886921,0.065344304,0.052227706,0.8728031],"study_design_scores_gemma":[0.000064006636,0.00011990525,0.0006656983,0.003555299,0.000097945136,0.00075472466,0.000048741167,0.00018680585,0.0012465987,0.021510616,0.97173125,0.000018312483],"about_ca_topic_score_codex":0.00033487572,"about_ca_topic_score_gemma":0.0010218376,"teacher_disagreement_score":0.9974798,"about_ca_system_score_codex":0.00112767,"about_ca_system_score_gemma":0.002436445,"threshold_uncertainty_score":0.030332148},"labels":[],"label_agreement":null},{"id":"W2884819844","doi":"10.1038/s41571-018-0071-6","title":"Infant medulloblastoma — learning new lessons from old strata","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"Pediatric Brain Tumor Foundation; American Brain Tumor Association","keywords":"Medulloblastoma; Medicine; DNA methylation; Disease; Risk stratification; Profiling (computer programming); Oncology; Stratification (seeds); Bioinformatics; Computational biology; Internal medicine; Cancer research; Genetics; Biology; Gene","score_opus":0.21576099181374278,"score_gpt":0.5445081010859789,"score_spread":0.32874710927223616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884819844","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006033859,0.9974164,0.000103839775,0.0013445192,0.0004841889,0.0000013411247,0.000012143764,0.0000068732184,0.0005703255],"genre_scores_gemma":[0.00094658264,0.9964934,0.00016338863,0.0012034684,0.0007806523,0.0000022544555,0.000019915156,0.0000028629252,0.00038753482],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99971014,0.00005783185,0.000049591945,0.000050713978,0.0001033851,0.000028254373],"domain_scores_gemma":[0.99900705,0.0005908486,0.00009159974,0.000029419356,0.00020057046,0.00008061108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010678896,0.0006015412,0.0012822003,0.002050041,0.0003136936,0.0014665346,0.0009751405,0.0013665986,0.002721371],"category_scores_gemma":[0.0023771871,0.00022757651,0.0004904189,0.0014278956,0.0011044003,0.0029636573,0.0010448507,0.0027621158,0.001136995],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058843445,0.000017764023,0.00036199452,0.009547696,0.00009661454,0.00048292478,0.00009874555,0.00024372841,0.00043032624,0.0069912523,0.069383085,0.9122871],"study_design_scores_gemma":[0.0000133534795,0.0000259566,0.00048101877,0.0056271343,0.000095351905,0.0019270694,0.0001044485,0.000060334216,0.00012865372,0.00448399,0.9870351,0.000017575732],"about_ca_topic_score_codex":0.0018860991,"about_ca_topic_score_gemma":0.005490155,"teacher_disagreement_score":0.002721371,"about_ca_system_score_codex":0.00096549,"about_ca_system_score_gemma":0.0019084977,"threshold_uncertainty_score":0.009103894},"labels":[],"label_agreement":null},{"id":"W2891861168","doi":"10.1038/s41571-018-0101-4","title":"Why patients receive treatments that are minimally effective?","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University of Toronto; University Health Network; Queen's University","funders":"","keywords":"Medicine; MEDLINE; Medical physics; Intensive care medicine; General surgery; Family medicine","score_opus":0.17794357545937708,"score_gpt":0.5473828599332276,"score_spread":0.36943928447385044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2891861168","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030212247,0.985341,0.00025667832,0.010777785,0.0008372091,0.000009242884,0.000044055272,0.0000114999275,0.002420329],"genre_scores_gemma":[0.0058371047,0.9736213,0.0007906049,0.016044019,0.002310773,0.000041698302,0.00006082072,0.000008899392,0.0012848963],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99892825,0.000458195,0.00017740522,0.00011461584,0.00025893006,0.00006264619],"domain_scores_gemma":[0.9970042,0.0022305928,0.0003716311,0.000057342684,0.00027064056,0.00006561643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019668438,0.0004130266,0.001577305,0.0007345523,0.00023218685,0.0013959701,0.00063872983,0.0019886722,0.0054260297],"category_scores_gemma":[0.006523689,0.00024186245,0.00073126605,0.00064416276,0.0012085151,0.0018487665,0.000639465,0.0030538435,0.0015433986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002925338,0.000072891904,0.0004240694,0.024008358,0.00034750084,0.00013283157,0.00010019579,0.000124352,0.00086521456,0.013305929,0.07591402,0.88441217],"study_design_scores_gemma":[0.00029354493,0.00022565827,0.0017774687,0.020308819,0.00065321947,0.0010759784,0.0001666601,0.00008084644,0.00050901686,0.015330156,0.95954543,0.000033183896],"about_ca_topic_score_codex":0.000688762,"about_ca_topic_score_gemma":0.0023603938,"teacher_disagreement_score":0.0054260297,"about_ca_system_score_codex":0.00073611876,"about_ca_system_score_gemma":0.0016956959,"threshold_uncertainty_score":0.01815182},"labels":[],"label_agreement":null},{"id":"W2899892772","doi":"10.1038/s41571-018-0116-x","title":"Active surveillance for prostate and thyroid cancers: evolution in clinical paradigms and lessons learned","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; University of Toronto; American Thyroid Association; American Cancer Society","keywords":"Overdiagnosis; Medicine; Prostate cancer; Thyroid; Intensive care medicine; Watchful waiting; Prostate-specific antigen; Thyroid cancer; Population; Epidemiology; Prostate; Internal medicine; Oncology; Gynecology; Cancer","score_opus":0.22396722444169168,"score_gpt":0.5563381693392888,"score_spread":0.3323709448975971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899892772","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006755921,0.99790657,0.00011238203,0.0013624117,0.00021264867,0.0000023420796,0.000014605994,0.0000040431823,0.00031741205],"genre_scores_gemma":[0.0011136355,0.996804,0.00027508568,0.0011555239,0.0004608556,0.000005733546,0.000026328022,0.0000024838816,0.00015643328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992762,0.00019788535,0.00012310778,0.00014657048,0.0001974917,0.000058801295],"domain_scores_gemma":[0.9953844,0.003344841,0.00034328163,0.00007642072,0.0006903829,0.00016074057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033236977,0.0006839732,0.0016801618,0.002132065,0.00031278367,0.0019024442,0.0013991679,0.0015877215,0.0027507283],"category_scores_gemma":[0.005677572,0.00031028138,0.00093823223,0.002030816,0.0011766377,0.0027547653,0.0011246026,0.0035660658,0.0007247467],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009642405,0.000039706476,0.0006024217,0.019575953,0.00016528249,0.000115937626,0.00011632102,0.00049164984,0.0003959406,0.008823632,0.02518933,0.9443875],"study_design_scores_gemma":[0.00004043732,0.00012527918,0.001797924,0.019950552,0.00029196925,0.0009978522,0.00025012594,0.00023298473,0.000233591,0.007852085,0.9681816,0.00004554892],"about_ca_topic_score_codex":0.0020218138,"about_ca_topic_score_gemma":0.004963458,"teacher_disagreement_score":0.0033236977,"about_ca_system_score_codex":0.0013356927,"about_ca_system_score_gemma":0.0027782856,"threshold_uncertainty_score":0.017577648},"labels":[],"label_agreement":null},{"id":"W2905520899","doi":"10.1038/s41571-018-0147-3","title":"Advances in prediction for ovarian cancer treatment stratification","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Modalities; Ovarian cancer; Treatment modality; Intensive care medicine; Risk stratification; Consolidation (business); Oncology; Stratification (seeds); Medical physics; Internal medicine; Cancer","score_opus":0.23252689184304717,"score_gpt":0.5767472291325556,"score_spread":0.3442203372895084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905520899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013383197,0.9966182,0.00071948883,0.0013405047,0.0004273244,0.0000068213662,0.00008026791,0.00001706276,0.00065655087],"genre_scores_gemma":[0.0028084947,0.99325824,0.0011259152,0.0012248594,0.0010750911,0.00001373827,0.0001594784,0.0000066554676,0.00032749848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907124,0.00027959794,0.00013096195,0.00020965017,0.00025109726,0.000057465408],"domain_scores_gemma":[0.9950407,0.0035995115,0.00037023413,0.000107992295,0.0007722931,0.00010930612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032118582,0.0011624205,0.0024981783,0.0021498124,0.0002798863,0.0020391354,0.0015180657,0.0014443437,0.0036686533],"category_scores_gemma":[0.009519977,0.00042869058,0.001274523,0.001785439,0.0007526754,0.0021025145,0.0012976218,0.002989861,0.001441829],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008997349,0.000040534895,0.0013181478,0.0098194145,0.00025919813,0.000060721854,0.000033531967,0.0006642912,0.00028258667,0.0034150085,0.02614852,0.95786804],"study_design_scores_gemma":[0.00007955076,0.00023409961,0.0050324043,0.020857915,0.0015671982,0.001009502,0.00016378048,0.0018424848,0.0008482372,0.015645305,0.9526085,0.000110980596],"about_ca_topic_score_codex":0.0021113167,"about_ca_topic_score_gemma":0.0030610105,"teacher_disagreement_score":0.0036686533,"about_ca_system_score_codex":0.001041073,"about_ca_system_score_gemma":0.0021880255,"threshold_uncertainty_score":0.016986132},"labels":[],"label_agreement":null},{"id":"W2913253891","doi":"10.1038/s41571-019-0167-7","title":"Real-world data: towards achieving the achievable in cancer care","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":316,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Queen's University","funders":"Canada Research Chairs","keywords":"Medicine; Real world data; Clinical trial; MEDLINE; Quality (philosophy); Clinical Practice; Randomized controlled trial; Health care; Data science; Intensive care medicine; Medical physics; Computer science; Family medicine; Internal medicine","score_opus":0.8509468801012106,"score_gpt":0.6837867345671093,"score_spread":0.1671601455341013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913253891","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003493516,0.9562743,0.0046458063,0.034025203,0.0020432991,0.00004871215,0.0014164005,0.000045063276,0.001152007],"genre_scores_gemma":[0.013809155,0.95589536,0.0093304925,0.01496233,0.003622644,0.00032536613,0.0017066827,0.00005546465,0.00029251838],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.949228,0.035121165,0.004674873,0.0020371845,0.008336222,0.0006024945],"domain_scores_gemma":[0.63781965,0.32317495,0.013481134,0.008568779,0.015107385,0.0018481027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07930316,0.0016841039,0.005903651,0.0056727184,0.00047900266,0.007932747,0.0043846047,0.0062364433,0.0068600248],"category_scores_gemma":[0.22858655,0.0012539995,0.0024994072,0.010443164,0.004989847,0.015452478,0.005503414,0.011178411,0.0016811482],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033323216,0.000096052354,0.0036798848,0.07674991,0.0029727723,0.00010055493,0.00023611824,0.0037677742,0.00015645394,0.12792714,0.106847346,0.6771328],"study_design_scores_gemma":[0.00021349094,0.00015918755,0.007241938,0.1080762,0.0018738157,0.00032002057,0.0005087168,0.0027867726,0.00022040382,0.22247446,0.65594214,0.00018291036],"about_ca_topic_score_codex":0.005335213,"about_ca_topic_score_gemma":0.007828545,"teacher_disagreement_score":0.07930316,"about_ca_system_score_codex":0.004891123,"about_ca_system_score_gemma":0.010799804,"threshold_uncertainty_score":0.41940022},"labels":[],"label_agreement":null},{"id":"W2913928134","doi":"10.1038/s41571-019-0177-5","title":"Challenges to curing primary brain tumours","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":972,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University Health Network","funders":"Cancer Research UK; National Institutes of Health; National Cancer Institute; National Institute of Neurological Disorders and Stroke; Medical Research Council; Brain Tumour Charity","keywords":"Brain cancer; Brain research; Medicine; Intensive care medicine; Neuroscience; Cancer; Psychology; Internal medicine","score_opus":0.3081992535077119,"score_gpt":0.5503383396841285,"score_spread":0.2421390861764166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2913928134","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000095279705,0.99499726,0.00016497294,0.003149786,0.00059936655,0.0000021138744,0.000014245873,0.000011318258,0.00096559344],"genre_scores_gemma":[0.0011149624,0.99570435,0.00018808775,0.0015624483,0.00069732824,0.000005224261,0.000023320097,0.0000038613825,0.00070035126],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995185,0.0001285058,0.000062281535,0.000070846116,0.00016454082,0.00005526638],"domain_scores_gemma":[0.9989453,0.00056930934,0.00008878279,0.000037395905,0.0002864012,0.00007277335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013916561,0.00061389036,0.0012162726,0.0012528355,0.00038299154,0.0015823036,0.0008589162,0.0019585814,0.0040256125],"category_scores_gemma":[0.0020259223,0.00024136461,0.0006585603,0.0008851548,0.001192885,0.0025886393,0.0010470683,0.0046718917,0.0031698837],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007465837,0.00006742879,0.000114667106,0.014528587,0.00006698591,0.00029291742,0.00017672117,0.00045323855,0.0018250293,0.017841635,0.0950879,0.86947024],"study_design_scores_gemma":[0.000007852081,0.000056937595,0.00019592834,0.0030412728,0.000027154096,0.000892036,0.000077852594,0.00004724467,0.00030964037,0.0053217513,0.990012,0.000010393243],"about_ca_topic_score_codex":0.0013016943,"about_ca_topic_score_gemma":0.0025508748,"teacher_disagreement_score":0.0040256125,"about_ca_system_score_codex":0.000992216,"about_ca_system_score_gemma":0.0015996037,"threshold_uncertainty_score":0.013467014},"labels":[],"label_agreement":null},{"id":"W2917677528","doi":"10.1038/s41571-019-0181-9","title":"Vessel co-option in cancer","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":444,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Angiogenesis; Medicine; Blood vessel; Metastasis; Cancer; Disease; Mechanism (biology); Pathology; Bioinformatics; Cancer research; Internal medicine; Biology","score_opus":0.21056619825139275,"score_gpt":0.5653323674891731,"score_spread":0.35476616923778037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2917677528","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004311139,0.9985984,0.00010772048,0.00031946547,0.00032233083,0.000002153634,0.000008109828,0.000005347224,0.0005933529],"genre_scores_gemma":[0.00064730225,0.9976967,0.00012773773,0.00037453693,0.0004821599,0.0000059287618,0.000020060166,0.0000016200561,0.00064390944],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997656,0.000049042515,0.000022629794,0.000043586097,0.00008548013,0.000033692224],"domain_scores_gemma":[0.9996592,0.0001801383,0.00004611692,0.000009597838,0.0000577918,0.000047176705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000930528,0.0009655373,0.0016169415,0.001664643,0.00033482877,0.0016310222,0.0009421504,0.0018909646,0.003960114],"category_scores_gemma":[0.0009862244,0.00042327683,0.0004079982,0.0016092408,0.00093180063,0.0019208888,0.0011759491,0.0032949867,0.0019450578],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013249616,0.000063821295,0.00014376768,0.008079194,0.00006664098,0.00022070263,0.000032577773,0.0006066916,0.0011616163,0.009014324,0.07369648,0.90678185],"study_design_scores_gemma":[0.00003600688,0.000070901995,0.00036438945,0.0019576715,0.000086923974,0.0007771977,0.000033327833,0.00018439222,0.00027470433,0.0036053546,0.99259335,0.000015776288],"about_ca_topic_score_codex":0.0010911417,"about_ca_topic_score_gemma":0.0027498927,"teacher_disagreement_score":0.003960114,"about_ca_system_score_codex":0.0010947451,"about_ca_system_score_gemma":0.0011766528,"threshold_uncertainty_score":0.013247848},"labels":[],"label_agreement":null},{"id":"W2947012492","doi":"10.1038/s41571-019-0236-y","title":"Reply to ‘Assembling the brain trust: the multidisciplinary imperative in neuro-oncology’","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University Health Network","funders":"National Cancer Institute; Cancer Research UK","keywords":"Multidisciplinary approach; Precision oncology; Medicine; Psychology; Oncology; Internal medicine; Cancer; Political science","score_opus":0.19022848612239612,"score_gpt":0.5445429713486446,"score_spread":0.3543144852262485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947012492","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000073194664,0.011010836,0.00009650084,0.895366,0.09300524,0.000008821955,0.0000689892,0.000030594652,0.00033979278],"genre_scores_gemma":[0.00074677117,0.0060060485,0.00013059704,0.93137896,0.060005642,0.000024398494,0.000041852927,0.000022532617,0.0016432226],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99453354,0.0014181706,0.0010598445,0.00083919324,0.0014322749,0.00071699196],"domain_scores_gemma":[0.9769473,0.013124389,0.002174457,0.00059715624,0.0046871263,0.0024696332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007475046,0.0014589333,0.002726997,0.0016180659,0.0027250592,0.0058127274,0.003155863,0.035263594,0.006258341],"category_scores_gemma":[0.04239041,0.0010296833,0.001514301,0.0015720789,0.0054148883,0.009055474,0.0047623543,0.054255,0.007325788],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024817977,0.000006975175,0.00006573285,0.0001921053,0.000017078404,0.000106910564,0.000109322995,0.0000192283,0.000049286966,0.0008965969,0.9934116,0.0051004007],"study_design_scores_gemma":[0.00006286534,0.000039925973,0.00055839395,0.00076795794,0.000039613795,0.0006249575,0.00042486307,0.00006259589,0.00009640158,0.0034535462,0.99379694,0.000072003684],"about_ca_topic_score_codex":0.0039166315,"about_ca_topic_score_gemma":0.008503134,"teacher_disagreement_score":0.035263594,"about_ca_system_score_codex":0.0027446696,"about_ca_system_score_gemma":0.0074475124,"threshold_uncertainty_score":0.039532304},"labels":[],"label_agreement":null},{"id":"W2947504704","doi":"10.1038/s41571-019-0235-z","title":"Assembling the brain trust: the multidisciplinary imperative in neuro-oncology","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Toronto","funders":"Cancer Research UK","keywords":"Multidisciplinary approach; Medicine; Psychology; Internal medicine; Oncology; Political science","score_opus":0.21357649914434365,"score_gpt":0.554877179958118,"score_spread":0.3413006808137744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2947504704","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005829362,0.9877158,0.00015992412,0.009685246,0.0012992548,0.0000021430947,0.000008487509,0.000008341416,0.0010624925],"genre_scores_gemma":[0.0016108697,0.9908777,0.00035754265,0.004758608,0.0016803504,0.000006001731,0.000018328008,0.00000529997,0.0006852996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989183,0.0003883968,0.00011341721,0.00010480789,0.00034274653,0.00013249704],"domain_scores_gemma":[0.9957267,0.002487762,0.00035232052,0.00008466997,0.0009797887,0.0003688757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002670911,0.00064976263,0.0013622566,0.0015817244,0.0006965714,0.0030051514,0.0011699059,0.003519366,0.0039352933],"category_scores_gemma":[0.005017925,0.00023550514,0.00049889786,0.0017955737,0.0019504998,0.004417747,0.002071848,0.0056602946,0.0016097341],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042390897,0.00003932376,0.00024176709,0.012638355,0.00008445524,0.00023725825,0.00025727676,0.00033753066,0.00037727578,0.023710368,0.14615038,0.8158836],"study_design_scores_gemma":[0.000008563457,0.000027090677,0.0003456373,0.0073874295,0.00003661735,0.0005225808,0.00028226658,0.000055470802,0.00007057936,0.008116585,0.98312885,0.000018388773],"about_ca_topic_score_codex":0.0028428056,"about_ca_topic_score_gemma":0.008062041,"teacher_disagreement_score":0.0039352933,"about_ca_system_score_codex":0.0023367761,"about_ca_system_score_gemma":0.0066120313,"threshold_uncertainty_score":0.016954541},"labels":[],"label_agreement":null},{"id":"W2958760191","doi":"10.1038/s41571-019-0254-9","title":"Continuing to improve outcomes of men with metastatic prostate cancer","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostate cancer; Medicine; Context (archaeology); Oncology; Disease; Androgen deprivation therapy; Clinical trial; Internal medicine; Androgen receptor; Overall survival; Androgen; Cancer; Hormone; Biology","score_opus":0.17349663504997226,"score_gpt":0.5694412218230142,"score_spread":0.3959445867730419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2958760191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004500909,0.9991364,0.000023401728,0.00040802793,0.00020081425,0.0000023167402,0.0000131690595,0.0000027707792,0.00016824195],"genre_scores_gemma":[0.00042943365,0.99853814,0.00007286158,0.0006129884,0.00020649875,0.00000350088,0.000022178509,0.0000010311186,0.00011350701],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99943095,0.0001737707,0.00008959146,0.000075559365,0.00017066435,0.000059510734],"domain_scores_gemma":[0.9987124,0.00082017144,0.00015333468,0.000026824508,0.00021220186,0.000075063916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001646266,0.0008556006,0.0025314908,0.0013666664,0.00023125364,0.0012619693,0.0013213351,0.0015991795,0.0055518807],"category_scores_gemma":[0.0036195181,0.00024258137,0.0015813811,0.0015511328,0.00044617945,0.0013688769,0.0008749836,0.0025036633,0.0011369783],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011759395,0.000038224087,0.00025921458,0.039146412,0.00043985544,0.000042081076,0.000033585653,0.00019134823,0.00028272773,0.0015347633,0.027604723,0.9303096],"study_design_scores_gemma":[0.00029812424,0.0004207342,0.0051249275,0.06523268,0.0021807472,0.00064051297,0.00017993368,0.00012421682,0.0002806441,0.004496989,0.92096895,0.000051533334],"about_ca_topic_score_codex":0.0029900318,"about_ca_topic_score_gemma":0.0079247495,"teacher_disagreement_score":0.0055518807,"about_ca_system_score_codex":0.0007111249,"about_ca_system_score_gemma":0.0020245642,"threshold_uncertainty_score":0.018572867},"labels":[],"label_agreement":null},{"id":"W2964802061","doi":"10.1038/s41571-019-0253-x","title":"Global Consultation on Cancer Staging: promoting consistent understanding and use","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":85,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Kingston Health Sciences Centre; Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; Centers for Disease Control and Prevention; World Health Organization; U.S. Department of Health and Human Services","keywords":"Terminology; Context (archaeology); Medicine; Disease; Cancer; Confusion; Identification (biology); Intensive care medicine; Pathology; Psychology; Internal medicine","score_opus":0.2939129351022284,"score_gpt":0.5190481148766658,"score_spread":0.22513517977443742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964802061","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001016404,0.025565516,0.008991068,0.93437964,0.015980456,0.00024956473,0.0001570502,0.00022735508,0.013432948],"genre_scores_gemma":[0.088888936,0.09672109,0.07699606,0.678361,0.027326455,0.0023069042,0.0016652113,0.0011672539,0.026567155],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.820598,0.13599984,0.012069763,0.005019047,0.019514548,0.006798734],"domain_scores_gemma":[0.7496259,0.15013537,0.010107868,0.009688937,0.056834072,0.023607794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1572144,0.0013813212,0.0020525565,0.0052034683,0.0059837727,0.01086051,0.0066922745,0.018690951,0.011327758],"category_scores_gemma":[0.20256764,0.0011719776,0.0023585912,0.00520549,0.013454629,0.01332093,0.022695165,0.024192741,0.0063696336],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038879123,0.000029732033,0.0004642254,0.0027853416,0.00004105632,0.00066157954,0.023375178,0.00034484256,0.0007677059,0.034838263,0.7901747,0.14647849],"study_design_scores_gemma":[0.000025885463,0.00003756939,0.00047826176,0.0047652107,0.000021899781,0.000479727,0.010089312,0.00018062274,0.00016753438,0.02130809,0.9623646,0.00008122056],"about_ca_topic_score_codex":0.011460458,"about_ca_topic_score_gemma":0.012973165,"teacher_disagreement_score":0.1572144,"about_ca_system_score_codex":0.018412236,"about_ca_system_score_gemma":0.056157086,"threshold_uncertainty_score":0.83143914},"labels":[],"label_agreement":null},{"id":"W2971204478","doi":"10.1038/s41571-019-0264-7","title":"Phase I trials as therapeutic options: (usually) a betrayal of evidence-based medicine","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Betrayal; Alternative medicine; Clinical trial; Phase (matter); Intensive care medicine; Psychotherapist; Internal medicine; Pathology; Psychology; Social psychology","score_opus":0.9696885455836366,"score_gpt":0.8168281786167281,"score_spread":0.15286036696690852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971204478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000067272784,0.969231,0.0010248277,0.025734788,0.0026359267,0.000022216647,0.00002169583,0.000007911306,0.0012543341],"genre_scores_gemma":[0.005710482,0.9303191,0.0029248947,0.054653887,0.0055252197,0.00012808829,0.000032738088,0.000031486135,0.00067411485],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.92927825,0.05141867,0.006362196,0.0021615175,0.010166266,0.00061302184],"domain_scores_gemma":[0.61239964,0.3605273,0.011864063,0.005515529,0.008554839,0.0011386101],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08426001,0.0012636032,0.0064726886,0.004265281,0.0012074255,0.011885317,0.0030660392,0.01125405,0.004170112],"category_scores_gemma":[0.17388682,0.0010277354,0.0024275687,0.0062988913,0.013584873,0.021162903,0.004245327,0.02159457,0.0013487815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002736783,0.000047541787,0.0001858057,0.08448138,0.000925167,0.000099897974,0.00095372146,0.00050772016,0.0003097159,0.2620063,0.08974339,0.5604657],"study_design_scores_gemma":[0.00030431297,0.00010566689,0.00045213825,0.19396563,0.0009017841,0.00058777694,0.00084907113,0.0003899519,0.00028030266,0.1892594,0.6128213,0.0000825627],"about_ca_topic_score_codex":0.0022263317,"about_ca_topic_score_gemma":0.00404328,"teacher_disagreement_score":0.91574,"about_ca_system_score_codex":0.0051207035,"about_ca_system_score_gemma":0.0093011195,"threshold_uncertainty_score":0.44561487},"labels":[],"label_agreement":null},{"id":"W2981815608","doi":"10.1038/s41571-019-0287-0","title":"Imatinib and the long tail of targeted drug development","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Imatinib; Medicine; Drug; Drug development; Imatinib mesylate; Anticancer drug; Targeted therapy; Cancer; Pharmacology; Intensive care medicine; Internal medicine","score_opus":0.12461724817597737,"score_gpt":0.48656931244882984,"score_spread":0.3619520642728525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2981815608","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000058425994,0.9980447,0.00009351703,0.0006084008,0.00027069342,0.0000021015542,0.000015128406,0.000005290441,0.0009016371],"genre_scores_gemma":[0.00077356945,0.9973476,0.00012103692,0.0007074124,0.0003710238,0.0000051339016,0.000028330867,0.00000154751,0.0006443205],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996573,0.0000836533,0.000041152492,0.000048616264,0.00013027272,0.00003910765],"domain_scores_gemma":[0.9994624,0.0003212181,0.000084986896,0.000015416952,0.00006450718,0.000051591767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009978861,0.0008444062,0.0012835163,0.0013212966,0.00023217204,0.0014075548,0.0007837763,0.0012758675,0.004990711],"category_scores_gemma":[0.0014391451,0.00026100062,0.000415762,0.0015500048,0.00072515634,0.0021391963,0.0011622144,0.0026551017,0.0019317222],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018373216,0.000047922407,0.00014535838,0.010924813,0.00010678468,0.00011533082,0.000040688985,0.0005477041,0.0014931572,0.013994553,0.057517227,0.9148827],"study_design_scores_gemma":[0.000039954444,0.000076629934,0.00034205726,0.0026349158,0.00008126397,0.0002930483,0.000022600434,0.00010004919,0.0001999102,0.004662154,0.9915358,0.000011561703],"about_ca_topic_score_codex":0.0005730319,"about_ca_topic_score_gemma":0.0017070303,"teacher_disagreement_score":0.004990711,"about_ca_system_score_codex":0.0008413358,"about_ca_system_score_gemma":0.0010650271,"threshold_uncertainty_score":0.016695559},"labels":[],"label_agreement":null},{"id":"W2995032149","doi":"10.1038/s41571-019-0312-3","title":"Reply to ‘Correcting the ASCO position on phase I clinical trials in cancer’","year":2019,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Clinical trial; Position paper; Cancer; Oncology; Medical physics; Internal medicine; Family medicine; Pathology","score_opus":0.9170537404042044,"score_gpt":0.7532702093287833,"score_spread":0.1637835310754211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995032149","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006754351,0.008337143,0.0002232858,0.8386326,0.1516957,0.00003448834,0.00035214997,0.00005863415,0.0005983644],"genre_scores_gemma":[0.00039472067,0.0023159445,0.00019891966,0.9388893,0.05658882,0.00006505219,0.00007783404,0.000034414003,0.0014350591],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97526044,0.008508335,0.0059464285,0.0023262312,0.006172099,0.0017863956],"domain_scores_gemma":[0.9026705,0.059531778,0.011537834,0.0029447565,0.017144447,0.0061706887],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028393209,0.0022058305,0.0055428604,0.0036518204,0.0030675202,0.0070555024,0.0043655625,0.049222603,0.009326908],"category_scores_gemma":[0.12519385,0.0020590452,0.004217967,0.0041511194,0.0059935595,0.0060285684,0.0051949667,0.06173526,0.012063306],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006663107,0.0000062915387,0.00006683491,0.00029513426,0.00004211296,0.00003705067,0.00003224733,0.0000253873,0.00004550718,0.00053356,0.99463403,0.004215133],"study_design_scores_gemma":[0.00035392054,0.00007859378,0.0011791917,0.0018646878,0.0002101382,0.00026905217,0.000099356206,0.00015751942,0.00016398793,0.0039297696,0.99159145,0.00010225624],"about_ca_topic_score_codex":0.0062428145,"about_ca_topic_score_gemma":0.012824853,"teacher_disagreement_score":0.9716068,"about_ca_system_score_codex":0.0056214705,"about_ca_system_score_gemma":0.010700706,"threshold_uncertainty_score":0.15015942},"labels":[],"label_agreement":null},{"id":"W3007679475","doi":"10.1038/s41571-019-0320-3","title":"Current approaches to the management of brain metastases","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":551,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Disease; Brain metastasis; Neuroimaging; Intensive care medicine; Radiation therapy; Lung cancer; Clinical trial; Cancer; Breast cancer; Oncology; Metastasis; Internal medicine; Psychiatry","score_opus":0.5357107495680552,"score_gpt":0.5524210198591318,"score_spread":0.016710270291076634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3007679475","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039609447,0.9985556,0.00011495615,0.000369514,0.0001970647,0.000004488182,0.000012440236,0.0000071808618,0.00069906],"genre_scores_gemma":[0.00031813278,0.9986656,0.00014696266,0.00031808604,0.00022803021,0.0000058522332,0.000022075274,0.000001282599,0.00029400145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973625,0.000060031634,0.000032844524,0.000040180523,0.00010068163,0.000029951463],"domain_scores_gemma":[0.99941206,0.00033503174,0.00007656088,0.000014199244,0.00011251294,0.00004960184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082851836,0.0010099433,0.0016724182,0.001937292,0.00026682057,0.001317385,0.0011832808,0.0013102051,0.0058871605],"category_scores_gemma":[0.0014795455,0.00024397121,0.00070601964,0.0015862506,0.00062439917,0.0013501677,0.00092268555,0.0024805076,0.002320791],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009364182,0.00005035182,0.00007896028,0.0141986655,0.00007297146,0.000096302305,0.000024348477,0.00047203072,0.0006873288,0.0023676406,0.02756922,0.9542886],"study_design_scores_gemma":[0.00006627916,0.00015267389,0.00063576765,0.009532924,0.00023442425,0.00084200996,0.00004641589,0.00016920746,0.000258719,0.0033265701,0.984711,0.0000240235],"about_ca_topic_score_codex":0.0017342841,"about_ca_topic_score_gemma":0.004873155,"teacher_disagreement_score":0.0058871605,"about_ca_system_score_codex":0.0008132748,"about_ca_system_score_gemma":0.0014060569,"threshold_uncertainty_score":0.019694507},"labels":[],"label_agreement":null},{"id":"W3008432399","doi":"10.1038/s41571-020-0345-7","title":"Real-world evidence and regulatory drug approval","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":49,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Real world evidence; Drug approval; Drug; Cancer drugs; Regulatory science; Drug development; Medicine; Business; Pharmacology; Internal medicine","score_opus":0.24496724960993593,"score_gpt":0.46638844999166723,"score_spread":0.2214212003817313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008432399","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024263814,0.9938573,0.00019741472,0.003610884,0.00033812708,0.000010488012,0.00018630522,0.0000056526374,0.0015511428],"genre_scores_gemma":[0.011541657,0.9839516,0.0002893169,0.0030905134,0.000559901,0.00003052797,0.00019628712,0.0000059896597,0.00033415016],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99398214,0.0034118933,0.0006610662,0.00046938704,0.00126644,0.00020902311],"domain_scores_gemma":[0.9554387,0.03705805,0.0042111985,0.00073352136,0.0022625853,0.00029593264],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013617794,0.0007222865,0.0028065238,0.0022961984,0.00023831756,0.0026456497,0.0017079129,0.003086062,0.01597948],"category_scores_gemma":[0.04431414,0.00050121726,0.0018845415,0.0035090982,0.0015348397,0.002686425,0.00094968884,0.0039216015,0.0016455703],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013016143,0.0001255299,0.001469114,0.10477289,0.0037051777,0.00027675123,0.00006394232,0.0035104982,0.00037877113,0.05471609,0.06586285,0.7638167],"study_design_scores_gemma":[0.00090186216,0.00044960185,0.00841943,0.10386348,0.0053140214,0.0007133231,0.00018040424,0.00088837725,0.00048541414,0.064942636,0.81374,0.000101494334],"about_ca_topic_score_codex":0.0027580787,"about_ca_topic_score_gemma":0.00469699,"teacher_disagreement_score":0.9863822,"about_ca_system_score_codex":0.0027923484,"about_ca_system_score_gemma":0.004565587,"threshold_uncertainty_score":0.07201868},"labels":[],"label_agreement":null},{"id":"W3014200667","doi":"10.1038/s41571-020-0362-6","title":"Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":415,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"University of Toronto; King's College London; Queen's University; Ontario Institute for Cancer Research; Government of Canada; Government of Ontario","keywords":"Pandemic; Medicine; Coronavirus disease 2019 (COVID-19); Precautionary principle; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Cancer; Intensive care medicine; Virology; Disease; Infectious disease (medical specialty); Pathology; Internal medicine","score_opus":0.4026145901668752,"score_gpt":0.6490970795603621,"score_spread":0.24648248939348694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014200667","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040080038,0.992461,0.00009773407,0.0057138954,0.00068511046,0.000006390108,0.000028629356,0.0000049882624,0.0009621251],"genre_scores_gemma":[0.0011259492,0.9923017,0.00035287297,0.0050295526,0.0007374557,0.000018668848,0.000043093027,0.000003918663,0.00038678417],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99809414,0.00081164314,0.00021436393,0.00014208982,0.00053344265,0.0002042927],"domain_scores_gemma":[0.9940667,0.004172115,0.0005787762,0.00009489882,0.0008141668,0.00027342295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047219736,0.0010189761,0.0022835364,0.0020274462,0.00052200985,0.0026486358,0.0016803369,0.0044163354,0.008362482],"category_scores_gemma":[0.009676579,0.00041546865,0.0013374105,0.0024102803,0.0017140083,0.003372972,0.0024721846,0.004982312,0.0017502218],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012786694,0.000052242096,0.00024875798,0.03333743,0.0003295718,0.00010674934,0.00013744074,0.00090192724,0.00030317626,0.040666215,0.09639591,0.8273927],"study_design_scores_gemma":[0.000049024547,0.000088219866,0.0005974959,0.03758438,0.00018717692,0.00027195772,0.00020178579,0.00015869764,0.00012561886,0.015212879,0.945486,0.000036875073],"about_ca_topic_score_codex":0.006772188,"about_ca_topic_score_gemma":0.015929883,"teacher_disagreement_score":0.008362482,"about_ca_system_score_codex":0.0038011633,"about_ca_system_score_gemma":0.0105615305,"threshold_uncertainty_score":0.027975261},"labels":[],"label_agreement":null},{"id":"W3015154527","doi":"10.1038/s41571-020-0352-8","title":"Moving towards personalized treatments of immune-related adverse events","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":345,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; McGill University","funders":"","keywords":"Adverse effect; Immune system; Medicine; Intensive care medicine; Cancer; Personalized medicine; Bioinformatics; Immunotherapy; Immunology; Internal medicine; Biology","score_opus":0.1277862675738988,"score_gpt":0.5063780017279471,"score_spread":0.37859173415404834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015154527","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045870573,0.99823666,0.00018190363,0.0006165792,0.00030386783,0.0000043729638,0.000015000911,0.0000076923925,0.0005880324],"genre_scores_gemma":[0.0005686466,0.9970585,0.0003137292,0.0011142041,0.00051321206,0.000008344358,0.000037104448,0.000002118076,0.00038415595],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955744,0.00012670872,0.000061790364,0.00006362509,0.00015053088,0.000039894476],"domain_scores_gemma":[0.9984894,0.0010177952,0.00016153257,0.000027146549,0.00024323048,0.000060955685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013784013,0.0009480832,0.0021661804,0.0015615573,0.00019152771,0.0012169848,0.0010224252,0.001463117,0.005095349],"category_scores_gemma":[0.002479362,0.00026030975,0.0010029443,0.001213878,0.00037788693,0.0013549054,0.00082579005,0.0028581778,0.0018150692],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000774312,0.00003815234,0.00012719157,0.01057675,0.00015922192,0.00006186414,0.000016753163,0.00031910764,0.00046824577,0.0026768239,0.024698963,0.9607795],"study_design_scores_gemma":[0.0001380996,0.00018056971,0.0012238272,0.015336976,0.00055911596,0.00073368667,0.000044983502,0.00029697779,0.00028961265,0.0057194806,0.975444,0.0000325189],"about_ca_topic_score_codex":0.00084025855,"about_ca_topic_score_gemma":0.002319591,"teacher_disagreement_score":0.005095349,"about_ca_system_score_codex":0.00066934567,"about_ca_system_score_gemma":0.0012240701,"threshold_uncertainty_score":0.017045677},"labels":[],"label_agreement":null},{"id":"W3015891597","doi":"10.1038/s41571-020-0368-0","title":"Informative censoring — a neglected cause of bias in oncology trials","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":96,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Censoring (clinical trials); Medicine; Clinical trial; Oncology; Internal medicine; Randomized controlled trial; Dropout (neural networks); Clinical endpoint; Disease; Pathology","score_opus":0.9448741470251816,"score_gpt":0.7660528400446187,"score_spread":0.17882130698056287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015891597","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00020215685,0.97826356,0.013747105,0.006121352,0.0007350338,0.00004174154,0.000063141975,0.000044697186,0.0007811827],"genre_scores_gemma":[0.02042151,0.94677496,0.014344724,0.012477718,0.0048978315,0.00030981321,0.00012313062,0.000105912164,0.00054441317],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.8630447,0.11424894,0.00830042,0.0031561842,0.01061444,0.0006353219],"domain_scores_gemma":[0.4814453,0.49285865,0.011408812,0.0074891993,0.0059435777,0.0008543934],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.11496323,0.001403447,0.008856257,0.00366049,0.00053090585,0.005074961,0.0037187145,0.005182075,0.0046586683],"category_scores_gemma":[0.23645833,0.00094390917,0.004067919,0.00481204,0.006067308,0.005676135,0.0026773838,0.009115385,0.001191877],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004001116,0.000036657315,0.0010951398,0.069575526,0.0040167756,0.000110631234,0.00025908905,0.002506857,0.00014887117,0.07918596,0.01934415,0.8233202],"study_design_scores_gemma":[0.00083488465,0.0005526553,0.004126081,0.11976888,0.0066535706,0.0015772231,0.00026485164,0.006309013,0.00068031956,0.6122848,0.24669614,0.00025158288],"about_ca_topic_score_codex":0.0014742189,"about_ca_topic_score_gemma":0.002263678,"teacher_disagreement_score":0.88503677,"about_ca_system_score_codex":0.0027449476,"about_ca_system_score_gemma":0.006588798,"threshold_uncertainty_score":0.607991},"labels":[],"label_agreement":null},{"id":"W3022408996","doi":"10.1038/s41571-020-0374-2","title":"Palliative care services at cancer centres — room for improvement","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Palliative care; Referral; Medicine; Nursing; Curative care; Ambulatory care; Family medicine; Quality of life (healthcare); Health care; Political science","score_opus":0.4018971727234965,"score_gpt":0.630122387847158,"score_spread":0.2282252151236615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022408996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025599007,0.9968342,0.00003584826,0.0023127715,0.0004559021,0.000003902476,0.000014525962,0.0000072354,0.0003100369],"genre_scores_gemma":[0.0004472931,0.9970234,0.00017333639,0.0018277226,0.00033000708,0.0000114409,0.000034898585,0.000002287927,0.00014965606],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978795,0.0007966185,0.0002986066,0.00021071946,0.0005194902,0.000295166],"domain_scores_gemma":[0.990717,0.005237619,0.0010767732,0.00013910959,0.0017362708,0.0010933304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007626326,0.0013459014,0.0040477333,0.00281735,0.00070084835,0.0042561125,0.002588053,0.004248468,0.011780996],"category_scores_gemma":[0.010309308,0.0006225972,0.0021018952,0.00409866,0.001358621,0.006562291,0.0033045355,0.0062626665,0.0028693448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016360886,0.000072112445,0.00025310865,0.06370302,0.00029540816,0.00008741598,0.00009933719,0.00036486893,0.00020384436,0.0056227036,0.0901452,0.83898944],"study_design_scores_gemma":[0.00019294371,0.00017636281,0.0021278276,0.13564752,0.00071728794,0.00042202303,0.00054955506,0.00023859247,0.000064381,0.0038211257,0.85599166,0.000050680814],"about_ca_topic_score_codex":0.0076902416,"about_ca_topic_score_gemma":0.024853138,"teacher_disagreement_score":0.011780996,"about_ca_system_score_codex":0.005686783,"about_ca_system_score_gemma":0.014258036,"threshold_uncertainty_score":0.04126072},"labels":[],"label_agreement":null},{"id":"W3025082263","doi":"10.1038/s41571-020-0394-y","title":"COVID-19 and cancer: do we really know what we think we know?","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston Health Sciences Centre; Queen's University","funders":"Queen's University","keywords":"Coronavirus disease 2019 (COVID-19); Observational study; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Quality (philosophy); Cancer; Limit (mathematics); Need to know; Medicine; Virology; Epistemology; Computer science; Pathology; Philosophy; Internal medicine; Disease","score_opus":0.308748734625815,"score_gpt":0.610603666652903,"score_spread":0.301854932027088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025082263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035253557,0.9923759,0.000032796997,0.0058835414,0.0010217292,0.0000038511434,0.000055111643,0.0000051028223,0.0005866657],"genre_scores_gemma":[0.00068326347,0.99323237,0.00011778568,0.0047273645,0.0008079358,0.000012680628,0.0000658464,0.000002845526,0.00035002374],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979665,0.00068736,0.00029467506,0.00015729544,0.0006377425,0.00025632986],"domain_scores_gemma":[0.99240255,0.0040495074,0.0011390743,0.000142598,0.0015335657,0.0007327282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006002065,0.00082497566,0.0026714797,0.002670545,0.00057038147,0.0033602829,0.0014339575,0.0031844175,0.013752659],"category_scores_gemma":[0.013418999,0.00048972754,0.0018578537,0.0037562454,0.0016597828,0.0039961003,0.0028183681,0.0046526343,0.0024158177],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001838107,0.000041468964,0.0006267861,0.042451464,0.0005401034,0.00007659024,0.000102962644,0.00021747027,0.00016736699,0.013204903,0.19730547,0.74508166],"study_design_scores_gemma":[0.000072088136,0.00006600974,0.0007802581,0.033165067,0.0003823017,0.00018506641,0.00012838653,0.000040897437,0.0000647283,0.0033909676,0.96169746,0.000026797927],"about_ca_topic_score_codex":0.00557393,"about_ca_topic_score_gemma":0.012921379,"teacher_disagreement_score":0.013752659,"about_ca_system_score_codex":0.0035903172,"about_ca_system_score_gemma":0.011766959,"threshold_uncertainty_score":0.046007276},"labels":[],"label_agreement":null},{"id":"W3027335902","doi":"10.1038/s41571-020-0388-9","title":"Personalized early detection and prevention of breast cancer: ENVISION consensus statement","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":439,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Faculty of Medicine and Health, University of Sydney; NIHR Cambridge Biomedical Research Centre; University of California, San Francisco; Unicancer; Max-Planck-Institut für Bildungsforschung; Centro de Investigación Biomédica en Red de Cáncer; Universiteit Antwerpen; Tartu Ülikool; Institut National Du Cancer; Radboud Universitair Medisch Centrum; Universidad San Pablo - CEU; Leids Universitair Medisch Centrum; Fondation ARC pour la Recherche sur le Cancer; Karolinska Institutet; Universitair Medisch Centrum Utrecht; Lunds Universitet; Queen Mary University of London; National Institute for Health and Care Research; Gentofte Hospital; Universitätsklinikum Köln; Centre International de Recherche sur le Cancer; University of Twente; University of Melbourne; National Cancer Institute; Universität Heidelberg; University of Toronto; World Health Organization; Cancer Research UK; University College London; University of Leicester; Universiteit Leiden; Vanderbilt University Medical Center; Radboud Universiteit; Horizon 2020 Framework Programme; Clalit Health Services; QIMR Berghofer Medical Research Institute; Institut Gustave-Roussy; Vrije Universiteit Amsterdam; Deutsches Krebsforschungszentrum; Université Laval; Cancer Care Ontario; Universidade de Santiago de Compostela; Universitat de Girona; Division of Mathematical Sciences; European Commission","keywords":"Breast cancer; Cancer prevention; Medicine; Psychological intervention; Breast cancer screening; Mammography; Cancer; Family medicine; Nursing; Internal medicine","score_opus":0.2770679094564181,"score_gpt":0.566229596267098,"score_spread":0.2891616868106799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027335902","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017509618,0.9582995,0.0016241021,0.03115242,0.005896717,0.00019015648,0.00048358281,0.000044047792,0.0021342812],"genre_scores_gemma":[0.0019284491,0.9747021,0.004899343,0.012993895,0.0018412281,0.0004077822,0.0012831009,0.000028422306,0.001915703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99352926,0.0021512245,0.0013353562,0.0005272259,0.0019534673,0.00050338777],"domain_scores_gemma":[0.9869581,0.0058259764,0.001313995,0.00034175522,0.0046303095,0.00092995464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022959435,0.0015124053,0.0031281435,0.0038980946,0.00058748754,0.0027295996,0.003973853,0.006164795,0.0035085378],"category_scores_gemma":[0.019351726,0.0007809313,0.0040027522,0.0036354857,0.0008419256,0.0025933366,0.0031469648,0.0067530195,0.0023777448],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019408943,0.000109626446,0.0003160162,0.059988577,0.0005170513,0.00019551044,0.00030504022,0.0011717421,0.0005963291,0.013542656,0.22945344,0.69360995],"study_design_scores_gemma":[0.000086870525,0.00009140526,0.00064561586,0.05554237,0.0007105186,0.0003431071,0.00010587958,0.00017030237,0.00028290454,0.005648126,0.936336,0.0000369317],"about_ca_topic_score_codex":0.0057289316,"about_ca_topic_score_gemma":0.0059849266,"teacher_disagreement_score":0.022959435,"about_ca_system_score_codex":0.0036463523,"about_ca_system_score_gemma":0.022704389,"threshold_uncertainty_score":0.12142259},"labels":[],"label_agreement":null},{"id":"W3033331291","doi":"10.1038/s41571-020-0382-2","title":"The adenosine pathway in immuno-oncology","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":565,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Adenosinergic; Immunotherapy; Immune system; Cancer; Cancer research; Medicine; Cancer immunotherapy; Immunology; Biology; Adenosine receptor; Internal medicine; Receptor","score_opus":0.09757574864050292,"score_gpt":0.4791573120742012,"score_spread":0.3815815634336983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3033331291","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000033395914,0.9973803,0.00012406537,0.0005730491,0.00072204205,0.000003976935,0.000012597364,0.000008904561,0.0011416273],"genre_scores_gemma":[0.00041124824,0.9968605,0.00016623571,0.0005900819,0.0009533763,0.000006770199,0.00002322951,0.0000018001915,0.0009866852],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998092,0.000040666742,0.000016294915,0.000027797712,0.00008280104,0.000023155439],"domain_scores_gemma":[0.99962556,0.00018889457,0.00004088573,0.000012092278,0.000078021105,0.000054521868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071041303,0.00096720475,0.0012797506,0.0015002091,0.00029055253,0.0012730318,0.00091009075,0.001588709,0.0049298145],"category_scores_gemma":[0.0009887165,0.00028608253,0.0003444589,0.0016021866,0.0006913517,0.0015178865,0.0008638568,0.0029514579,0.0029895839],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098348835,0.00005810523,0.00008384614,0.0059722685,0.000044015585,0.00015179405,0.000024022735,0.0005795445,0.001509597,0.0055963118,0.11516841,0.8707138],"study_design_scores_gemma":[0.000025288364,0.000051858122,0.00022325151,0.001450511,0.00004302385,0.00040870823,0.000018748306,0.00011068512,0.00016319618,0.003120166,0.99437475,0.000009858419],"about_ca_topic_score_codex":0.0008970154,"about_ca_topic_score_gemma":0.0024252315,"teacher_disagreement_score":0.0049298145,"about_ca_system_score_codex":0.0008954032,"about_ca_system_score_gemma":0.0012017991,"threshold_uncertainty_score":0.01649183},"labels":[],"label_agreement":null},{"id":"W3034821185","doi":"10.1038/s41571-020-0401-3","title":"Reply to ‘Personalized treatment of immune-related adverse events — balance is required’","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Microscopic Colitis","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Tofacitinib; Medicine; Infliximab; Vedolizumab; Adverse effect; Immune system; Clinical trial; Ulcerative colitis; Internal medicine; Bioinformatics; Immunology; Disease; Rheumatoid arthritis; Biology","score_opus":0.13375682114770235,"score_gpt":0.5219817870157574,"score_spread":0.388224965868055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034821185","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012872106,0.027238112,0.00033674604,0.7590917,0.21199377,0.000024334133,0.00025327073,0.00009604889,0.00083746697],"genre_scores_gemma":[0.00084765384,0.0140755,0.00030170422,0.8509449,0.1311499,0.000042559306,0.00012424169,0.000031124287,0.002482394],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960063,0.001019599,0.00091223844,0.00052078505,0.0011551455,0.00038588681],"domain_scores_gemma":[0.98327315,0.008917006,0.0016371871,0.00046510441,0.00445771,0.0012499208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058790175,0.0013862811,0.0035044244,0.0017929801,0.0014364737,0.0037465983,0.002389394,0.01849448,0.006376222],"category_scores_gemma":[0.029135007,0.00088272704,0.0017673345,0.0015217295,0.0026275383,0.004543536,0.0024784517,0.029527046,0.008144206],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006360155,0.000012310535,0.00010059392,0.00034469197,0.000039285846,0.000090868634,0.000033602613,0.000042110558,0.00010652961,0.00064223213,0.9840051,0.01451912],"study_design_scores_gemma":[0.00014690279,0.00007666427,0.0007529159,0.00074253074,0.00009556904,0.00054273236,0.000092465416,0.000116469746,0.00013830833,0.0028176974,0.9944133,0.00006447645],"about_ca_topic_score_codex":0.0017409422,"about_ca_topic_score_gemma":0.0040200376,"teacher_disagreement_score":0.01849448,"about_ca_system_score_codex":0.0015979322,"about_ca_system_score_gemma":0.0038405128,"threshold_uncertainty_score":0.03109157},"labels":[],"label_agreement":null},{"id":"W3037199247","doi":"10.1038/s41571-020-0412-0","title":"Publisher Correction: Personalized early detection and prevention of breast cancer: ENVISION consensus statement","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Nutrition, Genetics, and Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Cancer Research UK; World Health Organization","keywords":"Statement (logic); Breast cancer; Medical physics; Computer science; Medicine; Political science; Cancer; Law; Internal medicine","score_opus":0.06619570857062869,"score_gpt":0.45438549020357105,"score_spread":0.3881897816329424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037199247","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025930654,0.0045261234,0.00027528207,0.070894934,0.9220454,0.000019937204,0.00029274018,0.00011344638,0.0018061923],"genre_scores_gemma":[0.0042885165,0.03484486,0.0027099529,0.28094548,0.5752064,0.00029760695,0.0011421122,0.00067874737,0.09988633],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9908035,0.0017656233,0.0014850325,0.00095751113,0.0042519495,0.0007363752],"domain_scores_gemma":[0.9561402,0.013017363,0.0023882221,0.0022618067,0.023754958,0.0024373885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010649522,0.0017659116,0.0024683843,0.0037677255,0.002431696,0.005056931,0.0045703314,0.0119336685,0.03900717],"category_scores_gemma":[0.07559057,0.0009548372,0.0026449529,0.002541012,0.0031150556,0.0028881154,0.0026021295,0.019890612,0.033640996],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001286544,0.0000028160837,0.000012223181,0.00018107804,0.0000091604425,0.000071790855,0.000012055169,0.00001484771,0.000022933136,0.0006842487,0.99349666,0.005479314],"study_design_scores_gemma":[0.000038214712,0.000016456866,0.00014056683,0.00056739734,0.000030797182,0.0002736475,0.000021490487,0.000037871967,0.00010666881,0.0011145032,0.9976338,0.000018575794],"about_ca_topic_score_codex":0.00640251,"about_ca_topic_score_gemma":0.010139754,"teacher_disagreement_score":0.03900717,"about_ca_system_score_codex":0.0034843746,"about_ca_system_score_gemma":0.010370912,"threshold_uncertainty_score":0.13049191},"labels":[],"label_agreement":null},{"id":"W3040650012","doi":"10.1038/s41571-020-0392-0","title":"ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal–Anal Task Forces whitepaper","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":365,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Colorectal cancer; Multidisciplinary approach; Task force; Oncology; Internal medicine; Minimal residual disease; Disease; MEDLINE; Cancer; Intensive care medicine","score_opus":0.04859247317157884,"score_gpt":0.4486514804192196,"score_spread":0.40005900724764076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040650012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004099749,0.9589885,0.00047767189,0.021856297,0.007819123,0.00012415295,0.00028572165,0.00003627589,0.010002236],"genre_scores_gemma":[0.0013674606,0.9719997,0.0009316963,0.014099141,0.0019441734,0.00009498988,0.00033585192,0.000013918185,0.009213161],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936455,0.0001299719,0.00007107881,0.00005526888,0.0002995842,0.00007943925],"domain_scores_gemma":[0.99796754,0.00070313836,0.00018234222,0.00005446633,0.00081628904,0.000276267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00347372,0.00045742537,0.0006661552,0.0015491496,0.0004625315,0.0015967132,0.0008481183,0.0023615328,0.0037682499],"category_scores_gemma":[0.0027213139,0.00032725435,0.0008005946,0.0016045773,0.000487278,0.0015214063,0.0013510609,0.0033571466,0.0027612715],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006817288,0.0000574986,0.00018897436,0.004563791,0.00003093796,0.000120691264,0.00006305388,0.00019262072,0.00093827466,0.0042926813,0.36651272,0.62297064],"study_design_scores_gemma":[0.000008455806,0.000037672697,0.00030969855,0.0024002676,0.000021037318,0.0001591351,0.000018170738,0.000026980526,0.00016942233,0.0003998501,0.9964426,0.000006652512],"about_ca_topic_score_codex":0.0057529924,"about_ca_topic_score_gemma":0.012923386,"teacher_disagreement_score":0.0057529924,"about_ca_system_score_codex":0.0015437918,"about_ca_system_score_gemma":0.008285946,"threshold_uncertainty_score":0.018370986},"labels":[],"label_agreement":null},{"id":"W3043654181","doi":"10.1038/s41571-020-0415-x","title":"Publisher Correction: The adenosine pathway in immuno-oncology","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Adenosine and Purinergic Signaling","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Adenosine; Medicine; Psychology; Computer science; Oncology; Internal medicine","score_opus":0.09702945120851257,"score_gpt":0.45902843339692184,"score_spread":0.36199898218840926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043654181","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002965684,0.011361259,0.00025717763,0.028782569,0.9564222,0.000016066399,0.00016653941,0.00010928955,0.0028552236],"genre_scores_gemma":[0.0040142285,0.053639807,0.0017602004,0.07658083,0.7246726,0.00017062748,0.0006700744,0.00048234407,0.13800932],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962304,0.0007362767,0.0005957651,0.00041276944,0.0016803981,0.00034419866],"domain_scores_gemma":[0.9837579,0.0040247855,0.0010266468,0.0011068658,0.008726269,0.0013574885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004473002,0.0017792053,0.0022219054,0.0043002106,0.0019544817,0.0045720628,0.0039639603,0.0076408973,0.041338265],"category_scores_gemma":[0.035397574,0.000834087,0.0016286969,0.0025279725,0.0027075114,0.002563841,0.002151934,0.010945186,0.0338642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016792252,0.0000024017102,0.000011260363,0.00023337567,0.0000075586754,0.00013374901,0.000008588674,0.000020343094,0.0000290509,0.00060224347,0.9885775,0.01035708],"study_design_scores_gemma":[0.000024685603,0.000013031507,0.000101640144,0.0003675658,0.000019243766,0.000470499,0.000013366289,0.000036335594,0.00008854016,0.00079635356,0.99805814,0.000010706327],"about_ca_topic_score_codex":0.003919319,"about_ca_topic_score_gemma":0.0069915224,"teacher_disagreement_score":0.041338265,"about_ca_system_score_codex":0.0030460635,"about_ca_system_score_gemma":0.0056561446,"threshold_uncertainty_score":0.13829029},"labels":[],"label_agreement":null},{"id":"W3081423662","doi":"10.1038/s41571-020-0417-8","title":"Artificial intelligence in radiation oncology","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":401,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Artificial Intelligence in Medicine (Canada)","funders":"National Cancer Institute; CARIM School for Cardiovascular Diseases, Universiteit Maastricht; Universiteit Maastricht; National Institutes of Health; Brigham and Women's Hospital","keywords":"Radiation oncology; Medical physics; Medicine; Oncology; Computer science; Radiation therapy; Internal medicine","score_opus":0.1720944463343659,"score_gpt":0.574027760237618,"score_spread":0.40193331390325215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3081423662","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003681217,0.9960771,0.00023147713,0.0008498251,0.0007267761,0.0000045214388,0.000010384637,0.000010330457,0.0020527686],"genre_scores_gemma":[0.0007356303,0.9946408,0.00034485318,0.0012680446,0.0014155067,0.000009840127,0.000023706758,0.0000051408992,0.0015563776],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99949944,0.0001665952,0.000052129464,0.000060741328,0.00018402725,0.000036986374],"domain_scores_gemma":[0.99841714,0.0010826706,0.00014196605,0.000053015512,0.00022349544,0.00008163317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013214301,0.0010273957,0.0016107368,0.0022568163,0.00030403968,0.0020285181,0.00088954077,0.0020751937,0.008926162],"category_scores_gemma":[0.0030148732,0.00038451544,0.0005727308,0.002622153,0.0014969021,0.0026671067,0.0012668045,0.0033475112,0.004045911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004569624,0.000047228245,0.000096793294,0.01287035,0.000079382145,0.000061771134,0.000060330312,0.00054744806,0.0004711665,0.0118078785,0.08575002,0.88816184],"study_design_scores_gemma":[0.000021946205,0.000057890677,0.00034004112,0.00540307,0.00006785025,0.00032237842,0.000028718565,0.00017237665,0.000121920166,0.01019819,0.98324955,0.000016193171],"about_ca_topic_score_codex":0.0013324254,"about_ca_topic_score_gemma":0.0022207196,"teacher_disagreement_score":0.008926162,"about_ca_system_score_codex":0.0010733395,"about_ca_system_score_gemma":0.0018221273,"threshold_uncertainty_score":0.029860973},"labels":[],"label_agreement":null},{"id":"W3083938091","doi":"10.1038/s41571-020-0422-y","title":"Tumour budding in solid cancers","year":2020,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Cells and Metastasis","field":"Medicine","cited_by":366,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Budding; Biology; Medicine; Cancer research; Genetics","score_opus":0.24699227472587224,"score_gpt":0.5821903682922324,"score_spread":0.3351980935663601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083938091","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045529665,0.99840695,0.00007749733,0.00022858073,0.0003788354,0.0000037793882,0.000016049635,0.000008319132,0.00083448616],"genre_scores_gemma":[0.00041730382,0.99833715,0.000076840995,0.00024111844,0.0002225857,0.000003544742,0.000031287535,0.0000016891249,0.0006684341],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996978,0.000054007924,0.000034424174,0.00004450547,0.00012425442,0.000045001496],"domain_scores_gemma":[0.9996561,0.00014984931,0.000047882524,0.000013712464,0.00007806919,0.00005437046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080567773,0.0011827254,0.0019625383,0.002739377,0.0003868179,0.0021607657,0.0008670655,0.0016770422,0.006884204],"category_scores_gemma":[0.0010900883,0.0005279366,0.0005915144,0.0025696615,0.0008444384,0.0019042362,0.001592782,0.0027820782,0.0041497005],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010839251,0.00003442613,0.00010712868,0.016505158,0.000058951606,0.00014481149,0.000057832218,0.00045323497,0.0011223628,0.0045159906,0.06633739,0.9105544],"study_design_scores_gemma":[0.000026419808,0.000050583207,0.00030393226,0.0042112176,0.00010121771,0.00062242657,0.000044238186,0.000097143704,0.00025514362,0.0022051567,0.9920672,0.000015245763],"about_ca_topic_score_codex":0.0015941786,"about_ca_topic_score_gemma":0.0033674848,"teacher_disagreement_score":0.006884204,"about_ca_system_score_codex":0.0010211378,"about_ca_system_score_gemma":0.0017589469,"threshold_uncertainty_score":0.023029983},"labels":[],"label_agreement":null},{"id":"W3128131226","doi":"10.1038/s41571-021-00473-5","title":"PD-L1 as a biomarker of response to immune-checkpoint inhibitors","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1560,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Biomarker; Concordance; Biomarker discovery; Oncology; Companion diagnostic; Immune checkpoint; Clinical trial; PD-L1; Cancer; Disease; Internal medicine; Immunotherapy; Bioinformatics; Biology; Proteomics","score_opus":0.1525086424784524,"score_gpt":0.5349054464247085,"score_spread":0.3823968039462561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128131226","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009533158,0.9989618,0.00010626429,0.00028879734,0.00017100644,0.0000039046895,0.000020363148,0.0000041069675,0.00034835708],"genre_scores_gemma":[0.0019907707,0.9961817,0.00028822993,0.00062849716,0.00038309977,0.000016993026,0.00006648295,0.0000016191425,0.00044264263],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996407,0.00008278984,0.00005849744,0.00006545806,0.00012374946,0.00002880431],"domain_scores_gemma":[0.9990829,0.00054397905,0.00013927743,0.000017891209,0.00017815347,0.000037834496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012935749,0.0010200066,0.0022033248,0.0016629606,0.00013147623,0.0012338537,0.0008329708,0.0010404513,0.0013948445],"category_scores_gemma":[0.0022357213,0.00028727966,0.0007389111,0.0014902551,0.00043298735,0.00085377553,0.00060725235,0.0021765935,0.0009298136],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022100899,0.000052706175,0.00050579524,0.010263348,0.00023903743,0.00007580683,0.000017917226,0.00042738116,0.0008256427,0.0021073325,0.02172571,0.96353835],"study_design_scores_gemma":[0.00024558447,0.00055898255,0.0041907127,0.012634976,0.0013368021,0.0013836186,0.00006403381,0.0008337311,0.0017326442,0.0044568293,0.97249705,0.000065137356],"about_ca_topic_score_codex":0.0011315995,"about_ca_topic_score_gemma":0.0018976344,"teacher_disagreement_score":0.0022033248,"about_ca_system_score_codex":0.00083201885,"about_ca_system_score_gemma":0.001156214,"threshold_uncertainty_score":0.006841123},"labels":[],"label_agreement":null},{"id":"W3134327013","doi":"10.1038/s41571-021-00491-3","title":"The ten genes for breast (and ovarian) cancer susceptibility","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"PALB2; CHEK2; Breast cancer; Ovarian cancer; Gene; Oncology; Biology; Medicine; Cancer; Genetics; Mutation; Germline mutation","score_opus":0.10265145137852312,"score_gpt":0.5104314512757606,"score_spread":0.4077799998972375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134327013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000084511696,0.9975223,0.00021514733,0.00078186044,0.00040856472,0.000004354036,0.0000403967,0.000013583213,0.0009293044],"genre_scores_gemma":[0.0005369685,0.9977343,0.00022904275,0.00046254188,0.0002664268,0.000006850819,0.00006176371,0.0000015935855,0.0007005227],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997477,0.000049518378,0.000029639976,0.0000362935,0.00010231669,0.000034429308],"domain_scores_gemma":[0.9996189,0.00021082882,0.000036510435,0.000010950049,0.000083189305,0.00003967031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092502916,0.0013513454,0.0014201609,0.0015048891,0.00018715176,0.00092733506,0.0012071979,0.0014171096,0.0032744296],"category_scores_gemma":[0.0011087005,0.00029933968,0.00040018262,0.0016890407,0.000756705,0.0008805844,0.00079944194,0.0024487972,0.0016804881],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011681673,0.000037970334,0.00028358668,0.004775088,0.00007346967,0.00021001702,0.00002798342,0.00042874576,0.0018369347,0.0051547247,0.07165037,0.91540426],"study_design_scores_gemma":[0.000055802222,0.000061050785,0.0010561903,0.002794989,0.00014402119,0.0009752623,0.0000432718,0.00010000528,0.00045874395,0.0043639005,0.9899275,0.000019257037],"about_ca_topic_score_codex":0.0015631246,"about_ca_topic_score_gemma":0.0026538973,"teacher_disagreement_score":0.0032744296,"about_ca_system_score_codex":0.0008261667,"about_ca_system_score_gemma":0.001302031,"threshold_uncertainty_score":0.010954082},"labels":[],"label_agreement":null},{"id":"W3136398125","doi":"10.1038/s41571-021-00502-3","title":"First clinical proof-of-concept that FMT can overcome resistance to ICIs","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Fecal bacteriotherapy; Refractory (planetary science); Immunology; Resistance (ecology); Medicine; Transplantation; Intensive care medicine; Biology; Internal medicine; Microbiology; Ecology","score_opus":0.16817183811994693,"score_gpt":0.518229412337673,"score_spread":0.350057574217726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3136398125","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022167054,0.986985,0.0012821881,0.0022214625,0.0017946257,0.000121257275,0.00041219156,0.000089028996,0.004877454],"genre_scores_gemma":[0.016715096,0.9690591,0.002122959,0.0045545516,0.00070941186,0.00018004264,0.00076803286,0.000033984223,0.0058567994],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997856,0.000059518912,0.00001705447,0.000027618533,0.000060316717,0.00004997509],"domain_scores_gemma":[0.999564,0.00027209596,0.000036507314,0.000015306283,0.000066292196,0.000045876055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000980224,0.0009703208,0.0013475392,0.00058062084,0.00016769016,0.0011810609,0.0008604008,0.0014493426,0.007372854],"category_scores_gemma":[0.0015533987,0.00021207616,0.0009069895,0.00041385504,0.00046590916,0.00074012746,0.00054534397,0.0037709915,0.0019187013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097652175,0.0002289571,0.00020164027,0.011458921,0.00031107978,0.0003447907,0.00006581902,0.0005887374,0.005024904,0.004535388,0.0868267,0.88943654],"study_design_scores_gemma":[0.0011471204,0.0012015528,0.0010048464,0.0039611654,0.0005002988,0.000876894,0.00004794848,0.00026239856,0.0029644468,0.002727962,0.9852701,0.0000352598],"about_ca_topic_score_codex":0.0009314052,"about_ca_topic_score_gemma":0.003373738,"teacher_disagreement_score":0.007372854,"about_ca_system_score_codex":0.00071332516,"about_ca_system_score_gemma":0.00094779325,"threshold_uncertainty_score":0.02466464},"labels":[],"label_agreement":null},{"id":"W3138390832","doi":"10.1038/s41571-021-00504-1","title":"FDA approval standards for anticancer agents — lessons from two recent approvals in breast cancer","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Drug approval; Breast cancer; Overall survival; Oncology; Drug; Metastatic breast cancer; Anticancer drug; Cancer; Intensive care medicine; Pharmacology; Internal medicine","score_opus":0.30958660989652914,"score_gpt":0.5430798589318376,"score_spread":0.2334932490353085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3138390832","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00045529738,0.9651189,0.00097293645,0.029327355,0.0011070962,0.00001454332,0.000086009466,0.000020479933,0.0028974735],"genre_scores_gemma":[0.014860731,0.953388,0.0027333987,0.025176238,0.002228192,0.000066343,0.0001431027,0.00003828855,0.0013657204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99422896,0.002087471,0.00086400076,0.0005076426,0.0020070293,0.0003048901],"domain_scores_gemma":[0.94658285,0.039753936,0.0031450521,0.001075155,0.008731512,0.00071151194],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021241542,0.0006682369,0.001992118,0.0025917287,0.0005686417,0.003217553,0.001744722,0.005386749,0.002794818],"category_scores_gemma":[0.044623923,0.0005231602,0.001643702,0.0028100798,0.0025107958,0.004991426,0.001542197,0.010792756,0.0009835365],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022629116,0.00007038517,0.0003997461,0.006917708,0.0001958966,0.00018833338,0.00016436036,0.00078267226,0.00046254793,0.06780923,0.08754441,0.8352384],"study_design_scores_gemma":[0.00013050734,0.00015127122,0.0024787856,0.017718099,0.0003390692,0.00043362362,0.00013867297,0.0003348496,0.00037818815,0.036550473,0.941284,0.00006244695],"about_ca_topic_score_codex":0.0056920513,"about_ca_topic_score_gemma":0.010371396,"teacher_disagreement_score":0.97875845,"about_ca_system_score_codex":0.004711182,"about_ca_system_score_gemma":0.00787652,"threshold_uncertainty_score":0.11233735},"labels":[],"label_agreement":null},{"id":"W3163003678","doi":"10.1038/s41571-021-00508-x","title":"Beneficial autoimmunity improves cancer prognosis","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Institute for Research in Immunology and Cancer","funders":"National Cancer Institute; Canadian Institutes of Health Research; Agence Nationale de la Recherche","keywords":"Medicine; Autoimmunity; Oncology; Cancer; Internal medicine; Disease","score_opus":0.20716222520985014,"score_gpt":0.5541318934361366,"score_spread":0.3469696682262864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163003678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008207247,0.9982407,0.00007460208,0.00055045105,0.0003989036,0.000003640046,0.000024454934,0.000007875279,0.0006172592],"genre_scores_gemma":[0.0010593071,0.996874,0.00011416904,0.0008368034,0.000503329,0.000008263053,0.000039903724,0.0000019531078,0.000562254],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975497,0.00006835091,0.000028464872,0.00003883243,0.00007816452,0.000031218333],"domain_scores_gemma":[0.99961853,0.00018863275,0.000058200334,0.000013154623,0.000085215426,0.000036312907],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008345903,0.0010107929,0.0015768141,0.0011274865,0.00018485804,0.0011024829,0.0006108793,0.0012070477,0.004765232],"category_scores_gemma":[0.0013664223,0.00024305735,0.0005617745,0.00089676026,0.00036059006,0.000755986,0.0007676043,0.0025949478,0.0019208593],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019947946,0.000057007022,0.00023257412,0.011716671,0.0001872548,0.00006939604,0.000023245027,0.00027423588,0.0009992968,0.0026513475,0.053661406,0.9299281],"study_design_scores_gemma":[0.00017910734,0.00020846998,0.0014150024,0.007828615,0.00047737962,0.00043930986,0.000038609287,0.00012245002,0.00042014653,0.0037135838,0.98513246,0.000024840721],"about_ca_topic_score_codex":0.0006293095,"about_ca_topic_score_gemma":0.0017189418,"teacher_disagreement_score":0.004765232,"about_ca_system_score_codex":0.0004897,"about_ca_system_score_gemma":0.0008553667,"threshold_uncertainty_score":0.015941322},"labels":[],"label_agreement":null},{"id":"W3185510385","doi":"10.1038/s41571-021-00544-7","title":"Adjuvant olaparib — should all patients with breast cancer have genetic testing?","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Olaparib; Breast cancer; Medicine; Oncology; Genetic testing; Adjuvant; Internal medicine; Mutation; Cancer; Biology; Genetics; Gene","score_opus":0.1445943947971782,"score_gpt":0.487743436468439,"score_spread":0.3431490416712608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3185510385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018017495,0.9947779,0.00018303168,0.0028375995,0.00096959906,0.0000036543634,0.000035650206,0.000009523649,0.0010027715],"genre_scores_gemma":[0.0024915307,0.99101967,0.00034346926,0.0032512117,0.0018273169,0.000010128131,0.00009214081,0.0000038552853,0.00096059864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999764,0.00007863357,0.000026718437,0.000028434251,0.00007661917,0.000025622976],"domain_scores_gemma":[0.9994374,0.00033467298,0.000053390213,0.000015432202,0.00010919714,0.000049889644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091339974,0.00052411127,0.0012947929,0.00050947256,0.0001376801,0.00080983195,0.0007125662,0.0012048183,0.0025872078],"category_scores_gemma":[0.0020084851,0.00017978887,0.00040773302,0.0005852406,0.00035480267,0.0010382249,0.00037289356,0.0028235095,0.0010610911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000248728,0.00003549263,0.00027483964,0.0033312335,0.00008669832,0.00012818424,0.000013369197,0.000361088,0.0006264604,0.0023247644,0.08698443,0.90558463],"study_design_scores_gemma":[0.00029654894,0.00020544477,0.0020512391,0.0063570067,0.00028898512,0.0014580288,0.00004586979,0.0003022727,0.0003627198,0.005890146,0.9827108,0.00003098246],"about_ca_topic_score_codex":0.0010103423,"about_ca_topic_score_gemma":0.002621219,"teacher_disagreement_score":0.0025872078,"about_ca_system_score_codex":0.0005487538,"about_ca_system_score_gemma":0.0008358003,"threshold_uncertainty_score":0.008655071},"labels":[],"label_agreement":null},{"id":"W3191344580","doi":"10.1038/s41571-021-00550-9","title":"Practicing on the edge of oncology: when standard of care feels uncomfortable","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Guideline; Randomized controlled trial; Standard of care; MEDLINE; Alternative medicine; Medical physics; Family medicine; Internal medicine; Pathology","score_opus":0.23076794956579566,"score_gpt":0.4774872909975916,"score_spread":0.2467193414317959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191344580","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048879907,0.8720084,0.0006529253,0.11970075,0.0037359053,0.000016834441,0.000078633835,0.000025688609,0.0032921175],"genre_scores_gemma":[0.010897292,0.9314564,0.0015016992,0.049449813,0.005580929,0.00004017215,0.0001164609,0.0000318271,0.00092531746],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99104744,0.004361146,0.00087682175,0.0004438826,0.0028174736,0.0004532732],"domain_scores_gemma":[0.9534144,0.03128523,0.005337227,0.00081324566,0.007103501,0.002046335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013658904,0.00037128368,0.001948609,0.0017736608,0.000676339,0.004933835,0.0017411031,0.0046310895,0.0054327194],"category_scores_gemma":[0.0657637,0.0003532481,0.00095583254,0.0024690737,0.00262507,0.0046861684,0.0019609325,0.0071021095,0.0019291727],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011297841,0.0000412042,0.0010791945,0.009301792,0.0002490257,0.00011849016,0.0002641694,0.00028181105,0.00015512873,0.014304865,0.21176833,0.762323],"study_design_scores_gemma":[0.000091212445,0.00009842037,0.004870703,0.04505309,0.00024978523,0.0007411073,0.0009857513,0.00017884692,0.00013525641,0.027999459,0.91951615,0.00008014594],"about_ca_topic_score_codex":0.006298402,"about_ca_topic_score_gemma":0.017392224,"teacher_disagreement_score":0.013658904,"about_ca_system_score_codex":0.0031469455,"about_ca_system_score_gemma":0.009880327,"threshold_uncertainty_score":0.072236},"labels":[],"label_agreement":null},{"id":"W3213271749","doi":"10.1038/s41571-021-00581-2","title":"Daratumumab in newly diagnosed MM — incorporating lessons learnt from CASSIOPEIA, MAIA and beyond","year":2021,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Daratumumab; Medicine; Multiple myeloma; Oncology; Internal medicine; Intensive care medicine; Bortezomib","score_opus":0.2276479383870076,"score_gpt":0.5494101196842723,"score_spread":0.32176218129726475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3213271749","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000041334497,0.9992287,0.000023701637,0.0003342121,0.00020849994,0.000001739922,0.000007886744,0.0000020111127,0.000151769],"genre_scores_gemma":[0.0005991733,0.9981762,0.00010183507,0.0006241915,0.00029906482,0.000004028895,0.000015129259,0.0000010165797,0.00017935206],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99963796,0.000095055286,0.00007192833,0.000054024833,0.00010473206,0.000036273806],"domain_scores_gemma":[0.9992168,0.00047869358,0.00010543921,0.000019470228,0.0001323136,0.00004732432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001531154,0.00077802927,0.002253637,0.0017561702,0.00026650022,0.0016270835,0.00082020485,0.0011871584,0.0028008684],"category_scores_gemma":[0.0020330516,0.00030454533,0.0011420975,0.0014918133,0.0005219302,0.001855724,0.00091625995,0.0032951855,0.0008165241],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002654587,0.000050589373,0.00015435724,0.028806672,0.0003964689,0.000098303695,0.00005532901,0.0002616836,0.00051995757,0.004176258,0.03425439,0.93096054],"study_design_scores_gemma":[0.0002731924,0.00027269,0.001189655,0.021192161,0.00080684415,0.0006477326,0.00007119842,0.00018679826,0.00022336068,0.00412504,0.97097754,0.000033812106],"about_ca_topic_score_codex":0.0021056803,"about_ca_topic_score_gemma":0.0061161285,"teacher_disagreement_score":0.0028008684,"about_ca_system_score_codex":0.00073818053,"about_ca_system_score_gemma":0.0017156884,"threshold_uncertainty_score":0.00936991},"labels":[],"label_agreement":null},{"id":"W4221033081","doi":"10.1038/s41571-022-00624-2","title":"Should the control arms of randomized trials have an expiry date?","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Randomized controlled trial; Chemotherapy; Clinical trial; Clinical equipoise; Lung cancer; MEDLINE; Intensive care medicine; Oncology; Surgery; Internal medicine","score_opus":0.46518099347242153,"score_gpt":0.64827772807525,"score_spread":0.18309673460282844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221033081","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014840565,0.92894435,0.013695951,0.02919564,0.021335399,0.0014956726,0.0010108078,0.0001668805,0.0026713565],"genre_scores_gemma":[0.07697712,0.63579506,0.077063814,0.14596589,0.037554715,0.018693827,0.0020580532,0.00038605504,0.00550553],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.864318,0.10510425,0.015377717,0.006486268,0.007309665,0.0014040306],"domain_scores_gemma":[0.5347964,0.42418405,0.018368576,0.013305153,0.007905549,0.001440278],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24599625,0.0017005791,0.016597793,0.0014939822,0.0007651274,0.0058384025,0.0049980353,0.011644359,0.013354168],"category_scores_gemma":[0.36734897,0.0017850718,0.010752273,0.002404114,0.0039587957,0.010904261,0.0023168647,0.012899267,0.0022229943],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041479725,0.00038663996,0.0012773353,0.16884792,0.02561768,0.00012785624,0.00032377476,0.0009356894,0.0006523191,0.05166737,0.050777677,0.6579061],"study_design_scores_gemma":[0.12031452,0.006038236,0.005653501,0.16924694,0.052950393,0.0005657845,0.00036442978,0.0024033599,0.0013906854,0.15049158,0.49020296,0.0003776043],"about_ca_topic_score_codex":0.0012443596,"about_ca_topic_score_gemma":0.0015133908,"teacher_disagreement_score":0.75400376,"about_ca_system_score_codex":0.002796784,"about_ca_system_score_gemma":0.0070431563,"threshold_uncertainty_score":0.92982084},"labels":[],"label_agreement":null},{"id":"W4243737142","doi":"10.1038/s41571-018-0120-1","title":"Addendum: Low-value approvals and high prices might incentivize ineffective drug development","year":2018,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Revenue; Hindsight bias; Profit (economics); Actuarial science; Finance; Economics; Business; Microeconomics","score_opus":0.18648345030762592,"score_gpt":0.46972368995637276,"score_spread":0.28324023964874684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4243737142","genre_codex":"review","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019653307,0.76358455,0.0057541905,0.15084934,0.027389254,0.00013298809,0.0024030528,0.00018912218,0.047732107],"genre_scores_gemma":[0.050327037,0.77957636,0.0071544936,0.073556624,0.045841917,0.0002743773,0.0019121653,0.00013094273,0.041226074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99849904,0.0005781864,0.00014027116,0.000159535,0.0005077377,0.000115239076],"domain_scores_gemma":[0.9827533,0.013353478,0.0016522298,0.0004590282,0.0014424769,0.00033951298],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0035125448,0.00079141883,0.0008720505,0.0013151154,0.0003611584,0.0024236734,0.001073745,0.0034237048,0.059874233],"category_scores_gemma":[0.018941823,0.00021494164,0.0010603414,0.0012293772,0.0011226471,0.00236317,0.0016804088,0.0043077245,0.008894961],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034590106,0.000106393476,0.0007898274,0.010939808,0.00037874313,0.0003271562,0.00008484628,0.0006534287,0.00061153003,0.07186394,0.44829038,0.465608],"study_design_scores_gemma":[0.00020231542,0.000103742685,0.0013099193,0.0057393652,0.0005638195,0.0009107421,0.00006733119,0.000475383,0.00071145047,0.047321305,0.9425589,0.00003586698],"about_ca_topic_score_codex":0.00082206476,"about_ca_topic_score_gemma":0.0022552202,"teacher_disagreement_score":0.99648744,"about_ca_system_score_codex":0.0010174685,"about_ca_system_score_gemma":0.0024550639,"threshold_uncertainty_score":0.20029926},"labels":[],"label_agreement":null},{"id":"W4288052966","doi":"10.1038/s41571-022-00667-5","title":"Defining clinically important overall survival thresholds: lessons from quality of life","year":2022,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Northeast Cancer Centre; Queen's University","funders":"","keywords":"Medicine; Quality of life (healthcare); MEDLINE; Oncology; Intensive care medicine; Gerontology; Internal medicine; Nursing","score_opus":0.4457884125422678,"score_gpt":0.6182712969811195,"score_spread":0.17248288443885168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288052966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014956688,0.9942584,0.00082450884,0.0035980314,0.00048325214,0.00000767285,0.00007632182,0.0000091661195,0.00059298915],"genre_scores_gemma":[0.0069094426,0.98514324,0.0019756465,0.0038857704,0.0016404738,0.00005847638,0.00016491607,0.00001825539,0.00020377491],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972114,0.0011721781,0.0005012435,0.00038331014,0.00060611905,0.00012573201],"domain_scores_gemma":[0.97903675,0.017449677,0.00091913535,0.0003046052,0.0020400484,0.0002497524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010151525,0.0016559022,0.0057263603,0.0026475163,0.00036046375,0.0040637543,0.0029677432,0.002120738,0.0027323035],"category_scores_gemma":[0.023671048,0.00042865443,0.0020142512,0.0028470492,0.0026686697,0.0045224405,0.0021633294,0.009354436,0.0008663602],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002663448,0.000059031503,0.0013655522,0.02076961,0.0007880304,0.00007703412,0.00013654122,0.0015130559,0.00029467346,0.037698045,0.03249373,0.90453845],"study_design_scores_gemma":[0.00025658566,0.00045942137,0.010517097,0.084254995,0.0020536047,0.0010982251,0.00074151414,0.002002787,0.00065411313,0.18645704,0.7112541,0.00025049312],"about_ca_topic_score_codex":0.0030606873,"about_ca_topic_score_gemma":0.003241662,"teacher_disagreement_score":0.010151525,"about_ca_system_score_codex":0.0036849126,"about_ca_system_score_gemma":0.0033203221,"threshold_uncertainty_score":0.053687036},"labels":[],"label_agreement":null},{"id":"W4376642614","doi":"10.1038/s41571-023-00770-1","title":"Cholangiocarcinoma — novel biological insights and therapeutic strategies","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":199,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"National Cancer Institute; National Institutes of Health; Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona; European Commission","keywords":"Immune system; Immunotherapy; Tumor microenvironment; Biology; Cancer; Disease; Malignancy; Cancer research; Chimeric antigen receptor; Computational biology; Bioinformatics; Medicine; Immunology; Internal medicine","score_opus":0.38899566087997883,"score_gpt":0.5322932829363055,"score_spread":0.14329762205632668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376642614","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042559343,0.99944645,0.000032527823,0.0001830122,0.00006108939,0.0000018739028,0.000011996826,0.0000022255904,0.00021821026],"genre_scores_gemma":[0.00036815528,0.9991798,0.00006495346,0.0001755524,0.00009142565,0.0000029868731,0.000014245092,5.5409794e-7,0.000102246864],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976796,0.00005654137,0.000037435555,0.000038487728,0.000070999835,0.000028517843],"domain_scores_gemma":[0.9995184,0.0003041034,0.000058499878,0.000014820737,0.000074922944,0.000029232524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001038231,0.00085015164,0.0021899305,0.0022925145,0.00021627932,0.0017089768,0.0008408481,0.00097415375,0.0032374496],"category_scores_gemma":[0.0013774827,0.00029983438,0.0007521424,0.002636423,0.0006459081,0.0014628085,0.000981608,0.0018165135,0.0010619198],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016817797,0.00005149832,0.00028986117,0.028823493,0.00024981133,0.00017023864,0.000049911312,0.00045560068,0.0008764468,0.0046360027,0.024612412,0.9396166],"study_design_scores_gemma":[0.00009996541,0.00015886888,0.0014335104,0.0136770625,0.00068185385,0.001036386,0.00010944388,0.00014576974,0.00037083402,0.0038182987,0.97843355,0.000034565477],"about_ca_topic_score_codex":0.0011077684,"about_ca_topic_score_gemma":0.002926217,"teacher_disagreement_score":0.0032374496,"about_ca_system_score_codex":0.00075944077,"about_ca_system_score_gemma":0.0014015089,"threshold_uncertainty_score":0.010830343},"labels":[],"label_agreement":null},{"id":"W4382020994","doi":"10.1038/s41571-023-00785-8","title":"Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Fondation pour la Recherche Médicale; Horizon 2020 Framework Programme; Institut Universitaire de France; Stand Up To Cancer; Genentech; Labex Immuno-Oncology; National Institutes of Health; PharmaMar; University of Texas MD Anderson Cancer Center; Ligue Contre le Cancer; AstraZeneca; Institut National Du Cancer; Fonds de Recherche du Québec - Santé; Institut National de la Santé et de la Recherche Médicale; Exelixis; Sanofi; European Commission; Daiichi Sankyo Europe; National Cancer Institute; HORIZON EUROPE Framework Programme; Gilead Sciences; Melanoma Research Alliance; GlaxoSmithKline; Fondation ARC pour la Recherche sur le Cancer; Agence Nationale de la Recherche; Bristol-Myers Squibb; American Association for Cancer Research; Seerave Foundation","keywords":"Dysbiosis; Medicine; Gut flora; Clinical trial; Cancer; Biomarker; Metagenomics; Bioinformatics; Oncology; Computational biology; Immunology; Internal medicine; Biology","score_opus":0.3343139125727195,"score_gpt":0.5517493436111188,"score_spread":0.21743543103839935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382020994","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024761687,0.9974247,0.00037921272,0.00064830435,0.00032714306,0.000010764236,0.000063402214,0.000017207682,0.0008815788],"genre_scores_gemma":[0.0027157974,0.9942477,0.0006921367,0.000972902,0.000311912,0.00002312086,0.00015407329,0.0000039382508,0.00087840075],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997079,0.000067647474,0.000024128823,0.000049458733,0.00011072332,0.000040223626],"domain_scores_gemma":[0.9993901,0.00034004785,0.00007975768,0.000015268923,0.00013169661,0.000043153264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011761144,0.00082516595,0.0015668194,0.0014889884,0.00014247654,0.0013397213,0.000767118,0.0011866756,0.0032617687],"category_scores_gemma":[0.0016179226,0.0002529156,0.00062580575,0.0011062904,0.00044710658,0.001314043,0.00096173544,0.0022135875,0.0017037109],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001435229,0.0000539927,0.00038247672,0.0065371185,0.00011857641,0.00014051839,0.000024635172,0.000379012,0.0026513634,0.0039652144,0.024242764,0.9613609],"study_design_scores_gemma":[0.000094573064,0.00032616057,0.0014672447,0.0044211773,0.00034461563,0.0009503004,0.00006481823,0.00044967898,0.0022734809,0.00465765,0.984909,0.000041265233],"about_ca_topic_score_codex":0.00052935357,"about_ca_topic_score_gemma":0.001355148,"teacher_disagreement_score":0.0032617687,"about_ca_system_score_codex":0.00052720093,"about_ca_system_score_gemma":0.00086019177,"threshold_uncertainty_score":0.010911703},"labels":[],"label_agreement":null},{"id":"W4384560337","doi":"10.1038/s41571-023-00805-7","title":"Problematic crossovers in cancer drug trials","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Context (archaeology); Randomized controlled trial; Clinical trial; Cancer drugs; Drug trial; Crossover; Medical physics; Drug; Cancer; Skew; Oncology; Intensive care medicine; Internal medicine; Pharmacology; Artificial intelligence; Computer science","score_opus":0.31368035781239245,"score_gpt":0.589727256611743,"score_spread":0.2760468987993505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384560337","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007462213,0.9954189,0.00067991053,0.002320054,0.0003772795,0.000015830705,0.000028399314,0.000019299594,0.0010658497],"genre_scores_gemma":[0.0030356771,0.9851151,0.0017199422,0.007708257,0.0012578819,0.00007377269,0.0000651766,0.000020287742,0.0010039619],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9914766,0.005054799,0.00075455854,0.0007863472,0.0016763972,0.00025120276],"domain_scores_gemma":[0.95709735,0.037700266,0.0022956012,0.00076282176,0.001541811,0.0006022616],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021795414,0.0011319477,0.0035684162,0.002019306,0.0005488165,0.003661375,0.0026295346,0.0042586955,0.009346101],"category_scores_gemma":[0.036955602,0.0007110565,0.0016231308,0.0023551984,0.003933501,0.004957844,0.0025733255,0.008023773,0.0021955892],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003548438,0.000068611924,0.00022190485,0.01458101,0.00027280816,0.00016847985,0.000119888056,0.0006208084,0.00028745914,0.028596077,0.047497783,0.9072103],"study_design_scores_gemma":[0.00042865315,0.00023581018,0.0009358178,0.020596908,0.00047702747,0.0011844606,0.00011061037,0.00035817773,0.00026483563,0.057183936,0.91817546,0.00004821327],"about_ca_topic_score_codex":0.0010888351,"about_ca_topic_score_gemma":0.002760871,"teacher_disagreement_score":0.9782046,"about_ca_system_score_codex":0.0027297228,"about_ca_system_score_gemma":0.0031515004,"threshold_uncertainty_score":0.1152665},"labels":[],"label_agreement":null},{"id":"W4385213278","doi":"10.1038/s41571-023-00802-w","title":"Improving quality and quantity of life for childhood cancer survivors globally in the twenty-first century","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":111,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Survivorship curve; Quality of life (healthcare); Childhood cancer; Cancer; Population; Disease; Clinical trial; Cohort; Cancer survivorship; Health care; Gerontology; Intensive care medicine; Environmental health; Nursing; Pathology; Internal medicine","score_opus":0.23963492726775487,"score_gpt":0.5419280595400113,"score_spread":0.30229313227225646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385213278","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060727107,0.9985281,0.000017936456,0.0010198801,0.00019588467,0.0000012174662,0.000012408886,0.0000023544974,0.00016145073],"genre_scores_gemma":[0.00047303567,0.9987452,0.000046043213,0.00047290188,0.00015367422,0.0000026621185,0.000012363065,5.585609e-7,0.000093530114],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996724,0.00008950925,0.000044949567,0.000042941272,0.000107592765,0.00004258716],"domain_scores_gemma":[0.99894553,0.0005745908,0.00013894653,0.000016078384,0.00020674797,0.00011806226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001227536,0.000814137,0.0017566017,0.00127653,0.0002630657,0.0013340979,0.0006743065,0.0016003723,0.0033238996],"category_scores_gemma":[0.0022309548,0.00019031731,0.00077154534,0.0022590281,0.0006630297,0.0014949569,0.0012430908,0.0023476959,0.00066829234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008277288,0.000050129514,0.00043803809,0.029924532,0.00023902912,0.000056164186,0.00012338323,0.00031222327,0.00035928542,0.0051112454,0.038477845,0.92482525],"study_design_scores_gemma":[0.00006105129,0.0001785243,0.0044685015,0.030195327,0.00043085677,0.00045029985,0.00031382736,0.00010748711,0.00018059183,0.0034423063,0.9601329,0.00003824655],"about_ca_topic_score_codex":0.0032870425,"about_ca_topic_score_gemma":0.006962134,"teacher_disagreement_score":0.0033238996,"about_ca_system_score_codex":0.0014033354,"about_ca_system_score_gemma":0.0028567936,"threshold_uncertainty_score":0.011119604},"labels":[],"label_agreement":null},{"id":"W4387253827","doi":"10.1038/s41571-023-00819-1","title":"Heterogeneity and treatment landscape of ovarian carcinoma","year":2023,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":193,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; Princess Margaret Cancer Centre","funders":"","keywords":"Ovarian carcinoma; Malignancy; Ovarian cancer; Medicine; Carcinoma; Targeted therapy; Disease; Genetic heterogeneity; Tumor microenvironment; Cancer research; Oncology; Cancer; Bioinformatics; Internal medicine; Biology; Gene; Genetics; Phenotype","score_opus":0.27561281465262794,"score_gpt":0.5323425707244082,"score_spread":0.2567297560717802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387253827","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006804008,0.99952006,0.000020113146,0.00019102359,0.00003968035,0.0000016507215,0.000011771894,0.0000010825768,0.00014660387],"genre_scores_gemma":[0.0009739515,0.99860364,0.000039414837,0.00023063303,0.00007005579,0.0000029816856,0.00001963977,6.143768e-7,0.000059074522],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994647,0.00018488243,0.000095947486,0.00008352519,0.00012960863,0.000041408657],"domain_scores_gemma":[0.99899143,0.0006926624,0.00016835814,0.000017792096,0.000098410565,0.00003131607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012962155,0.00046710114,0.0020222939,0.0020222045,0.00016163023,0.0013641963,0.0006971223,0.0007428048,0.0025329369],"category_scores_gemma":[0.0026718292,0.00024555039,0.0009164735,0.0029795605,0.00049376336,0.0011863494,0.0009880032,0.0011016238,0.00040689606],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014816392,0.000020959234,0.0005153297,0.06309276,0.0007151718,0.000103223414,0.000092095564,0.0004966646,0.00036686278,0.0029039495,0.015452374,0.91609246],"study_design_scores_gemma":[0.00015651135,0.00021702796,0.0062500094,0.068817884,0.0035534604,0.0015631603,0.0002929278,0.00021469886,0.0002642284,0.0064432174,0.912177,0.000049793427],"about_ca_topic_score_codex":0.0025697849,"about_ca_topic_score_gemma":0.0057926266,"teacher_disagreement_score":0.0025697849,"about_ca_system_score_codex":0.0010944158,"about_ca_system_score_gemma":0.00197576,"threshold_uncertainty_score":0.0084735155},"labels":[],"label_agreement":null},{"id":"W4390616641","doi":"10.1038/s41571-023-00857-9","title":"‘Contribution of component’ and the perioperative immune-checkpoint inhibitor precedent","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Pembrolizumab; Perioperative; Medicine; Adjuvant; Oncology; Stage (stratigraphy); Lung cancer; Internal medicine; Population; Neoadjuvant therapy; Immunotherapy; Intensive care medicine; Surgery; Cancer; Biology","score_opus":0.08469361818736132,"score_gpt":0.4895845095704079,"score_spread":0.40489089138304657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390616641","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000971055,0.99575496,0.00023658342,0.002072243,0.0009808305,0.0000035757935,0.000011123091,0.0000040265422,0.0008395742],"genre_scores_gemma":[0.002022324,0.9893072,0.000457627,0.0049153487,0.0025522218,0.000014186197,0.000032616415,0.0000049269165,0.00069358386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993536,0.00021381947,0.00010730917,0.00012461469,0.00014722852,0.000053347663],"domain_scores_gemma":[0.99764794,0.0017500249,0.00019471915,0.000066354434,0.0002755521,0.000065382046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027419743,0.0007003366,0.001452349,0.0010524994,0.00028933072,0.0019788248,0.0013859604,0.0027460365,0.003474443],"category_scores_gemma":[0.004814448,0.00031096608,0.0007901856,0.0011291342,0.0016309934,0.003129339,0.0012295904,0.005738952,0.0015079438],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003577383,0.000084045256,0.0003014509,0.01931008,0.00022290356,0.00037158479,0.0001328516,0.0005156804,0.001276023,0.043514863,0.06363633,0.87027645],"study_design_scores_gemma":[0.000064441476,0.00013473607,0.00048942305,0.008841257,0.0001637351,0.0011067259,0.000050297473,0.00010721105,0.00043147072,0.009710827,0.97887796,0.000021900576],"about_ca_topic_score_codex":0.0009840656,"about_ca_topic_score_gemma":0.001791147,"teacher_disagreement_score":0.003474443,"about_ca_system_score_codex":0.0011440667,"about_ca_system_score_gemma":0.0025801074,"threshold_uncertainty_score":0.014501154},"labels":[],"label_agreement":null},{"id":"W4391248735","doi":"10.1038/s41571-024-00861-7","title":"Combination strategies for advanced-stage urothelial carcinoma: a paradigm shift","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Urothelial carcinoma; Context (archaeology); Metastatic Urothelial Carcinoma; Stage (stratigraphy); Medicine; Oncology; Paradigm shift; First line; Chemotherapy; Internal medicine; Bladder cancer; Cancer; Cyclophosphamide","score_opus":0.1680158617999199,"score_gpt":0.528506426900634,"score_spread":0.3604905651007141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391248735","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000114201175,0.99864584,0.0001459796,0.000437474,0.00018568368,0.0000059408408,0.000015262762,0.00000574357,0.0004438247],"genre_scores_gemma":[0.0012098514,0.9973031,0.00035334317,0.0006079994,0.0002050525,0.000011362276,0.00003132531,0.000002426396,0.00027550472],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996617,0.000105252424,0.00004322394,0.00006186491,0.000089631896,0.000038338392],"domain_scores_gemma":[0.9993318,0.00042819214,0.000080852435,0.000014342592,0.00010793414,0.000036788817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013579521,0.0009326213,0.0029086873,0.0014753381,0.00022975061,0.0015062375,0.0010988713,0.0011208155,0.0055546244],"category_scores_gemma":[0.0012306026,0.0003439762,0.001593161,0.0013273496,0.00055651384,0.002124872,0.0009878554,0.003605629,0.0012609155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002369216,0.00010101533,0.00014424049,0.026655013,0.00034696562,0.000114610426,0.00005463444,0.0005738421,0.0010171885,0.0043685343,0.019575303,0.94681174],"study_design_scores_gemma":[0.00036959394,0.0008763841,0.0012350432,0.018398631,0.0011749403,0.0012570431,0.00013253724,0.0004674082,0.0005453927,0.0059629823,0.9695265,0.000053412332],"about_ca_topic_score_codex":0.0008836843,"about_ca_topic_score_gemma":0.0030250049,"teacher_disagreement_score":0.0055546244,"about_ca_system_score_codex":0.00075461017,"about_ca_system_score_gemma":0.0011384245,"threshold_uncertainty_score":0.018582046},"labels":[],"label_agreement":null},{"id":"W4391954183","doi":"10.1038/s41571-024-00863-5","title":"Targeting ATR in patients with cancer","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"DNA Repair Mechanisms","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Telesta Therapeutics (Canada)","funders":"","keywords":"Medicine; DNA damage; Biomarker; Kinase; DNA repair; Cancer; Computational biology; Bioinformatics; Cancer research; Biology; DNA; Genetics","score_opus":0.053497314054840095,"score_gpt":0.4625624470275212,"score_spread":0.4090651329726811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391954183","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006725018,0.99793565,0.00015599762,0.0005610588,0.00028842778,0.0000050100134,0.000022002412,0.000011972124,0.00095258956],"genre_scores_gemma":[0.00064621575,0.9972705,0.00021838483,0.0007145194,0.00031664,0.000008778527,0.000044859622,0.0000028693962,0.0007772525],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99982005,0.000042633234,0.000016244589,0.000034993438,0.00006531203,0.000020803178],"domain_scores_gemma":[0.99965394,0.00019652265,0.000040834555,0.000010805695,0.00006326516,0.00003463942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007879167,0.00090926,0.0014693765,0.0011903453,0.00020868283,0.00077760534,0.0008800702,0.0011150663,0.0037922468],"category_scores_gemma":[0.0010445287,0.00023544024,0.0004834678,0.0010538403,0.00042235825,0.0007901953,0.00071683025,0.0028461586,0.002137485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011915591,0.000051644747,0.00010560717,0.005565831,0.00007094323,0.00008274361,0.000016331389,0.0003767898,0.0011262493,0.0024271347,0.051900323,0.9381573],"study_design_scores_gemma":[0.00010755833,0.00014970184,0.000718542,0.0037343598,0.00016115511,0.0007249014,0.000024292713,0.00016840837,0.0004199727,0.0026135517,0.9911584,0.000019062876],"about_ca_topic_score_codex":0.00074662,"about_ca_topic_score_gemma":0.0023463638,"teacher_disagreement_score":0.0037922468,"about_ca_system_score_codex":0.0005264116,"about_ca_system_score_gemma":0.0006529615,"threshold_uncertainty_score":0.012686372},"labels":[],"label_agreement":null},{"id":"W4392982551","doi":"10.1038/s41571-024-00882-2","title":"Identification of dynamic microbiota signatures in patients with melanoma receiving ICIs: opportunities and challenges","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"","keywords":"Microbiome; Melanoma; Computational biology; Gut flora; Gut microbiome; Identification (biology); Immunology; Biology; Medicine; Bioinformatics; Ecology; Cancer research","score_opus":0.13806588119189953,"score_gpt":0.4500587480147986,"score_spread":0.31199286682289906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392982551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081556255,0.99678135,0.0002509818,0.0013105621,0.00020916486,0.0000057790558,0.000052062718,0.000008366138,0.0005660767],"genre_scores_gemma":[0.011759346,0.98443246,0.00091051956,0.0014639637,0.0007347399,0.000021057565,0.0001646367,0.0000040235623,0.0005093271],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99971384,0.00009003324,0.000033667133,0.000048315014,0.00007936159,0.000034728517],"domain_scores_gemma":[0.99941754,0.0002742822,0.00009959379,0.000015518084,0.00015990793,0.000033140182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077386264,0.00043601857,0.0013413848,0.00054859114,0.000117488766,0.0011734728,0.0004197479,0.00066046196,0.0012361701],"category_scores_gemma":[0.0014667378,0.00012887998,0.0006429502,0.0007153422,0.00024267714,0.0007596583,0.0005788363,0.0013850499,0.0004684337],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020957795,0.000044385324,0.0031305968,0.005020066,0.00023645152,0.000102911596,0.000043865162,0.00017151498,0.0015055876,0.0013940227,0.013341687,0.9747993],"study_design_scores_gemma":[0.00017490819,0.00058160565,0.027466707,0.0133936005,0.0013382257,0.0025153111,0.00046034486,0.0008657695,0.0018985415,0.0068291496,0.9443918,0.00008413927],"about_ca_topic_score_codex":0.0008624377,"about_ca_topic_score_gemma":0.0019639716,"teacher_disagreement_score":0.0013413848,"about_ca_system_score_codex":0.00034357244,"about_ca_system_score_gemma":0.0008922193,"threshold_uncertainty_score":0.00413543},"labels":[],"label_agreement":null},{"id":"W4394689596","doi":"10.1038/s41571-024-00886-y","title":"Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":98,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Clinical trial; Immune system; Blockade; Vascular endothelial growth factor; Aflibercept; Cancer research; Angiogenesis; Pharmacology; Bevacizumab; Oncology; Immunology; VEGF receptors; Internal medicine; Chemotherapy; Receptor","score_opus":0.2805150098880188,"score_gpt":0.5924041186574771,"score_spread":0.3118891087694583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394689596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035382967,0.99495584,0.0004507365,0.0017264709,0.0006611493,0.00003098923,0.000115841634,0.000025227002,0.0016799528],"genre_scores_gemma":[0.0026983083,0.99117905,0.00081809465,0.0031457285,0.00056076347,0.00006348525,0.0002196484,0.0000152009015,0.0012997049],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995535,0.00013109067,0.00004939218,0.00007281044,0.00013571605,0.000057350928],"domain_scores_gemma":[0.99848133,0.000969464,0.00012619433,0.000037989037,0.00023998482,0.00014509344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028142568,0.0012508646,0.0025767437,0.0008114954,0.00021265466,0.0018861541,0.0014486436,0.00144619,0.005060404],"category_scores_gemma":[0.003015415,0.0002736348,0.0012618538,0.0009387316,0.0006184469,0.00152393,0.0007262899,0.005036472,0.0017558595],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071576517,0.00019314853,0.00015928957,0.0074256584,0.0003412353,0.00013544025,0.00003278379,0.0008239684,0.0012644674,0.0041858796,0.07241751,0.9123049],"study_design_scores_gemma":[0.0012986289,0.0010161521,0.0009984185,0.007802124,0.00069253833,0.0007534091,0.000051662617,0.00033028726,0.0007223648,0.004935279,0.9813638,0.00003539701],"about_ca_topic_score_codex":0.0009962,"about_ca_topic_score_gemma":0.00322546,"teacher_disagreement_score":0.005060404,"about_ca_system_score_codex":0.0009870736,"about_ca_system_score_gemma":0.001425342,"threshold_uncertainty_score":0.016928732},"labels":[],"label_agreement":null},{"id":"W4397023159","doi":"10.1038/s41571-024-00904-z","title":"Epidemiology of HPV-associated cancers past, present and future: towards prevention and elimination","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"World Health Organization","keywords":"Epidemiology; Medicine; Cervical cancer; Cancer prevention; HPV infection; HPV vaccines; Cancer; Psychological intervention; Incidence (geometry); Epidemiology of cancer; Vaccination; Disease; Causes of cancer; Oncology; Immunology; Gynecology; Internal medicine; Breast cancer","score_opus":0.2954926588836861,"score_gpt":0.6092025723175984,"score_spread":0.31370991343391236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4397023159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000046162044,0.99922025,0.00005998274,0.00034952423,0.000105485546,0.0000023863797,0.000026406795,0.000003001234,0.00018675883],"genre_scores_gemma":[0.000406754,0.9991627,0.00008884311,0.00012973008,0.00009963449,0.0000025937663,0.000019621702,4.709332e-7,0.000089738416],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99944526,0.00013254519,0.000093484436,0.00009771145,0.00018785027,0.000043107975],"domain_scores_gemma":[0.99879897,0.0006635448,0.000209065,0.000022582615,0.00026091564,0.00004498376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012420677,0.0008807351,0.0021477123,0.0023823061,0.00021502055,0.0014978788,0.0011459723,0.0013386734,0.0035251284],"category_scores_gemma":[0.0024413595,0.00038961315,0.0009850768,0.003000137,0.0005290966,0.0020953463,0.00084919995,0.0018469829,0.0010814242],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008321948,0.000038859976,0.0011830851,0.04604596,0.00033974616,0.00007913158,0.0000991021,0.00047625616,0.00043197398,0.003858166,0.026249142,0.9211154],"study_design_scores_gemma":[0.000035303565,0.00015448491,0.0069054784,0.053337596,0.001222391,0.0012919939,0.00035656584,0.00028135095,0.00028804413,0.004863562,0.93119574,0.00006750504],"about_ca_topic_score_codex":0.005811104,"about_ca_topic_score_gemma":0.009340342,"teacher_disagreement_score":0.005811104,"about_ca_system_score_codex":0.001272187,"about_ca_system_score_gemma":0.0027981915,"threshold_uncertainty_score":0.011792779},"labels":[],"label_agreement":null},{"id":"W4400279736","doi":"10.1038/s41571-024-00913-y","title":"Just scratching the surface: novel treatment approaches for multiple myeloma targeting cell membrane proteins","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Scratching; Multiple myeloma; Cell; Membrane protein; Cancer research; Membrane; Chemistry; Medicine; Cell biology; Biology; Immunology; Materials science; Biochemistry","score_opus":0.2146654647075981,"score_gpt":0.45244591242351617,"score_spread":0.23778044771591808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400279736","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006853066,0.998459,0.0002538779,0.0003470606,0.00035264922,0.0000053264002,0.000016765533,0.000013660705,0.00048310249],"genre_scores_gemma":[0.0005603962,0.99749076,0.00028958495,0.0005318948,0.0002254821,0.0000099467725,0.000043213404,0.0000032388025,0.00084549375],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997093,0.000037969654,0.000024848965,0.00004276304,0.00014602389,0.00003908374],"domain_scores_gemma":[0.9996816,0.00015210039,0.000039804454,0.00001095692,0.00008257063,0.00003299147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088782824,0.0013480335,0.0017740367,0.0016515778,0.0002929078,0.0014826519,0.0012985169,0.001840722,0.002783138],"category_scores_gemma":[0.0008067475,0.0003633404,0.00073623774,0.0015246593,0.0007582909,0.0016324959,0.00086204376,0.0039440617,0.0024403736],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017457857,0.000111483656,0.000084516694,0.009471264,0.00011701707,0.00014223787,0.000034189805,0.00057727005,0.004405883,0.0049127135,0.07927835,0.9006905],"study_design_scores_gemma":[0.000067885914,0.00014386777,0.0003659454,0.0013781697,0.000116662115,0.0006964503,0.000023163106,0.00017027027,0.0010724178,0.002047942,0.9938933,0.000023744129],"about_ca_topic_score_codex":0.0012747693,"about_ca_topic_score_gemma":0.0032405807,"teacher_disagreement_score":0.002783138,"about_ca_system_score_codex":0.0010887323,"about_ca_system_score_gemma":0.00088135124,"threshold_uncertainty_score":0.009310544},"labels":[],"label_agreement":null},{"id":"W4403032713","doi":"10.1038/s41571-024-00945-4","title":"Two decades of advances in clinical oncology — lessons learned and future directions","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Diabetes and Digestive and Kidney Diseases; University of Texas MD Anderson Cancer Center; Labex Immuno-Oncology; National Institutes of Health; Universitätsklinikum Heidelberg; Medac; Institut Gustave-Roussy; European Organisation for Research and Treatment of Cancer; Fondation pour la Recherche Médicale; European Commission; Ministerio de Ciencia e Innovación; Ligue Contre le Cancer; Generalitat de Catalunya; Fundación Científica Asociación Española Contra el Cáncer; National Cancer Institute; HORIZON EUROPE Framework Programme; Servier; Agència de Gestió d'Ajuts Universitaris i de Recerca; Novocure; Institut National Du Cancer; Prostate Cancer Foundation; Memorial Sloan-Kettering Cancer Center; Institut National de la Santé et de la Recherche Médicale; Ministère des Solidarités et de la Santé; Agence Nationale de la Recherche; Direction Générale de l’offre de Soins; U.S. Department of Defense; Associazione Italiana per la Ricerca sul Cancro; Seerave Foundation; Institut Universitaire de France; Pfizer; Cancer Research UK","keywords":"Medicine; Clinical Oncology; Oncology; MEDLINE; Internal medicine; Medical physics; Cancer","score_opus":0.13743282181576305,"score_gpt":0.5681612698389262,"score_spread":0.4307284480231632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403032713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004738582,0.9954254,0.00012761062,0.0028372365,0.0010374419,0.0000020656455,0.000018275587,0.000009160684,0.0004955177],"genre_scores_gemma":[0.0005126986,0.99436176,0.00021141995,0.0028643252,0.0014371792,0.000006436716,0.00003981281,0.000004612,0.00056171865],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991272,0.00021958511,0.000098244636,0.00012830929,0.0003091294,0.00011755136],"domain_scores_gemma":[0.99690264,0.0018455832,0.00020802967,0.00007706785,0.0005954284,0.00037114168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036514197,0.0012297255,0.002315634,0.0018769617,0.0004579932,0.0032053525,0.0015640915,0.0029384955,0.0065159705],"category_scores_gemma":[0.005264107,0.00041395743,0.000830701,0.0024707173,0.0017478267,0.0046637766,0.0021733223,0.005948531,0.002831657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002380661,0.000067180306,0.00021830823,0.010743039,0.00012073017,0.0002077852,0.0001002821,0.0005125654,0.0006844025,0.013704213,0.14430623,0.8290972],"study_design_scores_gemma":[0.000040686464,0.000068588495,0.00037317988,0.0048353667,0.00007935769,0.0004484785,0.00009491615,0.000084758016,0.0001216844,0.0056992616,0.9881323,0.000021436439],"about_ca_topic_score_codex":0.001609991,"about_ca_topic_score_gemma":0.00384774,"teacher_disagreement_score":0.0065159705,"about_ca_system_score_codex":0.0018358739,"about_ca_system_score_gemma":0.0039429134,"threshold_uncertainty_score":0.021798134},"labels":[],"label_agreement":null},{"id":"W4404058850","doi":"10.1038/s41571-024-00964-1","title":"On the cusp of targeted therapy for cancer cachexia — what clinical benefits might we promise our patients?","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer cachexia; Cachexia; Cancer therapy; Oncology; Targeted therapy; Internal medicine; MEDLINE; Cancer; Intensive care medicine","score_opus":0.42064440673630255,"score_gpt":0.6163134491502561,"score_spread":0.19566904241395355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404058850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000035813813,0.99633044,0.000036345027,0.00271834,0.0005593927,0.000001933434,0.00001443168,0.000004010301,0.00029932024],"genre_scores_gemma":[0.00036949554,0.9961893,0.00008836139,0.0023403035,0.0006921897,0.000004463907,0.000017894528,0.0000017096351,0.0002962564],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951863,0.00015887685,0.000055268498,0.000051632524,0.00016291229,0.000052682022],"domain_scores_gemma":[0.9985514,0.00084216334,0.00014992688,0.000031739204,0.00030599697,0.00011864062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002207287,0.0007673531,0.0029414573,0.0013278004,0.0004122965,0.0022045516,0.001511515,0.0024660127,0.0059575066],"category_scores_gemma":[0.0030292645,0.0003239707,0.0008835559,0.0015389395,0.0011749169,0.003803699,0.0013656158,0.0055991937,0.002514559],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000337829,0.00008092214,0.00021924412,0.02191913,0.00033951655,0.00017049852,0.000095063304,0.00033752754,0.00087241817,0.012835744,0.1268569,0.8359352],"study_design_scores_gemma":[0.00010251117,0.0001359719,0.0006229998,0.012821824,0.00023021348,0.0003650214,0.00013834581,0.00010017766,0.000111382906,0.007471315,0.9778692,0.000031015134],"about_ca_topic_score_codex":0.0016701635,"about_ca_topic_score_gemma":0.005058611,"teacher_disagreement_score":0.0059575066,"about_ca_system_score_codex":0.0009774487,"about_ca_system_score_gemma":0.0021330877,"threshold_uncertainty_score":0.019929886},"labels":[],"label_agreement":null},{"id":"W4404940657","doi":"10.1038/s41571-024-00966-z","title":"Synthetic lethal strategies for the development of cancer therapeutics","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":61,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Mount Sinai Hospital; Lunenfeld-Tanenbaum Research Institute; Telesta Therapeutics (Canada)","funders":"","keywords":"Synthetic lethality; CRISPR; Medicine; Computational biology; Epigenetics; Drug discovery; Bioinformatics; DNA repair; Biology; Genetics; DNA; Gene","score_opus":0.15958765689535367,"score_gpt":0.5725352650957538,"score_spread":0.4129476082004001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404940657","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000930639,0.99615896,0.0012578985,0.0004754908,0.0003602876,0.000008238492,0.000025900896,0.00003361284,0.001586564],"genre_scores_gemma":[0.0010559859,0.9962603,0.00076559884,0.00036677264,0.00020904256,0.000013810157,0.000059596274,0.0000061518294,0.0012628147],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99962497,0.00007167526,0.000027284264,0.00004640103,0.00017944253,0.000050165207],"domain_scores_gemma":[0.9996562,0.00019184766,0.00004047991,0.000015758407,0.00006121069,0.000034433382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011208283,0.0013951136,0.0014483111,0.0020637352,0.0002913859,0.0014108133,0.0015814579,0.0015962799,0.0042985757],"category_scores_gemma":[0.0008637955,0.00038451544,0.0005833221,0.0016397724,0.0012244921,0.0013433811,0.001202996,0.0039834827,0.0024481416],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104534825,0.00009906214,0.00006630933,0.008507092,0.00009341193,0.00022605291,0.000043364875,0.0009107418,0.009079394,0.02408363,0.05798028,0.89880615],"study_design_scores_gemma":[0.000035158548,0.000077387725,0.00016763466,0.0010122205,0.000055257693,0.0005856314,0.000015994703,0.00014434112,0.0020523344,0.0050319377,0.99080163,0.000020494113],"about_ca_topic_score_codex":0.0010182007,"about_ca_topic_score_gemma":0.001873193,"teacher_disagreement_score":0.0042985757,"about_ca_system_score_codex":0.0012085935,"about_ca_system_score_gemma":0.0009944557,"threshold_uncertainty_score":0.014380157},"labels":[],"label_agreement":null},{"id":"W4405250040","doi":"10.1038/s41571-024-00970-3","title":"Leptomeningeal metastatic disease: new frontiers and future directions","year":2024,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Medicine; Clinical trial; Disease; Cancer; Intensive care medicine; Leptomeninges; Oncology; Pathology; Internal medicine; Central nervous system","score_opus":0.1472500419084576,"score_gpt":0.5315277315165922,"score_spread":0.3842776896081346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405250040","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043402557,0.99856985,0.00006934855,0.0005306543,0.00026012168,0.0000023153052,0.000015352443,0.000005414323,0.0005036703],"genre_scores_gemma":[0.00032122296,0.99864286,0.00009096613,0.00037437424,0.00027738168,0.0000031300592,0.000019591324,0.0000010327166,0.00026951527],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99976665,0.000055552697,0.000026475565,0.00003700897,0.00008242188,0.000031804506],"domain_scores_gemma":[0.9992848,0.00039587356,0.000077235156,0.000014702022,0.00015402451,0.00007345671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009579284,0.0008592563,0.0018898607,0.0015473857,0.00025255344,0.0018115221,0.0010636527,0.0013941096,0.0064616986],"category_scores_gemma":[0.0014446789,0.00024093514,0.00061995356,0.0018058848,0.0006868401,0.0017402082,0.0009157634,0.0024800461,0.0020867605],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011733523,0.00004888691,0.00013988146,0.016368015,0.00009665255,0.0001587267,0.000047080706,0.00052651844,0.0008034536,0.004070715,0.060243484,0.9173792],"study_design_scores_gemma":[0.000044578766,0.00009345863,0.0004992226,0.007310092,0.00018255954,0.000744974,0.00007874134,0.00015404535,0.00013287748,0.002952133,0.98778486,0.000022390252],"about_ca_topic_score_codex":0.0014763831,"about_ca_topic_score_gemma":0.0048883623,"teacher_disagreement_score":0.0064616986,"about_ca_system_score_codex":0.00085934065,"about_ca_system_score_gemma":0.0018987418,"threshold_uncertainty_score":0.021616578},"labels":[],"label_agreement":null},{"id":"W4408654141","doi":"10.1038/s41571-025-01013-1","title":"Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Radiosurgery; Medicine; Context (archaeology); Systemic therapy; Clinical trial; Multidisciplinary approach; Brain tumor; Medical physics; Intensive care medicine; Radiation therapy; Internal medicine; Cancer; Pathology","score_opus":0.268919922275821,"score_gpt":0.523161701804245,"score_spread":0.25424177952842403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408654141","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000048634294,0.9991872,0.00006854056,0.00022938,0.00011003422,0.0000023860687,0.000009317671,0.000003978858,0.0003406225],"genre_scores_gemma":[0.00035116693,0.9990331,0.00012950585,0.00021092944,0.00010873064,0.0000028432748,0.000016485168,0.0000010174834,0.00014615853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997621,0.000046630903,0.00003259288,0.000040876967,0.00009445563,0.000023306236],"domain_scores_gemma":[0.99955934,0.00022735729,0.000067856316,0.00000995468,0.000102728365,0.000032855758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087382016,0.0008182536,0.0013600218,0.0016258468,0.00023894325,0.0011786366,0.0009726005,0.00086383376,0.0029979483],"category_scores_gemma":[0.0010331514,0.0002010862,0.00060895225,0.0016899415,0.00050813373,0.001239754,0.00080592156,0.0017615736,0.0011273151],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006475166,0.000033336928,0.00015618185,0.016906388,0.00009691265,0.00008379975,0.000030956922,0.00035613857,0.00065043103,0.0022884521,0.024832303,0.95450044],"study_design_scores_gemma":[0.000051988576,0.0001336764,0.0015942084,0.0125049185,0.00030235248,0.0011897114,0.00008753437,0.0002217239,0.00027734708,0.0030639055,0.9805387,0.00003387474],"about_ca_topic_score_codex":0.0016397607,"about_ca_topic_score_gemma":0.005666839,"teacher_disagreement_score":0.0029979483,"about_ca_system_score_codex":0.0007941982,"about_ca_system_score_gemma":0.0016137263,"threshold_uncertainty_score":0.0100290775},"labels":[],"label_agreement":null},{"id":"W4411094243","doi":"10.1038/s41571-025-01031-z","title":"Surrogate end points in oncology: aligning drug development incentives and patient needs","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Surrogate endpoint; Drug development; Incentive; Oncology; Drug; Internal medicine; Intensive care medicine; Medical physics; Pharmacology","score_opus":0.1841165872883653,"score_gpt":0.47868406450756495,"score_spread":0.2945674772191996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411094243","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002153312,0.9924124,0.0007425367,0.005667,0.00024139856,0.000012674921,0.00004145884,0.0000072721423,0.00065993855],"genre_scores_gemma":[0.009531013,0.9846746,0.0015055278,0.0030497245,0.00080500095,0.000064027,0.00006744097,0.0000078816365,0.00029494756],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99216545,0.005839729,0.00042233084,0.00032151333,0.0010304304,0.00022048957],"domain_scores_gemma":[0.96576446,0.03013213,0.0022460937,0.0002799015,0.0011933396,0.0003840118],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01586563,0.00086216326,0.0035566755,0.0018027759,0.00025020703,0.0026821308,0.0016443626,0.0031165401,0.005179324],"category_scores_gemma":[0.032729138,0.00042166913,0.0014547796,0.0024624013,0.0013137751,0.0030378397,0.0018559166,0.0045925574,0.0007094533],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047787136,0.00010843792,0.0008885275,0.02406039,0.0008916684,0.000083050225,0.000046274206,0.0035157364,0.0001275219,0.046109017,0.026096422,0.8975951],"study_design_scores_gemma":[0.0011255494,0.00066511804,0.0076625943,0.11754265,0.002358696,0.0009940406,0.00026496613,0.0050659166,0.00045415264,0.17042321,0.6932693,0.00017375925],"about_ca_topic_score_codex":0.0019376812,"about_ca_topic_score_gemma":0.004809495,"teacher_disagreement_score":0.9841344,"about_ca_system_score_codex":0.002739614,"about_ca_system_score_gemma":0.005216326,"threshold_uncertainty_score":0.08390647},"labels":[],"label_agreement":null},{"id":"W4412699285","doi":"10.1038/s41571-025-01063-5","title":"Clarifying the role of SONIA: supporting academic evidence on CDK4/6 inhibitor timing","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; MEDLINE; Internal medicine; Oncology","score_opus":0.24823529704736547,"score_gpt":0.5942362198508672,"score_spread":0.3460009228035017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412699285","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011410421,0.9980178,0.00006070412,0.0008837684,0.0002755607,0.00000334445,0.000034678596,0.000004135528,0.00060598995],"genre_scores_gemma":[0.0020894494,0.9958169,0.00014544842,0.0011400415,0.0003984604,0.000009093725,0.000054559696,0.0000033007232,0.00034278815],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99955076,0.00015716022,0.0000782629,0.0000796551,0.00008942089,0.000044753087],"domain_scores_gemma":[0.9981483,0.0013390669,0.00022461738,0.000036757934,0.00018935562,0.000061956925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018975077,0.00063602027,0.0020080379,0.0012621129,0.0001986373,0.0015980751,0.0012418405,0.0011075542,0.007329052],"category_scores_gemma":[0.003620065,0.00025477313,0.0011944444,0.0012096317,0.0006210477,0.0016726292,0.0008301115,0.0025546327,0.0015356196],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058840605,0.00005336751,0.00041210186,0.03113416,0.0006344428,0.00013759153,0.000057224574,0.0003957532,0.00072898314,0.0073804557,0.03909061,0.91938686],"study_design_scores_gemma":[0.0003816,0.00032624556,0.001637272,0.017896613,0.0013214962,0.0007816546,0.00008109734,0.00018170878,0.00052975444,0.006147527,0.9706824,0.000032640008],"about_ca_topic_score_codex":0.0011665463,"about_ca_topic_score_gemma":0.0032290923,"teacher_disagreement_score":0.007329052,"about_ca_system_score_codex":0.0007600225,"about_ca_system_score_gemma":0.0017255668,"threshold_uncertainty_score":0.024518132},"labels":[],"label_agreement":null},{"id":"W4413954889","doi":"10.1038/s41571-025-01073-3","title":"Non-financial conflicts of interest","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of British Columbia, Okanagan Campus; Kelowna General Hospital","funders":"","keywords":"Medicine; Conflict of interest; Finance; Economics","score_opus":0.8569446025520843,"score_gpt":0.740936353755192,"score_spread":0.11600824879689231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413954889","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0038501346,0.41862047,0.007868174,0.0731823,0.09298662,0.001598738,0.009201689,0.0010884401,0.39160338],"genre_scores_gemma":[0.08016465,0.27135894,0.010625025,0.044621523,0.044565234,0.0033706643,0.0102191605,0.0003766706,0.534698],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975146,0.00045481103,0.00021016481,0.0003285254,0.0011076456,0.0003842672],"domain_scores_gemma":[0.99447143,0.0013224276,0.000924923,0.00026048772,0.0018673822,0.0011533411],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0027562983,0.00086780277,0.0013278269,0.00067301345,0.00066474563,0.0020869204,0.0016478153,0.0030001826,0.14958818],"category_scores_gemma":[0.010082864,0.00037933377,0.00062737695,0.00096638955,0.0009114844,0.0010928988,0.0034942217,0.0018122593,0.054927785],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028155596,0.00015408613,0.000626382,0.0051570865,0.000094586765,0.0010608041,0.00019876756,0.00012492933,0.0027139548,0.013362474,0.52997893,0.44624645],"study_design_scores_gemma":[0.00015741364,0.00008724868,0.00075602694,0.0013951651,0.000042796913,0.0011103813,0.000093171155,0.00008945258,0.00024933013,0.0013333659,0.9946749,0.000010690181],"about_ca_topic_score_codex":0.0009157752,"about_ca_topic_score_gemma":0.00167418,"teacher_disagreement_score":0.9972437,"about_ca_system_score_codex":0.00085233594,"about_ca_system_score_gemma":0.006646689,"threshold_uncertainty_score":0.50042236},"labels":[],"label_agreement":null},{"id":"W4414782587","doi":"10.1038/s41571-025-01083-1","title":"Author Correction: Stereotactic radiosurgery for patients with brain metastases: current principles, expanding indications and opportunities for multidisciplinary care","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Hospital for Sick Children","funders":"","keywords":"Radiosurgery; Multidisciplinary approach; Current (fluid); MEDLINE; Multidisciplinary team","score_opus":0.271412466987298,"score_gpt":0.5238763999248607,"score_spread":0.2524639329375627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414782587","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006416051,0.013686237,0.00036572394,0.04099996,0.9419777,0.000021019441,0.00027115823,0.0001326018,0.0024813802],"genre_scores_gemma":[0.0080561945,0.09157059,0.0033478856,0.10699947,0.6772949,0.0001779134,0.0008508051,0.00060170173,0.11110045],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969117,0.00056648586,0.00049564574,0.00037208598,0.0013702149,0.00028383147],"domain_scores_gemma":[0.9861314,0.0029950538,0.0012126898,0.0006476332,0.008021565,0.0009916355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032633413,0.0011572889,0.0018400826,0.0027543802,0.0011822208,0.0027928927,0.002647136,0.0051739807,0.03590865],"category_scores_gemma":[0.029567575,0.00057234307,0.0013326083,0.0018646005,0.0017892792,0.0019164426,0.002046866,0.007197344,0.02351854],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021477885,0.0000033994004,0.000038570557,0.000584274,0.00001192424,0.00016930906,0.000018435738,0.00004752162,0.00004040915,0.0006162277,0.97688895,0.021559538],"study_design_scores_gemma":[0.000030121619,0.000015977696,0.0002645027,0.00085222785,0.000028904677,0.00093087903,0.000032045187,0.000069324895,0.00011667552,0.00083984784,0.99680126,0.00001813958],"about_ca_topic_score_codex":0.0040331446,"about_ca_topic_score_gemma":0.009259886,"teacher_disagreement_score":0.03590865,"about_ca_system_score_codex":0.0018557282,"about_ca_system_score_gemma":0.0059002717,"threshold_uncertainty_score":0.12012637},"labels":[],"label_agreement":null},{"id":"W4414976681","doi":"10.1038/s41571-025-01080-4","title":"Unresectable stage III non-small-cell lung cancer: state of the art and challenges","year":2025,"lang":"en","type":"review","venue":"Nature Reviews Clinical Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Chemoimmunotherapy; Durvalumab; Stage (stratigraphy); Radiation therapy; Chemoradiotherapy; Immunotherapy; Clinical trial; Lung cancer","score_opus":0.10519094712061199,"score_gpt":0.48397862658316976,"score_spread":0.37878767946255776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414976681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004342396,0.9990061,0.00004403499,0.00044626612,0.00015244211,0.0000016180198,0.000012622434,0.0000034182895,0.00029002462],"genre_scores_gemma":[0.00042609734,0.99875975,0.000071627015,0.00036018528,0.00020739787,0.000002520718,0.000019584315,0.000001037791,0.00015184727],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999696,0.00007610915,0.000040687584,0.00004926157,0.000104367035,0.000033620523],"domain_scores_gemma":[0.99899584,0.0006163277,0.000116498966,0.000017380451,0.00018518417,0.00006878987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011967301,0.0005945199,0.0020378432,0.0011737339,0.0001985994,0.0013832893,0.0009918739,0.0009870408,0.004114942],"category_scores_gemma":[0.0016891082,0.00023496551,0.0006983246,0.0013769895,0.0005598571,0.0017859072,0.00080889254,0.0017669114,0.0014503319],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067385656,0.000026603688,0.00020347384,0.016789924,0.00007816842,0.00006714791,0.000030439467,0.0003121163,0.0004243154,0.0025009674,0.035144877,0.94435465],"study_design_scores_gemma":[0.00003293387,0.000121912446,0.0010006467,0.012560915,0.00020719266,0.0007055849,0.0000849048,0.00018336778,0.0001357796,0.0024476498,0.9824965,0.000022548782],"about_ca_topic_score_codex":0.0013806932,"about_ca_topic_score_gemma":0.005050906,"teacher_disagreement_score":0.004114942,"about_ca_system_score_codex":0.0006912032,"about_ca_system_score_gemma":0.0015197941,"threshold_uncertainty_score":0.0137658715},"labels":[],"label_agreement":null}]}